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CHAPTER 1: INTRODUCTION 
 
 
1 
 
 
1.1. INFLAMMATION 
 
Inflammation is an important physiological reaction which occurs in response to a 
wide variety of injurious agents (e.g. bacterial infection, physical trauma, chemicals 
or any other phenomenon) ultimately aiming to perform the dual function of limiting 
damage and promoting tissue repair (Nathan, 2002). Inﬂammatory processes are 
required for immune surveillance, optimal repair, and regeneration after injury 
(Vodovotz et al., 2008). The inflammatory process protects our body from diseases by 
releasing cells and mediators that combat foreign substances and prevent infection 
(Frank and Fries, 1991; El-Gamal et al., 2010). However, sustained, excessive or 
inappropriate inﬂammation is the cause of numerous diseases including rheumatoid 
arthritis, psoriasis and inﬂammatory bowel disease (Franklin et al., 2008). 
Inﬂammation is a major component of the damage caused by autoimmune diseases, 
and is a fundamental contributor of various infectious and non-infectious diseases 
such as cancer, diabetes, cardiovascular disease, rheumatoid arthritis, Alzheimer’s and 
arteriosclerosis. Depending on the intensity of this process, mediators generated in the 
inflammatory site can reach the circulation and cause fever (Lucas et al., 2006; 
Kassuya et al., 2009).  
 
Inflammation is a complex pathophysiological process mediated by a variety of 
signalling molecules produced by leucocytes, macrophages and mast cells undergoing 
various cellular responses such as phagocytic uptake, and the production of 
inflammatory mediators such as nitric oxide (NO), prostaglandin E2 (PGE2) and 
tumour necrosis factor (TNF)-α (Kinne et al., 2000; Yu et al., 2010), that bring about 
edema formation as a result of extravasation of fluid and proteins and accumulation of 
leucocytes at the inflammatory site (White, 1999). In addition, it is broadly accepted 
that cytokines, produced by either immune or central nervous system cells, might 
directly sensitize the peripheral nociceptors (Obreja et al., 2002). 
 
Inflammation is an important cellular response triggered by various mechanical, 
chemical or immunological stress factors and it is regulated by a delicate balance 
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between local factors that finally determine the outcome of the disease process: 
progression or resolution. The inflammatory response is a complex and highly 
regulated sequence of events that start with an initial production of pro-inflammatory 
mediators that recruit professional inflammatory cells to the site of injury to clear the 
offending trigger (Huwiler and Pfeilschifter, 2009). This is followed by an anti-
inflammatory phase, in which resident tissue cells may acquire the potential for 
protecting themselves from further activation and injury.  
 
More recently, inflammation was described as “the succession of changes which 
occurs in a living tissue when it is injured provided that the injury is not of such a 
degree as to at once destroy its structure and vitality” or “the reaction to injury of the 
living microcirculation and related tissues” (Spector and Willoughby, 1963). 
Although, in ancient times inflammation was recognised as being part of the healing 
process, up to the end of the 19th century, inflammation was viewed as being an 
undesirable response that was harmful to the host.  
 
Based on visual observation, the ancients characterised inflammation by five cardinal 
signs, namely redness (rubor), swelling (tumour), heat (calor; only applicable to the 
body extremities), pain (dolor) and loss of function (functio laesa). The first four of 
these signs named by Celsus in ancient Rome (30-38 B.C.) and the last by Galen 
(A.D. 130-200) (Hurley, 1972). 
 
The classical description of inflammation accounts for the visual changes seen. The 
sensation of heat is caused by the increased movement of blood through dilated 
vessels into the environmentally cooled extremities. Redness is due to the additional 
number of erythrocytes passing through the area. Swelling (edema) is the result of 
increased passage of fluid from dilated and permeable blood vessels into the 
surrounding tissues, infiltration of cells into the damaged area, and in prolonged 
inflammatory responses deposition of connective tissue. Pain is due to the direct 
effects of mediators, either from initial damage or that resulting of sensory nerves due 
to oedema. Loss of function refers to either simple loss of mobility in a joint, due to 
the oedema and pain, or to the replacement of functional cells with scar tissue. 
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Inflammatory process has two phases: acute and chronic. Acute and chronic 
inflammations are known to be complicated processes induced by several different 
classes of chemical mediators, e.g. prostaglandins, leukotrienes and platelet-activating 
factor, etc. Anti inflammatory agents exert their effect through a spectrum of different 
modes of action (Samuelsson et al., 1978).  
 
Acute inflammatory response is characterized by an increase in vascular permeability 
and cellular infiltration leading to oedema formation as a result of extravasation of 
fluid and proteins and accumulation of leukocytes at the inflammatory site for short 
time (Posadas et al., 2004). 
 
Chronic inflammation is the reaction arising when the acute response is insufficient to 
eliminate the pro-inflammatory agents. Chronic inflammation includes a proliferation 
of fibroblasts and infiltration of neutrophils with exudation of fluid. It occurs by 
means of development of proliferative cells which can either spread or form 
granuloma. Chronic inﬂammation may also occur due to the persistence of infection 
or antigen, recurring tissue injury, or a failure of endogenous anti-inﬂammatory 
mechanisms. 
 
Chronic (or acute) inﬂammation is a multiple process mediated by activating 
inﬂammatory or immune cells (Lundberg, 2000),  among  which macrophages play a 
central role in managing many different immunopathological phenomena including 
the overproduction of proinﬂammatory cytokines and inﬂammatory mediators, 
generated by activated iNOS and COX-2 (Walsh, 2003). Under inﬂammatory 
conditions, immune cells are also stimulated by adhesion molecule activation signals 
in order to enhance the migration capacity to inﬂamed tissue and ﬁnally to form 
heterotypic cell clustering between the immune cells, endothelial cells and inﬂamed 
cells (Tao et al., 2009).  
 
Macrophages in the inflammatory reaction initially requires an interaction between 
surface receptors such as Toll-like receptors (TLR) and stimuli (Takeda and Akira, 
2001), and subsequent up-regulation of intracellular signalling events mediated by 
enzymes such as phosphoinositide 3-kinases (PI3K) and mitogen activated protein 
kinases (MAPKs) as well as transcription factors (e.g., nuclear factor [NF]-κB and 
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activator protein [AP]-1) (Sekine et al., 2006). Overall, these events lead macrophages 
to express pro-inflammatory genes such as inducible NO synthase (iNOS) and 
cyclooxygenase (COX)-2 (Burmester et al., 1997; Bresnihan, 1999). Because large 
amounts of macrophage-derived inflammatory mediators can cause collateral or 
severe damage such as septic shock, rheumatoid arthritis and arteriosclerosis 
(Michaelsson et al., 1995; Stuhlmuller et al., 2000), the effective blockade of these 
inflammatory responses is an important therapeutic target. 
 
Inflammatory diseases are a major cause of morbidity of the work force throughout 
the world. These have been called the “King of Human Miseries” (Chatterjee and Pal, 
1984). Pain is an objectionable sensory and emotional incident associated with actual 
or potential tissue inflammation. Pyrexia or fever is caused as a secondary impact of 
inflammation (Khan et al., 2007). Inflammation, pain and fever are all associated with 
enhanced production of prostaglandins (Rang et al., 2003). Thus, most anti-
inflammatory agents are expected to possess analgesic and antipyretic activity 
(Tripathi, 2001; Dewanjee et al., 2009). 
 
1.1.1. Analgesia 
 
Pain is an unpleasant subjective experience that is the net effect of a complex 
interaction of the ascending and descending nervous systems involving biochemical, 
physiological, psychological, and neocortical processes (Chisholm-Burns et al., 
2008). Pain can affect all areas of a person’s life including sleep, thought, emotion, 
and daily activities. There are several ways to classify pain, but the first distinction 
usually made is that between acute and chronic pain. Pain is a subjective sensation 
which cannot be measured objectively, and its intensity is not always a direct 
reflection of the nociceptive inputs provoking it. Nociceptive inputs which are easily 
ignored by an individual in one situation may be unbearable in another (Buschmann, 
2002). 
 
The management and treatment of pain is probably one of the most common and yet 
difficult aspects of medicinal practice. Analgesic therapy is domain by two major 
classes of analgesic drugs; viz. opioids and non steroidal anti-inflammatory drugs 
(NSAIDs). Both classes of analgesic drugs produce serious side effects, such as 
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gastrointestinal disturbance, renal damage (with NSAIDs drugs), etc. (Dahl and 
Reader, 2000; Bures et al., 2002). 
 
1.1.2. Inflammatory diseases  
 
Inflammation is a physiological response of a body to stimuli, including infections 
and tissue injury. However, excessive or persistent inflammation causes a variety of 
pathological conditions (Palladino et al., 2003; Kang et al., 2008). As the primary 
interface between the body and the external environment, the skin provides the first 
line of defense against traumatic injury and invasion by microbial pathogens. In 
addition to its properties as a physical barrier, the skin has many active defence 
mechanisms (Kupper and Fuhlbrigge, 2004) and regulation of these mechanisms is 
crucial, as inappropriate or misdirected immune activity is implicated in the 
pathogenesis of a large variety of inflammatory skin disorders. While some of these 
conditions are easily remedied, treatments for chronic inflammatory diseases such as 
psoriasis and atopic dermatitis are not 100% successful (Chi et al., 2003). High levels 
of inflammatory cytokines and reactive oxygen species are proposed to contribute to 
the pathophysiological mechanisms associated with various inflammatory skin 
disorders (Trouba et al., 2002). 
 
Many degenerative diseases such as rheumatoid arthritis, shoulder tendonitis, gouty 
arthritis, polymyalgia rheumatica, heart disease, asthma, and inflammatory bowel 
disease are often associated with inflammatory processes (Polya, 2003; Iwalewa et al., 
2007). Furthermore, oxidative and inflammatory processes are among the 
pathological features associated with the central nervous system in Alzheimer’s 
disease (AD) (Howes and Houghton, 2003).  
 
Rheumatoid arthritis (RA) and osteoarthritis (OA) are frequent and important diseases 
with complex pathophysiology. There is convincing evidence that cytokines (e.g., IL-
1 and TNF), prostaglandins (PG), and nitric oxide (NO) play critical roles in the 
development and perpetuation of inflammation and cartilage and meniscus damage in 
rheumatoid arthritis and osteoarthritis.  
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Obese individuals have high circulating levels of a range of inflammatory markers 
produced by adipose tissue, including TNF-α, interleukin-1 (IL-1), and IL-6 (Bullo-
Bonet et al., 1999; Yudkin et al., 2000). These factors, whose levels can be reduced 
by weight loss, are likely to contribute to vascular damage in obese individuals.  
 
Since its discovery in the early 1990s, COX-2 has emerged as a major factor in 
inflammatory reactions in peripheral tissues (Hinz and Brune, 2002). By extension, 
COX-2 expression in brain has been associated with pro-inflammatory activities, 
which are thought to be instrumental in the neurodegenerative processes occurring in 
acute and chronic diseases.  
 
Many malignancies arise in the areas of infection and inflammation (Ebert et al., 
2002; Martinez-Maza and Breen, 2002). There is a growing body of evidences that 
chronic inflammation is strongly associated with incidence of cancer. For example, 
colon cancer can arise from inflammatory bowel disease such as chronic ulcerative 
colitis and Crohn’s disease persistent more than 10 years. 
 
1.1.3. Standard drugs for inflammation and side effects 
 
Many steroids, specifically glucocorticoids and Mineralocorticoids reduce 
inflammation or swelling by binding to corticoid receptors. These drugs are often 
referred to as corticosteroids. Long-term corticosteroids use has several severe side 
effects eg. hyperglycemia, insulin resistance, diabetes mellitus, osteoporosis, anxiety 
effects etc. (Donihi et al., 2006). 
 
There are over 50 different NSAIDs available (Chiroli et al., 2003) and they can be 
divided into different groups based on their chemical structure, pharmacokinetics and 
selectivity towards Cox-1 or Cox-2 (FitzGerald and Patrono, 2001; Bancos et al., 
2009). NSAIDs can be classified (Paul, 2004) broadly into two types based on their 
chemical structure. Most NSAIDs are carboxylic acids; but a few, most noticeably 
phenylbutazones, are enolic acids. Carboxylic acid containing drugs include salicylate 
derivatives (eg. aspirin), carbocyclic and hetrocyclic acid derivatives (eg. 
indomethacin), fenamic acid derivatives (eg. Ibuprofen, ketoprofen, fenbufen, 
flurbiprofen, suprofen and naproxen) and phenyl acetic acid derivatives (eg. 
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diclofenac, aceclofenac, etc.). Enolic acid containing drugs include oxicam 
derivatives (eg. piroxicam, tenoxicam and meloxicam) and pyrazoles (eg. 
phenylbutazone and oxyphenbutazone). Non acidic group compounds include 
nabumenton (Derle, 2006).  
 
Most of the NSAIDs have three major types of action (Vane, 1998):  
1)  Anti-inflammatory action for treating several conditions including rheumatoid 
arthritis, osteoarthritis, musculoskeletal disorders and pericarditis.  
2) Analgesia for treating pain of mild to moderate intensity. Their maximum 
therapeutic efficiency is much lower than that of the opioids, but they do not cause 
dependence.  
3) Antipyretic action, which mediates by the release of endogenous pyrogen from 
monocytes and macrophages in the presence of infection or inflammation. 
 
Non-steroidal anti-inflammatory drugs (NSAIDs) typically relieve inflammation and 
associated pain by inhibiting cyclooxygenase enzymes involved in the production of 
prostaglandins. These enzymes exist in two isoforms (COX-1 and COX-2) coded by 
distinct genes on different chromosomes (Polya, 2003). NSAIDs can cause liver 
damage (Purcell et al., 1991), renal failure (Fored et al., 2001), aseptic meningitis 
(Nguyen and Juurlink, 2004) and can interfere with bone fracture healing (Wheeler 
and Batt, 2005). NSAID use is associated with a high risk of upper gastrointestinal 
symptoms and lesions such as oesophagitis, gastritis, peptic ulcers, and their severe 
complications including bleeding and perforation (Cryer and Kimmey, 1998) and 
results mostly from inhibition of Cox-1 in the gastric mucosa. 
 
Diclofenac reduces inflammation, swelling and arthritic pain by inhibiting 
prostaglandins synthesis and/or production (Todd and Sorkin, 1988; Skoutakis et al., 
1988). The drug also affects polymorphonuclear leukocytes function in vitro, thereby 
reducing chemotaxis, superoxide toxic radical formation, oxygen-derived free radical 
generation, and neutral protease production (Mahgoub, 2002). Diclofenac has also 
been reported to suppress inflammation induced by various phlogistic agents in 
experimental animal models (Al-Tuwaijri and Mustafa, 1992). However, it may cause 
side effects including gastrointestinal disorders when administered by oral route and 
cutaneous lesions by intramuscular injection (Lopes et al., 2006; Suwalsky et al., 
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2009). There are several published reports of cases of diclofenac-associated 
hepatotoxicity (Purcell et al., 1991; Aydin et al., 2003). 
 
Indomethacin is used in the treatment of disorders such as rheumatoid arthritis, 
ankylosing spondylitis, and osteoarthritis.  Indomethacin produce its therapeutic and 
toxic effect by inhibiting prostaglandin synthesis in various tissues (Lione and Scialli, 
1995). However long time use of  indomethacin causes gastrointestinal complications, 
including intestinal perforation (Cassady et al., 1989);  bronchopulmonary dysplasia 
and respiratory distress syndrome (Eronen et al., 1994). 
 
Aspirin is the most widely used drug in the world today, because of its ability to act as 
anti-inflammatory medicine (Serhan et al., 2004; Schwab et al., 2007). However, 
patients with a history of peptic ulcer or other gastrointestinal disorders, are prone to 
gastroduodenal lesions on prolonged use of aspirin. The toxicity of aspirin is both 
dose- and disease-dependent. 
 
Ibuprofen is also a commonly and successful used NSAIDs. However, long term use 
of ibuprofen, sulindac, phenylbutazone, and piroxicam has been associated with 
hepatotoxicity (Manoukian and Carson, 1996). 
 
The coxibs like rofecoxib, lumiracoxib, celecoxib and etoricoxib  were reported to be 
associated with reduced gastrointestinal toxicity from the upper gastrointestinal tract 
when compared to non-selective NSAIDs; however there are also reports that   coxibs 
are associated with serious cardiovascular events (Pilotto et al., 2009) and 
hepatotoxicity (Alegria et al., 2002).  
 
Based on all these findings, the US Food and Drug Administration (FDA) in 2005 
mandated that all NSAIDs should include a warning to highlight the potential increase 
in the risk of serious cardiovascular events, along with the warning about potential 
severe life-threatening gastrointestinal events. The same has been delivered by the 
European Medicines Agency (EMEA) as well as by a large number of national drug 
agencies all over the world. Thus, a careful evaluation of the risk profiles for adverse 
events before prescribing non-selective NSAIDs and coxibs is strongly recommended 
(Layton et al., 2008). 
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1.1.4. Inflammatory mediators  
 
The inflammatory response is a complex and highly regulated sequence of events that 
start with an initial production of pro-inflammatory mediators that recruit professional 
inflammatory cells to the site of injury to clear the offending trigger. Macrophages 
play major roles in the immune and inflammatory responses involved in host defence. 
Activated macrophages secrete a number of different inflammatory mediators, 
including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-
6), reactive oxygen species (ROS), prostaglandin E2 (PGE2), nitric oxide (NO), etc 
(Kaplanski et al., 2003; Bosca et al., 2005).  
 
1.1.4.1. Cyclooxygenase (COX) 
 
COX is the key enzyme that catalyses the first two steps in the biosynthesis of the 
prostaglandins (PGs). The COX pathway leads to the generation of prostaglandins and 
thromboxanes, which mediate the pain and edema associated with inflammation. 
There are two isoforms of COX: COX-1 and COX-2. COX-1 is detectable, but COX-
2 is not detectable in most normal tissues, however, COX-2 can be induced by many 
factors such as pro-inflammatory cytokines, phlogistic factors, etc. Studies indicated 
that COX-2 plays an important role in inflammation (Oshima et al., 1996; Shu et al., 
2006). Thus, those agents that could suppress the activity or protein expression of 
COX-2 are likely to be valuable medicine for anti-inflammation and pain ease. Thus, 
decreasing of synthesis and activity of COX-2 can result in anti-inflammatory action 
both in localized and systemic conditions (Salvemini et al., 1993). 
 
1.1.4.2. Prostaglandins 
 
Prostaglandins (PGs) are generated by a variety of cell types, including activated 
macrophages (Harris et al., 2002). The rate-limiting enzyme in PG synthesis is 
cyclooxygenase (COX). Prostaglandins are the end products of the metabolism of 
arachidonic acid by cyclooxygenases (COX) and prostaglandin synthases (PGS), and 
comprise a series of classical pro-inflammatory mediators like PGD2, PGE2, PGF2α, 
and PGI2.  
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1.1.4.3. Arachidonic acid 
 
The lipoxygenase pathway utilizes arachidonic acid by 5-lipoxygenase to produce the 
lipoxygenase products e.g. leucotrienes (LTs) which are also involved in 
inflammatory reactions as pro-inflammatory mediators. Leukotrienes, i.e. LTC4 and 
LTD4 cause edema together with increased microvascular permeability.  
 
1.1.4.4. Thromboxane 
 
Thromboxane A2 (TXA2) is an arachidonic acid metabolite produced during the 
catalysis of arachidonic acid by the sequential action of COX and thromboxane 
synthase (TXS), and is well established as a potent vasoconstrictor. This metabolite 
participates in various physiological and pathological processes ranging from synaptic 
transmission to inflammation (Turini and DuBois, 2002). Platelets represent the best 
known cell type to produce TXA2 in response to various stimuli. However, many 
other cells and tissues are also able to synthesize TXA2 (Nakahata, 2008).  
 
1.1.4.5. Leukotrienes 
 
Leukotrienes (LT) are end products of the metabolism of arachidonic acid by 5-
lipoxygenase. Leukotrienes have physiological roles in innate immune responses and 
pathological roles in a variety of inflammatory and allergic diseases, such as 
rheumatoid arthritis, inflammatory bowel disease, psoriasis, allergic rhinitis, but most 
prominently in bronchial asthma (Werz and Steinhilber, 2005).  
 
1.1.4.6. Polyunsaturated fatty acids (PUFA) 
 
Linoleic acid (LA) and α-linolenic acid (ALA) belong to the n−6 (ω−6) and n−3 
(ω−3) series of polyunsaturated fatty acids (PUFA). LA and ALA are precursors for 
the synthesis of higher unsaturated species: arachidonic acid deriving from LA, and 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) deriving from ALA. 
One possible mechanistic explanation for these anti-inflammatory and anti-
tumorigenic effects may be that an increased consumption of EPA and DHA results in 
an increased incorporation of these fatty acids into phospholipids at the expense of 
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arachidonic acid. Consequently, they also replace arachidonic acid as a substrate for 
COX and LO that results in a reduced formation of PGE2, TXA2, LTB4 and LTE4 
(Huwiler and Pfeilschifter, 2009).  
 
1.1.4.7. Histamine 
 
Histamine (HA) is a biogenic amine that affects a variety of functions in the human 
body. It has been known to play a role in inflammation, gastric acid secretion, and 
neurotransmission (Passani et al., 2007; Huang and Thurmond, 2008). Multiple 
receptors exist for histamine in mammalian tissues and these have been classified into 
4 distinct receptor types (H1R, H2R, H3R, and H4R), all of which are G-protein 
coupled receptors (GPCRs) (Schneider et al., 2002). Histamine appears to play a 
complex role in pain modulation. Histamine released from mast cells is an established 
mediator of acute allergic reactions and chronic inflammation. Histamine and other 
mediators of inflammation increase vascular permeability at various times after 
injury. Chemical-induced vascular permeability (such as seen with acetic acid) causes 
an immediate sustained reaction that is prolonged over 24 h (Okoli et al., 2007). 
 
1.1.4.8. Nitric oxide (NO) 
 
It is widely known that nitric oxide (NO), synthesized from L-arginine by nitric oxide 
synthase (NOS), is involved in diverse physiological processes. An excess in NO 
production is largely thought of as causing a variety of inflammatory diseases, such as 
sepsis, psoriasis, arthritis, multiple sclerosis, and systemic lupus erythromatosus 
(Clancy et al., 1998). 
 
1.2. INTRODUCTION TO LIVER 
 
Liver is the most important organ, which plays a pivotal role in regulating various 
physiological processes in the body. It is involved in several vital functions, such as 
metabolism, secretion and storage. It has great capacity to detoxicate toxic substances 
and synthesize useful principles (Shanmugasundaram and Venkataraman, 2006). 
Liver functions as a centre of metabolism of nutrients such as carbohydrates, proteins 
and lipids and excretion of waste metabolites. Additionally, it also handles the 
metabolism and excretion of drugs and other xenobiotics from the body thereby 
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providing protection against foreign substances by detoxifying and eliminating them 
(Saleem et al., 2010). 
 
Liver cells possess the antioxidant defence system consisting of antioxidants such as 
GSH, ascorbic acid, and vitamin E and antioxidant enzymes such as SOD, catalase, 
and GPx to protect own cells against oxidative stress, which causes destruction of cell 
components and cell death (Kaplowitz and Tsukamoto, 1996). 
 
The liver is a major target organ for toxicity of xenobiotics and drugs, because most 
of the orally ingested chemicals and drugs first go to liver where they are metabolized 
into toxic intermediates. A large number of xenobiotics are reported to be potentially 
hepatotoxic (Ajith et al., 2007). Hepatocytes, which make up the majority of the liver 
structure, are very active in the metabolism of exogenous chemicals, and this is one of 
the major reasons why the liver is a target for toxic substances (Timbrell, 2001). 
During the detoxification of xenobiotics, reactive oxygen species (ROS) are generated 
which cause oxidative stress (Kohen and Nyska, 2002) which leads to the hepatic 
damage. 
 
1.2.1. Liver diseases 
 
Liver disease is one of the major causes of morbidity and mortality in public, 
affecting humans of all ages. About 20,000 deaths occur every year due to liver 
disorders. Some of the commonly known disorders are viral hepatitis, alcohol liver 
disease, non-alcoholic fatty liver disease, autoimmune liver disease, metabolic liver 
disease, drug induced liver injury, gallstones, etc. Hepatocellular carcinoma is one of 
the ten most common tumors in the world with over 2,50,000 new cases each year 
(Gupta and Misra, 2006). According to WHO estimates, globally 170 million people 
are chronically infected with hepatitis C alone and every year 3–4 millions are newly 
added into the list. Also, there are more than 2 billion infected by hepatitis B virus 
(HBV) and over 5 million are getting infected with acute HBV annually (Negi et al., 
2008). 
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Depending on the duration of the disease the liver diseases are classified as acute or 
chronic. If the disease does not exceed six months it is considered as acute liver 
disorder while diseases of longer duration are classified as chronic. 
 
Acute viral hepatitis and drug reactions account for the majority of cases of acute liver 
disease. Hepatitis A and B are the commonest causes of viral hepatitis in Europe and 
hepatitis E is common in India. Hepatitis C is not usually recognised as an acute 
infection because it rarely causes jaundice at this stage. 
 
Chronic liver damage is a worldwide common pathology characterized by 
inflammation and fibrosis that can lead to chronic hepatitis, cirrhosis and cancer 
(Tessitore and Bollito, 2006; Kohle et al., 2008). Chronic hepatitis or long term 
intoxification can severely injure hepatic cells. Initially, the damaged cells are 
denatured, but subsequently transformed to hypertrophic fibrosis and necrosis, and 
eventually may progress to hepatoma.  
 
Hepatic fibrosis is usually initiated by hepatocyte damage. Biologic factors such as 
hepatitis virus, bile duct obstruction, cholesterol overload, schistosomiasis, etc; or 
chemical factors such as CCl4 administration, alcohol intake, etc. were known to 
contribute to liver fibrosis. Hepatic fibrosis is major features of a wide range of 
chronic liver injuries including metabolic, viral, cholestatic and genetic disease. The 
failure of bile salt excretion in cholestasis leads to retention of hydrophobic bile salts 
within the hepatocytes and causes apoptosis and/or necrosis (Miyoshi et al., 1999). 
 
Oxidative stress has been implicated in the pathogenesis of various liver diseases 
including alcoholic liver disease, nonalcoholic fatty liver disease, and chronic 
hepatitis C (Seki et al., 2005; Kitase et al., 2005). In many patients, hepatitis such as 
non-alcoholic fatty liver disease becomes chronic and eventually progresses to more 
serious liver pathologies, such as fibrosis, cirrhosis, or even carcinogenesis, causing 
devastating economic losses and mortality (Albano et al., 2005). 
 
Drug/chemical-mediated hepatic injury is the common sign of drug toxicity (Lee, 
2003) and accounts for greater than 50% of acute liver failure cases. Hepatic damage 
is the largest obstacle to the development of drugs and is the major reason for 
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withdrawal of drugs from the market (Cullen and Miller, 2006). Drug-induced liver 
disease can be predictable (high incidence and dose-related) or unpredictable (low 
incidence and may or may not be dose-related). Unpredictable reactions, also referred 
to as idiosyncratic, can be viewed as either immune-mediated hypersensitivity or 
nonimmune reactions. Most potent predictable hepatotoxins are recognized in the 
animal testing or clinical phase of drug development.  
 
1.2.2. Drugs for liver diseases 
 
The liver is quantitatively the most important site of drug metabolism. However, 
many drugs are known to cause hepatic injury. Conventional and synthetic drugs used 
in the treatment of liver diseases are sometimes inadequate and can have serious 
adverse effects. 
 
Steroids, vaccines, and antiviral drugs, have been used as therapies for liver 
pathologies, have potential adverse side-effects, especially if administered chronically 
or sub-chronically. Current medical treatments for these liver diseases are often 
ineffective, and therefore efforts are being made to seek new effective medications 
(Seeff et al., 2001). Developing pharmacologically effective agents from natural 
products has become a new trend by virtue of their little toxicity or few side effects. 
There are few plant derived drugs in the market which are used for the liver disorders. 
 
1.2.2.1. Silymarin 
 
Silymarin, derived from the seeds of Silybum marianum L. (Family: Asteraceae or 
Compositae), commonly known as milk thistle, has been used for centuries as a 
natural remedy for liver and biliary tract diseases (Saller et al., 2001). Milk thistle 
protects and regenerates the liver in most liver diseases such as cirrhosis, jaundice, 
and hepatitis (Flora et al., 1998). Silymarin offers good protection in various models 
of experimental liver disease. It acts by antioxidative, antilipid peroxidative (Pascual 
et al., 1993), antifibrotic (Mourelle et al., 1989), membrane stabilizing, 
immunomodulatory and liver regenerating mechanisms (Pradhan and Girish, 2006). 
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Limitations 
 
Silymarin is insoluble in water and typically administered as a sugar coated tablet 
(Thakur, 2002) or as an encapsulated standardized extract. The absorption by oral 
route is as low as 2-3 percent of the silybin recovered from rat bile in 24 h. About 20-
40 percent of the administered dose of silymarin is excreted in bile as sulphates and 
glucuronide conjugates in human beings (Saller et al., 2001).  
 
Side Effects 
 
Silymarin has low level of toxicity. Although, silymarin has a good safety record, 
there are few reports of gastrointestinal disturbances and allergic skin rashes (Negi et 
al., 2008). 
 
1.2.2.2. Liv-52 
 
Liv-52 was introduced in 1954 as a specially formulated Ayurvedic herbal remedy for 
the treatment of viral hepatitis and has been widely prescribed for infective hepatitis 
since then (Mukerjee and Dasgupta, 1970). Experimentally, Liv-52 prevented 
injurious effects of carbon tetrachloride and other toxic substances on the liver.  
 
Liv.52 is available as tablets and syrup containing the following herbs: Capparis 
spinosa; Cichorium intybus; Solanum nigrum; Terminalia arjuna; Cassia 
occidentalis, Achillea millefolium; Tamarix galica and Phyllanthus amarus. These 
herbs are processed and formulated according to the principles of Ayurveda, which 
are aimed at enhancing efficacy and avoiding toxicity (Charak and vimanasthan, 
1981).  
 
1.2.3. Hepatotoxicant 
 
Liver toxicity mainly occurs due to alcohol, viral and induced by drugs. The third 
factor for the cause of acute liver disease is the use of drugs like paracetamol, pain 
killers and antibiotics. 
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1.2.3.1. Non-steroidal anti-inflammatory drugs (NSAIDs)  
 
Non-steroidal anti-inflammatory drugs (NSAIDs) are the centrepiece of 
pharmacotherapy for most rheumatological disorders, and are used in large numbers 
as analgesics and antipyretics, both as prescription drugs and over the counter 
purchases. Non-steroidal anti-inflammatory drugs (NSAIDs), which are often used for 
the relief of non-specific fever (Radwan, 2000), continue to be important for the 
palliation of pain. They are the most frequently used medications for the treatment of 
a variety of common chronic and acute inflammatory conditions (Manoukian and 
Carson, 1996), and continue to be important for the palliation of pain and in 
decreasing inflammation and fever (Skoutakis et al., 1988; McGettigan and Henry, 
2000). 
 
Nearly all of the NSAIDs have been implicated in causing liver injury (Rabinovitz 
and Van Thiel, 1992). Diclofenac, and particularly sulindac, are reported to be more 
commonly associated with hepatotoxicity (Bjorkman, 1998). Several NSAIDs have 
been withdrawn from clinical use because of associated hepatotoxicity (Rabkin et al., 
1999). The new more selective COX-2 inhibitors (e.g. celecoxib, rofecoxib, 
nimesulide) are also associated with hepatotoxicity (Merlani et al., 2001). 
Hepatotoxicity from NSAIDs can occur at any time after drug administration, but like 
most adverse drug reactions, most commonly occurs within 6–12 weeks of initiation 
of therapy (Aithal and Day, 1999). 
 
There are two main clinical patterns of hepatotoxicity due to NSAIDs (Rabinovitz and 
Van Thiel, 1992; Aithal and Day, 1999). The first is an acute hepatitis with jaundice, 
fever, nausea, greatly elevated transaminases and sometimes eosinophilia. The 
alternative pattern is with serological and histological (periportal inflammation with 
plasma and lymphocyte infiltration and fibrosis extending into the lobule) features of 
chronic active hepatitis. Some of the NSAIDs which causes liver damage are listed 
below. 
 
1.2.3.1.1. Diclofenac 
 
Diclofenac sodium has antipyretic, analgesic and anti-inflammatory effects, is an 
inhibitor of cycloxygenase enzyme. Like other nonsteroidal anti-inflammatory drugs, 
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clinical use of diclofenac has been associated with a small but significant incidence of 
hepatotoxicity, ranging from mild, asymptomatic, reversible increases in liver 
function tests to jaundice and hepatitis, including several reports of fatal hepatitis 
(Purcell et al., 1991; Banks et al., 1995).  
 
In many cases, the clinical and biochemical features of diclofenac hepatotoxicity 
suggest the involvement of reactive or toxic metabolites. These products presumably 
were formed via the hepatic cytochrome P450 (CYP)-catalyzed oxidation of diclofenac 
to reactive benzoquinone imines that are trapped by GSH (glutathione) conjugation. It 
is, therefore, possible that reactive benzoquinone imines may be formed and 
contribute to diclofenac mediated hepatic injury (Tang et al., 1999).  
 
1.2.3.1.2. Sulindac 
 
Liver injury from sulindac appears within a few days to six weeks after therapy is 
initiated. Fever, rash, eosinophilia, and edema are frequently found in association with 
evidence of liver injury. It is considered as one of the most likely NSAIDs to produce 
hepatic injury (Garcia Rodriguez et al., 1992).  
 
1.2.3.1.3. Nimesulide 
 
The anti-inflammatory drug, nimesulide is a selective COX-2 inhibitor, with only 
residual activity against COX-1 (Giuliano et al., 2001). It is almost exclusively 
metabolized and cleared by the liver (Chatterjee and Sil, 2007). The drug can cause 
several types of liver damage, ranging from mild abnormal function such as increase 
in serum amino transferase activity to severe organ injuries such as hepatocellular 
necrosis or intrahepatic cholestasis (Lucena et al., 2001).  
 
1.2.3.1.4. Bromfenac 
 
This acetic acid derivative was introduced in 1997 as a non-narcotic analgesic of the 
phenyl acetate class for short-term pain relief, but was removed from the market in 
1998 owing to several instances of fulminant hepatic failure (FHF) leading to death or 
transplant that occurred after prolonged administration (Goldkind and Laine, 2006).   
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1.2.3.1.5. Indomethacin  
 
Indomethacin has produced hepatocellular necrosis, sometimes accompanied by 
microvesicular steatosis and striking cholestasis (Fenech et al., 1967); children are 
more vulnerable and the drug is not recommended in the pediatric age group based on 
several deaths involving hepatocellular necrosis  (Boardman and Hart, 1967). 
 
1.2.3.1.6. Ibuprofen  
 
Ibuprofen was withdrawn from use in the 1960s because of fatal hepatocellular injury.  
 
1.2.3.2. Alcohol 
 
Alcohol administration causes accumulation of reactive oxygen species, which in turn 
causes lipid peroxidation of cellular membranes and proteins and DNA oxidation 
resulting in hepatocyte injury (Zhou et al., 2002). Alcohol treatment of rats is known 
to cause the translocation of fat from the peripheral adipose tissue to liver, kidney and 
brain for accumulation (Nadro et al., 2006). 
 
1.2.3.3. Carbon tetrachloride (CCl4) 
 
Many compounds including clinically useful drugs can cause cellular damage through 
metabolic activation of the compound to highly reactive substances such as free 
radicals. One such toxicant is carbon tetrachloride (CCl4); the hepatotoxicity of CCl4 is 
attributed to the formation of trichloromethyl and trichloromethyl peroxyl radicals, 
initiating lipid peroxidation and resulting in fibrosis and cell necrosis (Kadiiska et al., 
2000). Long-term administration of CCl4 causes chronic liver injury (Hernandez-
Munoz et al., 1990).  
 
1.2.3.4. Acetaminophen 
 
Acetaminophen (APAP) has been widely used as a medicine for pain and fever relief 
(Whitcomb, 1994). It is commonly considered as a ‘‘safe drug’’ when taken within 
the suggested therapeutic dose. However, APAP can be hepatotoxic when an 
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overdose is administered. Clinically, APAP has been demonstrated to be nephrotoxic 
and hepatotoxic  (Bonkovsky et al. 1994). 
 
1.2.3.5. Galactosamine 
 
Galactosamine (GalN) has been proposed to be hepatotoxic due to its ability to 
destruct liver cells (Anandan et al., 1999). Its toxicity is of clinical importance 
because there is a close resemblance between the multifocal necrosis produced by d- 
GalN and the lesion of viral hepatitis in humans. This amino sugar is known to 
selectively block the transcription and indirectly hepatic protein synthesis and as a 
consequence of endotoxin toxicity, it causes fulminant hepatitis within 8 h after 
administration (Ravikumar et al., 2005).  
 
‘‘Burden of disease” is an all encompassing term that captures not only the frequency 
(such as the incidence and prevalence) of the disease but also reflects how the disease 
impacts other aspects of the health of a population. These include negative impact of 
disease on longevity (such as pre-mature death and years of lost life), morbidity (pain 
and impaired health related quality of life), and economic consequences of the disease 
(such as direct health care expenditures in caring for the disease and indirect costs 
related to lost income from premature death or disability). Therefore, one needs to 
take all these aspects into account to understand the true magnitude of a disease’s 
burden. Such understanding is also essential in formulating health care policies to 
prioritize health interventions and to allocate scarce resources across a range of 
medical diseases. For example expensive interventions (e.g., screening to detect early 
disease, treatment) will add cost and therefore may increase the overall disease 
burden, however these interventions may actually reduce the overall disease burden 
by prolonging life, and improving quality of life (Kanwal and El-Serag, 2009). 
 
1.3. HERBAL MEDICINE 
 
India is a rich source of medicinal plants and a number of plant derived extracts are 
used against diseases in various systems of medicine such as Ayurveda, Unani and 
Siddha. Use of herbal medicines can be traced back as far as 2100 B.C. in ancient 
China (Xia dynasty) and India (Vedic period). The first written reports date back to 
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600 B.C. with the Charaka Samhita of India and the early notes of the Eastern Zhou 
dynasty of China that became systematized around 400 B.C. The recipes, once 
formulated, were usually expanded rather than abandoned during subsequent 
centuries. Expansion was stimulated by a growing understanding of the natural 
evolution of frequently encountered diseases and by emerging hypotheses regarding 
their causes (Schuppan et al., 1999).  
 
The use of medicinal plants in curing diseases is as old as man (Aibinu et al., 2007). 
The World Health organization (WHO) has long recognized and drawn the attention 
of many countries to the ever increasing interest of the public in the use of medicinal 
plants and their products in the treatment of various ailments. These plants which are 
found in our environment enjoy wide acceptability by the population and serve as 
cheaper alternatives to orthodox medicine (Akah and Nwabie., 1994). Since ancient 
times of civilization, people have been relying on plants as either prophylactic or 
therapeutically arsenal to restore and maintain health, and plants are well known as an 
important source of many biologically active compounds. 
 
Plant derived natural products such as flavonoids, terpenes and alkaloids (Witherup et 
al., 1990; Shukla et al., 2010) have received considerable attention due to their diverse 
pharmacological properties including inflammatory, antipyretic and analgesic 
activities. Consumption of natural products reduce the risk of developing pathological 
conditions, including cancer, nervous system disorders, cardiovascular, genetic, and 
inflammatory diseases (Jurenka, 2009; Newman and Cragg, 2007). Plants contain 
numerous bioactive molecules that can improve the body’s resistance to cellular stress 
and prevent the cytotoxicity of various agents. 
 
Natural products and their derivatives have traditionally been the most common 
sources of drugs, and still represent a fairly large percentage of the pharmaceutical 
market (Kirkpatrick, 2002). It has long been recognised that natural product structures 
have the characteristics of high chemical diversity, biochemical specificity and other 
molecular properties that make them favourable as lead structures for drug discovery 
(Okoye and Osadebe, 2010).  
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Plants are a rich source of active ingredients for health care products, with many 
blockbuster drugs being directly or indirectly derived from plants (Newman et al., 
2000). Examples of some drugs are shown in table 1. However, many high value 
plant-derived natural products remain undiscovered or unexplored for their 
pharmacological activity (Raskin et al., 2002). 
 
India has been identified as one of the top twelve mega bio-diversity center of the 
world. This is because India has a vast area with wide variation in climate, soil, 
altitude and latitude (Tiwari, 2008). India is rich in all the three levels of biodiversity, 
namely species diversity, genetic diversity and habitat diversity. In India thousands of 
species are known to have medicinal value and the use of different parts of several 
medicinal plants to cure specific ailments has been in vogue since ancient times 
(Parekh et al., 2005).  India with its biggest repository of medicinal plants in the world 
may maintain an important position in the production of raw materials either directly 
for crude drugs or as the bioactive compounds in the formulation of pharmaceuticals 
and cosmetics etc (Tiwari, 2008). Extraction of bioactive compounds from medicinal 
plants permits the demonstration of their physiological activity. It also facilitates 
pharmacology studies leading to synthesis of a more potent drug with reduced toxicity 
(Manna and Abalaka, 2000). Furthermore, the active components of herbal remedies 
have the advantage of being combined with many other substances that appear to be 
inactive (Parekh and Chanda, 2007a). 
 
Due to the known side effects of approved pharmaceuticals, patients often turn to 
alternative medicine which is considered “natural” and “healthy”. Herbal medicine is 
thus gaining popularity, but lack of knowledge of the mechanisms and side effects of 
these preparations as well of safety regulations for their preparation may have serious 
consequences (Boullata and Nace, 2000). 
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Table 1: Plant derived drugs, with their clinical uses and sources. 
Drug Action or clinical use Plant source 
Bromelain Anti-inflammatory; 
proteolytic agent 
Ananas comosus (L.) Merrill 
Codeine Analgesic Papaver somniferum L. 
Colchicine Antitumor agent; antigout Colchicum autumnale L. 
Danthron Laxative Cassia spp. 
Digitalin Cardiotonic Digitalis purpurea L. 
Digoxin Cardiotonic Digitalis lanata Ehrh. 
Quinine Antimalarial Cinchona ledgeriana Moens ex. 
Trimen 
Salicin Analgesic Salix alba L. 
Silymarin Antihepatotoxic Silybum marianum (L.) Gaertn. 
Taxol Antitumor Taxus brevifolia Nutt. 
 
1.3.1. Standardization of herbal medicine 
 
The use of herbal medicines continues to expand rapidly across the world. Many 
people now take herbal medicines or herbal products for their health care in different 
national health-care settings. According to WHO, 80% if the rural population in 
developing countries depend on traditional medicines to meet their primary health 
care needs (Bannerman et al., 1993). Authentication and standardization are 
prerequisite steps while considering source materials for herbal formulation in any 
system of medicine (Ahmad et al., 2009). 
 
In traditional systems of medicine, the drugs are primarily dispensed as water 
decoction or ethanolic extract. Fresh plant parts, juice or crude powder are a rarity 
rather than a rule. Thus medicinal plant parts should be authentic and free from 
harmful materials like pesticides, heavy metals, microbial or radioactive 
contamination, etc. (Kamboj 2000). It is very important that a system of 
standardization is established for every plant medicine in the market because the 
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scope for variation in different batches of medicine is enormous. World Health 
Organization (WHO) encourages, recommends and promotes traditional /herbal 
remedies in national health care programmes because these drugs are easily available 
at low cost, safe and people have faith in them. The WHO assembly in number of 
resolutions has emphasized the need to ensure quality control of medicinal plant 
products by using modern techniques and applying suitable standards (Raina, 2003).  
Some of the standardization test for herbal medicines are listed below (Ritch, 2000). 
 
Macro and microscopic examination: For identification of right variety and 
search of adulterants. 
Foreign organic matter: Remove of matter other than source plant to get the 
drug in pure form. 
Ash values: It is criteria to judge the identity and purity of crude drug – Total ash, 
sulfated ash, water soluble ash and acid insoluble ash etc. 
Moisture content: To check moisture content is helps in prevent degradation of 
product. 
Extractive values: These are indicating the approximate measure of chemical 
constituents of crude drug. 
Crude fiber: To determine excessive woody material criteria for judging purity. 
Qualitative chemical evaluation: It covers identification and characterization of 
crude drug with respect to phytochemicals constituent. 
Quantitative chemical evaluation: To estimate amount the major class of 
constituents. 
Toxicological studies: Pesticide residue, potentially toxic elements, and microbial 
count approach to minimize their effect in final product. 
 
1.3.2. Toxicological aspects of herbal medicine 
 
Phytotherapy has never stopped gaining in popularity. In low and middle income 
countries, it often represents the main, if not, only therapeutic system to which 
majority of people are referred to for their primary health care (WHO, 2007; Mukinda 
and Eagles, 2010). Its widespread use is further substantiated by the affordability, 
knowledge of medicinal plants and the belief that they are harmless (Springfield et al., 
2005), since these treatments are “natural” and commonly used for self-medication 
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without supervision. Although medicinal plants may cause several biological 
activities in humans, very little is known regarding the potential toxicity for many of 
these bioactive substances. The increase in number of users as oppose to the scarcity 
of scientific evidences on the safety of the medicinal plants have raised concerns 
regarding toxicity and detrimental effects of these remedies (Saad et al., 2006). 
Because they are considered natural and are available without a prescription, many 
users ignore the potential for toxicity (Larrey, 1997). Many herbal remedies have not 
been submitted to rigorous scientific testing and are largely justified by prescribers via 
trial-and-error experience. Acute toxicity test gives clues on the range of doses that 
could be toxic to the animal; it could also be used to estimate the therapeutic index 
(LD50/ED50) of drugs and xenobiotics (Rang et al., 2001; Maikai et al., 2008).  
 
Non-steroidal anti-inflammatory drugs (NSAIDs) are used in large numbers as 
analgesics and antipyretics. But they are having many side effects in the body organs.  
Diclofenac, is one of the non-steroidal anti-inflammatory drugs, and widely used in 
treatment of several rheumatic diseases, and as an analgesic and anti-inflammatory 
agent. There are many reports that long term use of diclofenac has toxic effects to the 
liver as well as other organs (Sallustio and Holbrook, 2001). Natural products/plant 
derived extracts has great capacity to overcome this problem. Therefore, the prime 
objective of the present study is to select a medicinal plant which can be used as anti-
inflammatory agent as well as in hepatic disorders/damage; and may not have side 
effects to the other organs of the body. 
 
1.4. SELECTION OF THE PLANT FOR PRESENT STUDY 
 
When selecting a plant for pharmacological activities, four basics methods are usually 
followed (Suffness and Douros, 1979):  
a) Random choice of plant species 
b) Choice based on ethnomedical use 
c) Follow up of existing literature on the use of the species  
d) Chemotaxonomic approaches 
 
Comparison of the four methods showed that the choice based on folklore has given 
about 25% more positive leads than other methods. Based on the second and third 
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approach, selection of the plant has been made in the present work. In light of the 
above context, Woodfordia fruticosa Kurz. flowers were selected for the study. 
  
1.4.1. Woodfordia fruticosa 
 
Woodfordia fruticosa Kurz. (syn. Woodfordia floribunda Salisb.) belongs to the 
family Lythraceae, is a much branched beautiful shrub, 1-3 m high. It is the plant of 
tropical and subtropical regions with a long history of medicinal use. English names 
of the plant are Fire Flame Bush and Shiranjitea. The plant is abundantly present 
throughout India, ascending up to an altitude of about 1500 m, and also in a majority 
of the countries of South East and Far East Asia like Malaysia, Indonesia, Sri Lanka, 
China, Japan and Pakistan as well as Tropical Africa (Kirtikar and Basu, 1935). The 
original Sanskrit name Agnijwala or Tamra-pushpi appears to be derived from the 
bright red colour of the flower and the bark. Locally (In Gujarat) it is known as 
Dhavdi (Shome et al., 1981; Khare, 2004). The bark of the plant, characteristically 
cinnamon-brown coloured and smooth, peels off in fibres and the young shoots are 
terete, often clothed with fine white pubescence. The leaves are 1.5-13 x 0.8-4 cm, 
opposite or sub-opposite, decussate, sometimes in whorls of 3, sessile. Flowers are 
brilliant red. 
 
Considering the above, the objectives set forth are: 
 
 Review of Literature for; 
 Reported anti-inflammatory activity of some medicinal plants  
 Reported hepatoprotective activity of some medicinal plants 
 Woodfordia fruticosa and their reported activities 
 Pharmacognostic study of Woodfordia fruticosa flowers 
 Physicochemical study of Woodfordia fruticosa flowers 
 Phytochemical study of Woodfordia fruticosa flowers 
 Anti-inflammatory study of Woodfordia fruticosa flowers 
 Hepatoprotective study of Woodfordia fruticosa flowers 
 Toxicity study of Woodfordia fruticosa flowers 
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2.1. ANTI-INFLAMMATORY STUDY 
 
Inﬂammation is the primary response to infection or injury that functions to clear the 
injurious material or agent and promote tissue repair. It is characterized by the 
sequential release of mediators including; bioactive amines, eicosanoids, cytokines, 
chemokines and growth factors that regulate increased vascular permeability and 
recruitment of blood borne leukocytes. Increased vascular permeability also results in 
extravasation of plasma proteins that further amplify the inﬂammatory reaction. 
Inﬂammation is essentially a salutary response that normally resolves with the 
restoration of normal tissue structure and function, however when inﬂammation 
persists it can cause tissue damage and loss of function (Rodriguez-Vita and 
Lawrence, 2010). Many degenerative diseases such as rheumatoid arthritis, shoulder 
tendonitis, gouty arthritis, polymyalgia rheumatica, heart disease, asthma, cancer, and 
inflammatory bowel disease are often associated with inflammatory processes 
(Iwalewa et al., 2007; Fawole et al., 2010). 
 
During inflammatory responses, the activation of phospholipase A2 induces the 
mobilization of fatty acids, in particular arachidonic acid from the membrane lipid 
pool (Fiorucci et al., 2001). Arachidonic acid is then oxidized by constitutive 
cyclooxygenase-1 (COX-1) or inducible cyclooxygenase-2 (COX-2) enzymes, 
leading to the production of prostaglandins. Prostaglandins are a group of 
inflammatory mediators, implicated in many pain-related ailments (Rang and Dale, 
1987). 
 
COX-1 was constitutionally present in low abundance in most human tissues, acting 
as a housekeeping enzyme by regulating normal physiological processes such as the 
maintenance of gastric mucosal integrity, kidney function, and platelet aggregation. 
Conversely, COX-2 was selectively upregulated after exposure to inflammatory 
mediators or trauma, causing subsequent inflammatory responses and mediation of 
pain. Therefore COX-2 selective NSAID is an ideal drug, with analgesic, antipyretic, 
and anti-inflammatory benefits without hepatic damage or other side effects. 
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There are number of steroidal and non steroidal anti-inflammatory drugs available in 
the market; and they are having good potential as anti-inflammatory and antipyretic 
drugs (eg. diclofenac, aspirin, indomethacin, etc.), but they cause undesired, un 
pleasant and serious adverse side effects on liver and gastrointestinal track. Therefore, 
development of new and more powerful anti-inflammatory and hepatoprotective 
drugs is needed to substitute the chemical therapeutics (Conforti et al., 2009).  
 
There are a number of models used for studying anti-inflammatory potential of 
medicinal plants.  People all over the world are using one of the below mentioned 
models for evaluating the anti-inflammatory and analgesic potential of medicinal 
plants.  
 
2.1.1. Models for acute inflammation 
 
1. Agar induced paw edema 
2. Arachidonic acid induced paw edema 
3. Capsaicin induced ear edema  
4. Carrageenan induced paw edema 
5. Croton oil induced ear edema 
6. Dextran induced paw edema 
7. Formaldehyde  induced paw edema 
8. Egg-albumen induced paw edema 
9. Histamine induced paw edema 
10. Prostaglandin induced ear edema 
11. Serotonin induced paw edema 
12. TPA (12-O-tetradecanoylphorbol-
13-acetate) induced ear edema 
13. Xylene induced ear edema 
14. Zymosan induced peritonitis 
 
2.1.2. Model for chronic inflammation 
 
1. Cotton pellet induced granuloma 
2. Complete Freund’s Adjuvant 
 
2.1.3. Models for analgesia 
 
1. Acetic acid induced writhing 
2. Formaldehyde  induced paw licking 
3. Hot plate test 
4. Rotarod test 
5. Tail flick test 
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Amongst all these models, carrageenan induced rat paw edema is the most widely 
used animal model for evaluation of anti-inflammatory property of medicinal plants. 
The search for new pharmacologically active agents for inflammatory disorders 
obtained by screening natural sources is in high demand.  
 
2.2. HEPATOPROTECTIVE STUDY 
 
Natural products and their active principles as sources for new drug discovery and 
treatment of diseases have attracted attention in recent years. Herbs and spices are 
generally considered safe and proved to be effective against various human ailments. 
Herbal based therapeutics for liver disorders has been in use in India for a long time 
and has been popularized in world over by leading pharmaceuticals (Saleem et al., 
2010). The currently observed rapid increase in consumption of herbal remedies 
worldwide has been stimulated by several factors, including the notion that all herbal 
products are safe and effective (Said et al., 2002). The 21st century has seen a 
paradigm shift towards therapeutic evaluation of herbal products in liver disease 
models by carefully synergizing the strength of the traditional systems of medicine 
with that of the modern concept of evidence based medicinal evaluation, 
standardization and randomized placebo controlled clinical trials to support clinical 
efficacy (Thyagarajan et al., 2002).  
 
To evaluate the hepatoprotective potential of medicinal plants in animal models some 
chemical compounds and drugs are used as a toxicant; few of them are listed below: 
 
2.2.1. Hepatotoxicant 
 
1. Acetaminophen 
2. Aflatoxin B1 
3. Azathioprine 
4. Carbon tetrachloride (CCl4) 
5. D-galactosamine 
6. Diclofenac 
7. Diethylnitrosamine  
8. Ethanol 
9. Isoniazid 
10. Lipopolysaccharide 
11. Nimesulide 
12. Poloxamer (PX)- 407 
13. Rifampicin 
14. Sodium oxalate  
15. tert-Butyl hydroperoxide 
16. Thioacetamide 
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Among the listed chemical compounds and drugs, carbon tetrachloride and 
acetaminophen are the most widely used hepatotoxicants. 
 
In the present study, review has been done for some medicinal plants, which have 
been evaluated for their anti-inflammatory (Table 2) and hepatoprotective (Table 3) 
potency using different animal models. The plant name, part and solvent used for the 
extraction and different parameters done are given. 
 
There are many medicinal plants in the literature, which are reported either for anti-
inflammatory or hepatoprotective activity. But very few plants are there, which are 
reported for both anti-inflammatory and hepatoprotective property (Lau et al., 2002; 
Al-Howiriny et al., 2003; Tanna et al., 2009). Therefore, the search for potentially 
effective anti-inflammatory agent with hepatoprotective property continues.  
 
2.3. Woodfordia fruticosa Kurz. 
 
In India, Woodfordia fruticosa Kurz. is a much used medicinal plant in Ayurvedic and 
Unani systems of medicines (Chopra et al., 1956; Watt, 1972; Dymock et al., 1995). 
Although all parts of this plant possess valuable medicinal properties, there is a heavy 
demand for the flowers, both in domestic and international markets specialized in the 
preparation of herbal medicines (Oudhia, 2003).  
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The flower is pungent, acrid, cooling, toxic, sedative and anthelmintic, and is useful in 
thirst, dysentery, leprosy, erysipelas, blood diseases, leucorrhoea, menorrhagia and 
toothache. It is considered as ‘Kapha’ (mucilage type body secretion) and ‘Pitta’ 
(energy-dependent metabolic activity) suppressant in the Ayurvedic concepts of 
medicine (Sharma, 1956). Many marketed drugs comprise flowers, fruits, leaves and 
buds mixed with pedicels and thinner twigs of the plant (Chopra et al., 1956; Ahuja, 
1965).  
 
The flowers are used in the preparation of Ayurvedic fermented drugs called 
“Aristhas” (hot extraction followed by month-long slow fermentation) and “Asavas” 
(cold percolation followed by month-long slow fermentation) (Atal et al., 1982). 
Aristhas are believed to be general health tonics in nature, having overall health 
stimulating properties via ameliorating and/or delaying one or other systemic 
disorders. Of the 18 aristhas mentioned in the Indian Ministry of Health & Family 
Welfare’s monograph (CCRIMH, 1978), 17 have been found to contain Woodfordia 
fruticosa. Tribal people in the Chhattisgarh district of central India uses fresh flowers 
to stop bleeding in emergency cuts, but they prefer to employ dried flower powder to 
heal wounds more efficiently. It is also one of the ingredients of a preparation used to 
increase fertility in women (Burkill, 1966; Dey, 1984).  
 
Flowers used for the ayurvedic preperation “Kutajarista” for Sprue, dysentery, 
diarrhoea (Shenoy and Yoganarasimhan, 2008), “Lukol” for the leucorrhoea DUB 
(dysfunctional uterine bleeding) and symptoms of pelvic inflammatory disease. Oil 
based flower extract has always been recommended for open wounds (Tewari et al., 
2001; Das et al., 2007). The dried flowers powder sprinkled over ulcers and wounds 
to diminish discharge and promote granulation (Khorya and Katrak, 1984). They are 
also used as tonic in disorders of mucous membranes, hemorrhoids and in 
derangement of the liver (Chopra et al., 1956; The Wealth of India, 1988; Mhaskar et 
al., 2000). An Ayurvedic medicine called “Balarishta”, a drug of ‘Asava’ and 
‘Aristha’ group, contains Woodfordia fruticosa flowers as one of the major 
constituents and is used in burning sensation in stomach (Agnimandya), weakness 
(Daurbalya) and rheumatic diseases (Vataja roga) (Anonymous, 1978). A popular 
crude drug (Sidowaya or Sidawayah) of Indonesia and Malaysia mainly contains 
dried flowers of Woodfordia fruticosa (Burkill, 1966). It has been used as an 
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astringent to treat dysentery and sprue and also for the treatment of bowel complaints, 
rheumatism, dysuria and hematuria in many southeast Asian countries. 
 
Water decoction of the fresh flowers, either alone or in combination with ginger 
(Zingiber officinale) or intrajua (Wrightia tinctoria), is used for the treatment of 
dysentery. Oral use of powdered bark in managing diarrhea is well known. Successful 
treatment of otorrhoea by dried powdered flowers in tribal areas of Chhatisgarh is 
reported to be popular (Oudhia, 2003). Management of female-specific disorders like 
leucorrhoea and dysmenorrhoea with flower-based preparations is very popular 
among these tribes. However, many of these tribal therapies are not supported by 
systematic ethnobotanical and ethnopharmacological research. Some of the reported 
activity of different parts of Woodfordia fruticosa are listed in Table 4. 
 
2.3.1. Chemical constituents 
 
The extracts of Woodfordia fruticosa flowers showed the presence of carbohydrates, 
gums, flavonoids, sterols and phenolic compounds/tannins (Khushalani et al., 2006). 
A series of publications have appeared on the structural characterization of the 
secondary metabolites of the plant. The compounds identified are predominantly 
phenolics, particularly hydrolysable tannins and flavonoids. The following chemical 
constituents are found in different part of the Woodfordia fruticosa. 
 
Octacosanol and β-sitosterol (Chauhan et al., 1979a), steroid sapogenin hecogenin and 
meso-inositol from the flowers (Chauhan et al., 1979b), lupeol, betulin, betulinic acid, 
oleanolic acid and ursolic acid from the leaves (Dan and Dan, 1984) .  
 
The phenolic constituents include gallic acid in leaves and stems (Kalidhar et al., 
1981; Kadota et al., 1990), ellagic acid in leaves and flowers (Nair et al., 1976), 
bergenin (a C-glycoside of gallic acid) and the norbergenin in stems (Kalidhar et al., 
1981), chrysophanol-8-O-β-D-glucopyranoside in flowers (Chauhan et al., 1979a), 
and the naphthaquinone pigment lawsone in leaves (Saoji et al., 1972).  
 
The flavonoid constituents: six quercetin glycosides; 3-rhamnoside from flowers 
(Chauhan et al., 1979b), 3-β-L-arabinoside (polystachoside) from flowers and leaves 
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(Nair et al., 1976), and 3-O-α-L-arabinopyranoside, 3-O-β-D-xylopyranoside, 3-O-
(6″-galloyl)-β-D-glucopyranoside from leaves (Kadota et al., 1990). Three myricetin 
glycosides; 3-O-β-D-galactoside in flowers and leaves (Nair et al., 1976), and 3-O-α-
L-arabinopyranoside, 3-O-(6″-galloyl)-β-D-galactopyranoside in leaves (Kadota et al., 
1990), as also naringenin 7-glucoside and kaempferol 3-O-glucoside in flowers 
(Chauhan et al., 1979b).  
 
A large number of new and known hydrolysable tannins have been isolated from the 
flowers. The known tannins reported are: 1,2,3,6-tetra-O-galloyl-β-D-glucose, 
1,2,4,6-tetra-O-galloyl-β-D-glucose, 1,2,3,4,6-penta-O-galloyl-β-D-glucose, 
tellimagrandin, gemin D, heterophyllin A and oenothein B (Yoshida et al., 1989a, 
1990), woodfordins A-C (Yoshida et al., 1989b, 1990), woodfordin D, oenothein A 
(Yoshida et al., 1991), as also isoschimawalin A and woodfordins E-I (Yoshida et al., 
1992; Kuramochi-Motegi et al., 1992).   
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Table 2: List of medicinal plants, their family, part, solvent and model used for anti-
inflammatory activity 
Sr. 
No. 
Plant (Family) Part used Solvent 
used 
Model used References 
1 Acacia modesta 
Wall. (Mimoseae) 
Leaves 70% 
Methanol 
- Carrageenan 
- Acetic acid  
- Hot plate 
- Formalin 
 
Bukhari et 
al.,  2010 
2 Aconitum 
heterophyllum 
Wall. ex Royle. 
(Valeraneaceae)  
 
Root Ethanol - Cotton pellet Verma et al., 
2010 
3 Albizia  lebbeck 
Benth. 
(Mimosaceae) 
Bark Petroleum 
ether, 
Chloroform, 
95% Ethanol 
 
- Carrageenan 
- Dextran 
- Cotton pellet 
Babu et al., 
2009 
4 Allanblackia 
monticola Staner 
LC. (Guttiferae) 
Stem bark Methylene 
chloride:Me
thanol 
(1:1) 
- Carrageenan 
- Dextran 
- Histamine 
- Serotonin 
- Arachidonic 
acid 
- Hot plate 
Nguemfo et 
al., 2007 
5 Aniba canelilla 
(H.B.K.) Mez. 
(Lauraceae) 
Bark  Bark wood 
oil 
- Acetic acid  
- Hot plate 
- Formalin 
 
De Lima et 
al., 2009 
6 Annona Squamosa 
L. (Annonaceae) 
Bark Petroleum 
ether 
- Carrageenan 
- Acetic acid  
- Hot plate 
 
Chavan et al., 
2010 
7 Aquilaria sinensis 
(Lour.) Gilr. 
(Thymelaeaceae) 
Leaves 50% 
Ethanol 
- Carrageenan 
- Xylene 
- CMC-Na 
induced 
leukocyte 
emigration 
- Acetic acid  
- Hot plate 
Zhou et al., 
2008 
8 Arctium minus (Hill) 
Bernh. ssp. Minus. 
(Asteraceae) 
 
Leaves Water,  
Ethanol 
- Carrageenan 
- p-benzoquinone 
Erdemoglu et 
al., 2009 
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 Table 2: Cont… 
 
Sr. 
No. 
Plant (Family) Part used Solvent 
used 
Model used References 
9 Aristolochia indica L. 
(Aristolochiaceae) 
Argemone mexicana 
L. (Papaveraceae) 
Alpinia speciosa 
Schum. 
(Zingiberaceae) 
Gymnema sylvestre 
(Retz.) Schult. 
(Asclepidaceae) 
Leaves  
 
Whole plant 
 
Leaves, 
Stem 
 
Leaves, 
Stem 
Methanol - Carrageenan Vaghasiya et 
al., 2010 
10 Artemisia copa 
Phil. (Compositae) 
Aerial parts Water,  
50% 
Ethanol, 
Dichlorome
thane 
- Carrageenan 
- TPA 
- Acetic acid  
- Hot plate 
- Formalin 
Mino et al., 
2004 
 
11 Austroplenckia 
populnea Reiss. 
(Celastraceae) 
Bark 96 % 
Ethanol  
- Carrageenan 
- Dextran 
- Histamine 
- Acetic acid  
- Hot plate 
Andrade et 
al., 2007 
12 Baccharis 
dracunculifolia DC. 
(Asteraceae) 
Leaves Ethanol/wat
er (7:3) 
- Acetic acid 
- Formalin 
- Carrageenan 
- Histamine 
dos Santos et 
al., 2010 
13 Baccharis illinita 
DC. (Asteraceae) 
Leaves 96% 
Ethanol 
- TPA  
- Capsaicin 
- Arachidonic 
acid 
 
Boller et al., 
2010 
14 Bauhinia purpurea 
Linn. 
(Leguminoseae) 
Leaves Water - Carrageenan 
- Acetic acid  
- Hot plate 
- Formalin 
 
Zakaria et al., 
2007 
 
15 Bauhinia racemosa 
L. (Caesalpiniaceae) 
Stem bark Methanol - Carrageenan 
- Dextran 
- Histamine 
- Serotonin 
- Cotton pellet 
- Acetic acid  
- Hot plate 
- Yeast induced 
hyperpyrexia 
Gupta et al., 
2005 
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 Table 2: Cont… 
 
Sr. 
No. 
Plant (Family) Part used Solvent 
used 
Model used References 
16 Bowdichia 
virgilioides Kunth. 
(Leguminosae, 
Papilonoideae) 
Bark, 
Leaves 
Water - Carrageenan 
- Acetic  
- Hot plate 
- Formalin 
Thomazzi 
et al., 2010 
17 Caesalpinia 
bonducella  F. 
(Caesalpiniaceae) 
Seed Seed oil - Carrageenan 
- Acetic acid  
- Hot plate 
Shukla et al., 
2010 
18 Camellia sinensis 
L. (Theaceae) 
 
Leaves Water 
(boiling) 
- Carrageenan 
- Arachidonic 
acid 
Roy et al., 
2008 
 
19 Celosia argentea L.  
(Amaranthaceae) 
 
Leaves 95% 
Ethanol 
- Carrageenan 
- Cotton pellet 
Bhujbal et 
al., 2008 
20 Chloranthus eretus 
(Buch-Ham) Verd. 
(Chloranthaceae) 
Leaves 90% 
Methanol 
- Carrageenan 
- Histamine 
- Serotinin 
- Cotton pellet 
Tag et al., 
2009 
21 Cissampelos 
pareira L. 
(Menispermaceae) 
Roots 50% 
Ethanol 
- Acetic acid  
- Hot plate 
Amresh et 
al., 2007 
22 Citrullus 
colocynthis Schrad. 
(Cucurbitaceae) 
Root, Seed, 
Stem, 
Leaves, 
Fruit 
Water - Carrageenan 
- Acetic acid  
Marzouk et 
al., 2010 
23 Coccinia indica 
Wight & Arn. 
(Cucurbitaceae) 
Leaves Water - Carrageenan 
- Tail flick 
Niazi et al., 
2009 
24 Combretum 
micranthum G. Don. 
(Combretaceae) 
Leaves Water - Carrageenan 
- Acetic acid  
- Cotton pellet 
Olajide et al., 
2003 
 
25 Coronopus didymus 
(L.) Smith. 
(Brassicaceae) 
Whole 
plant 
Ethanol - Carrageenan 
- Histamine 
- dextran 
Busnardo et 
al., 2010 
26 Dodonaea 
polyandra Merr. & 
L.M.Perry. 
(Sapindaceae) 
Leaves 80% 
Ethanol 
- Croton oil Simpson et 
al., 2010 
27 Dregea volubilis 
(L.f.) Benth. ex 
Hook.f. 
(Asclepiadaceae) 
Leave Methanol 
Petroleum 
ether,  
Chloroform 
- Carrageenan  Hossain et 
al., 2010 
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 Table 2: Cont… 
 
Sr. 
No. 
Plant (Family) Part used Solvent 
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28 Drimys angustifolia 
Miers. (Winteraceae)
Leaves, 
Stem bark 
Water - Carrageenan 
- Acetic acid  
- Hot plate 
- Tail flick 
Witaicenis et 
al., 2007 
 
29 Ecbolium viride 
(Forsk) Merrill. 
(Acanthaceae) 
Root 80 % 
Ethanol 
- Carrageenan 
- Cotton pellet 
 
Lalitha and 
Sethuraman, 
2010 
30 Geranium pretense 
subsp. Finitimum 
(Geraniaceae) 
Aerial parts Methanol - Carrageenan 
- PGE2 
- p-benzoquinone 
Kupeli et al., 
2007 
31 Hygrophila spinosa 
T. Anders. 
(Acanthaceae) 
 
Leaves Petroleum 
ether, 
Chloroform, 
Ethanol, 
Water 
- Carrageenan 
 
Patra et al., 
2009 
32 Hypericum 
rumeliacum Boiss. 
subsp. apollinis 
(Boiss. & Heldr.) 
Robson & Strid.  
(Guttiferae) 
Aerial parts Methanol 
 
- Carrageenan 
 
Galati et al., 
2008 
 
33 Lamiophlomis 
rotata (Benth.) 
Kudo. (Labiatae) 
Aerial parts Water - Carrageenan 
- Xylene 
- Acetic acid  
- Hot plate 
- Formalin 
Li et al., 
2010 
34 Lantana trifolia L. 
(Verbenaceae) 
Leaf  Ethanol - Carrageenan 
- Histamine 
- Serotonin 
- Acetic acid  
- Tail flick 
Silava et al., 
2005 
35 Leonotis 
nepetaefolia R. Br. 
(Lamiaceae) 
Leaves, 
Stem, 
Flowers 
Hexane, 
Ethyl 
acetate,  
Methanol 
- TPA  Delgado 
et al., 2004 
36 Leucas aspera  
Spreng. (Labiatae) 
Aerial parts 95% 
Ethanol 
- Formalin Goudgaon et 
al., 2003 
37 Ligustrum 
robustum L. O. 
Kuntze. (Theaceae) 
Leaves Ethanol - Acetic acid  
- Croton oil 
Lau et al., 
2002 
38 Lindera erythrocarpa 
Makino. (Lauraceae) 
Fruit Ethanol - Croton oil  Wang SY et 
al., 2008 
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39 Mallotus 
philippinensis  
Muell.-Arg. 
(Euphorbiacea) 
Stem wood Ethanol  - Formaldehyde 
- Carrageenan 
Arfan et al., 
2010 
40 Malva parviflora 
Linn. (Malvaceae) 
Stem Methanol - Carrageenan 
- Histamine 
- Acetic acid 
- Formalin 
Afolayan et 
al., 2010 
41 Moringa  oleifera 
L. (Moringaceae) 
Leaves Water - Carrageenan 
- Acetic acid  
- Hot plate 
- Formalin 
Sulaiman et 
al., 2008 
42 Mortonia greggii 
Gray. (Celastraceae) 
Roots, 
Leaves 
Acetone - Carrageenan 
- TPA  
Arciniegas 
et al., 2004 
43 Olax viridis Oliv 
(Olacaeceae) 
Root bark Hexane - Egg albumen  Ajali  and 
Okoye, 2009 
44 Onosma L. species 
(Boraginaceae) 
Roots 70% 
Chloroform, 
70% 
Ethanol 
- Carrageenan 
- p-benzoquinone  
induced 
abdomen 
constriction 
Tosun et al., 
2008 
 
45 Paederia scandens  
(Lour.) Merri. 
(Rubiaceae) 
Whole 
plant  
Methanol - Formalin 
- Acetic acid  
- Hot plate 
- Tail flick 
Chu et al., 
2008 
46 Parquetina 
nigrescens (Afzel) 
Bullock. 
(Periploceae) 
Leaves Water - Carrageenan 
- Formalin 
- Hot plate 
- Cotton pellet 
Owoyele et 
al., 2009 
 
47 Pedilanthus 
tithymaloides L. Poit. 
(Euphorbiaceae) 
Stem,  
Leave  
Tincture - Carrageenan 
 
Abreu et al., 
2006 
48 Petroselinum 
crispum (Mill.) 
(Umbelliferae) 
Leaves Ethanol - Carrageenan  
- Cotton pellet 
Al-Howiriny 
et al., 2003  
49 Pimenta racemosa 
var. ozua. 
(Mirtaceae) 
Leaves  Water - Carrageenan 
- TPA 
- Formalin 
- Acetic acid  
- Hot plate 
Garcia et al., 
2004 
50. Pinus brutia Ten. 
(Pinaceae) 
Bark - - Carrageenan 
 
Ince et al., 
2009 
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51 Pinus densiflora 
Siebold & Zucc. 
(Pinaceae) 
Pollen 70% 
Ethanol 
- Carrageenan 
- Formalin 
- Arachidonic 
acid 
Choi et al., 
2007 
52 Piper sarmentosum 
Roxb. (Piperaceae) 
Leaves Water - Acetic acid  
- Hot plate 
- Carrageenan 
Zakaria et al., 
2010 
53 Piper sp. 
(Piperaceae) 
Leaves Methanol - Carrageenan 
- Cotton pellet 
- Dextran 
Vaghasiya et 
al., 2007 
54 Piptadenia 
stipulacea Benth. 
(Fabaceae) 
Aerial parts Ethyl  
acetate 
- Acetic acid  
- Hot plate 
- Formalin 
- Zymosan A 
de Queiroz 
et al., 2010 
55 Plumeria 
acuminate Ait. 
(Apocynaceae) 
Leaves Methanol - Carrageenan 
- Dextran 
- Histamine 
- Serotonin 
- Cotton pellet 
Gupta et al., 
2006 
56 Polyalthia 
longifolia var. 
pendula. 
(Annonaceae) 
Leaves Toluene, 
Chloroform, 
Acetone,  
Methanol 
- Carrageenan Tanna et al., 
2009 
57 Rhus chirindensis 
(Baker F) 
(Anacardiaceae) 
Stem bark Water - Egg albumin 
- Acetic acid  
- Hot plate 
Ojewole, 
2007 
58 Russelia 
equisetiformis 
(Schlect&Chan)  
(Scrophulariacae) 
Whole 
plant 
Methanol - Egg albumin 
- Agar 
Awe et al., 
2010 
59 Schima wallichii 
Choisy. 
(Ternstroemiaceae) 
Bark 70% 
Ethanol 
- Carrageenan 
- Dextran 
- Cotton pellet 
Dewanjee et 
al., 2009 
60 Sclerocarya birrea 
(A. Rich.) 
(Anacardiaceae) 
Stem bark Water, 
Methanol 
- Carrageenan 
- Histamine 
- Serotonin 
- Complete 
Freund’s 
Adjuvant 
- Formalin 
Fotio et al., 
2009 
61 Smilax china Linn. 
(Liliaceae) 
Whole 
plant 
Methanol - Carrageenan 
 
Khan et al., 
2009 
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62 Solanum 
melongena Linn. 
(Solanaceae) 
Leaves Water - Acetic acid  Mutalik et 
al., 2003 
 
63 Sonchus oleraceus 
L. (Asteraceae) 
Aerial parts 50% 
Ethanol 
- Carrageenan 
- Cotton pellet 
Vilela et al., 
2010 
64 Strychnos nux-
vomica L. 
(Loganiaceae) 
Brucine 
and 
Brucine N-
oxide from 
Seeds 
- - Carrageenan 
- Formalin 
- Acetic acid  
- Hot plate 
Yin et al., 
2003 
65 Tabernaemontana 
catharinensis DC. 
(Apocynaceae) 
Bark 95% 
Ethanol 
- Carrageenan 
- Acetic acid  
Gomes et al., 
2009 
66 Thespesia populnea 
Soland ex. Correa. 
(Malvaceae) 
Bark 95% 
Methanol 
- Carrageenan 
- Histamine 
- Serotonin 
- Acetic acid  
- Hot plate 
Vasudevan et 
al., 2007 
67 Trachelospermum 
jasminoides Lindl. 
(Apocynaceae) 
- Water - Acetic acid 
- Formalin 
- Carrageenan 
Sheu et al., 
2009 
68 Trichodesma 
indicum Linn. 
(Boraginaceae) 
Root Chloroform - Carrageenan 
- Histamine 
- Dextran 
- Serotonin 
- Cotton pellet 
Perianayagam 
et al., 2006 
69 Vitex negundo 
Linn. (Verbenaceae) 
Leaves Petroleum 
ether 
- Carrageenan 
- Cotton pellet 
Subramani et 
al., 2009 
70 Zingiber zerumber 
L. (Zingiberaceae) 
Rhizomes Water,  
Ethanol 
- Acetic acid  Somchit et 
al., 2005 
  
Abbreviations 
CMC-Na: Carboxymethylcellulose sodium, PGE2: prostaglandin E2, TPA: 12-O-
tetradecanoylphorbol-13-acetate.  
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Table 3: List of medicinal plants, their family, part, solvent and hepatotoxicant used for 
hepatoprotective activity 
 
Sr. 
No. 
Plant (Family) Part used Solvent 
used 
Hepatotoxicant used 
and parameters done 
References 
1 Abutilon indicum 
L. (Malvaceae) 
Leaves Water CCl4,  
Acetaminophen  
- Serum AST, ALT, 
ALP, TB, DB 
- Liver GSH 
Porchezhian 
and Ansari, 
2005  
2 Acanthopanax 
senticosus 
Stem bark Water tert-butyl 
hydroperoxide (t-BHP) 
- Liver SOD, CAT, 
GPx, GSH, GSSG 
- Histopathology 
Wang et al., 
2010  
3 Aloe barbadensis 
Mill. (Liliaceae) 
Aerial part Water CCl4 
- Hexobarbitone 
induced narcosis 
- Zoxazolamine 
induced paralysis 
time 
- Serum AST, ALT, 
ALP, LDH, TB, TG 
- Liver GSH, LPO, TG 
Chandan et 
al., 2007  
4 Andrographis 
lineate Fam. 
(Acanthaceae) 
Leaves Methanol, 
Water 
CCl4  
- Serum ALT, AST, 
ALP 
Sangameswaran 
et al., 2008  
5 Anoectochilus 
formosanus Hayata. 
(Orchidaceae) 
Whole plant Water CCl4  
- Serum ALT 
- Liver LPO 
- Histopathology  
Fang et al., 
2008  
6 Apium graveolens 
Linn. (Apiaceae) 
Croton 
oblongifolius Roxb. 
(Euphorbiaceae) 
Seeds Petroleum 
ether, 
Acetone, 
Methanol 
CCl4 
- Serum AST, ALT, 
ALP, TP, ALB 
Ahmed et al., 
2002  
7 Aralia 
continentalis 
Kitagawa. 
(Araliaceae) 
Root Ethanol CCl4  
- Serum ALT, AST 
- Liver GSH, GST, LPO 
- Histopathology 
Hwang et al., 
2009  
8 Artemisia 
absinthium L. 
(Asteraceae) 
Aerial part  Water CCl4  
Bacillus Calmette –
Guerin and 
lipopolysaccharide 
- Serum AST, ALT, 
TNF-α, IL-1 
- Liver LPO, SOD, GPx 
- Histopathology 
Amat et al., 
2010  
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9 Artemisia 
sacrorum Ledeb. 
(Compositae) 
Aerial part Water Acetaminophen  
- Serum ALT, AST 
- Liver LPO, GSH 
- Histopathology 
Yuan et al., 
2010  
10 Azadirachta indica 
Juss. (Meliaceae) 
Leaves Fresh juice Acetaminophen 
- Serum AST, ALT, 
ALP 
- Liver LPO, T-SH 
- Histopathology 
Yanpallewar 
et al., 2002  
11 Bauhinia variegate 
L. (Leguminosae) 
 
Stem bark Alcohol CCl4  
- Serum AST, ALT, 
ALP, TP, GGT, TL 
- Liver TP, TL 
- Histopathology 
Bodakhe and 
Ram, 2007  
12 Berberis tinctoria 
Lisch. 
(Berberidaceae) 
Leaves Methanol 
 
Acetaminophen  
- Serum AST, ALT, 
ALP, TB, TP 
- Liver GSH, LPO, 
SOD, CAT 
- Histopathology  
Murugesh et 
al., 2005  
13 Boerhaavia 
diffusa Linn. 
(Nynctaginaceae) 
Leaves Ethanol Acetaminophen 
- Serum AST, ALT, 
ALP, ALB, LDH 
- Liver AST, ALT, 
ALP, TB, LDH, 
LPO 
Olaleye et al., 
2010  
14 Camellia sinensis 
Kuntze. (Theaceae) 
- Water Sodium oxalate  
- Serum, liver and 
kidney AST, ALT, 
LPO, CAT, Vit-C 
Oyejide and 
Olushola, 
2005  
15 Cassia tora L. 
(Caesalpiniaceae) 
Ononitol 
monohydrate 
from Leaves 
- CCl4  
- Serum ALT, AST, 
ALP 
- Liver CAT, SOD, 
GR, GPx, GST 
- Histopathology 
Dhanasekaran 
et al., 2009  
16 Chamomile capitula 
L. Rousch. 
(Asteraceae) 
Whole plant Ethanol Acetaminophen  
- Serum AST, ALT, 
ALP, TP, TB 
- Liver GSH, LPO, 
GLY, TP, Na+K+-
ATPase 
Gupta and 
Misra, 2006  
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and parameters done 
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17 Cistanche tubulosa 
Wight. 
(Orobanchaceae) 
 
Phenylethan
-oid 
oligoglycosi
-des 
(kankanosid
-es) from 
Stem 
Methanol D-galactosamine  
Lipopolysaccharide 
- Serum ALT, AST 
Morikawa et 
al., 2010  
18 Cistus laurifolius 
L. (Cistaceae) 
Isolation of 
flavonoid 
from Leaves 
Ethanol Acetaminophen  
- Plasma AST, ALT, 
LPO 
- Liver LPO 
Kupeli et al., 
2006  
19 Citrus limon L. 
Burm. (Rutaceae) 
Fruits 70% 
Ethanol 
CCl4 
- Serum AST, ALT, 
ALP, TP, ALB, TB, 
DB 
- Liver GSH, LPO, 
CAT, SOD 
- Histopathology 
Bhavsar et al., 
2007  
20 Cordia macleodii 
Griff. 
(Boraginaceae) 
Leaves Ethanol CCl4  
- Serum ALT, AST, 
ALP, TB 
Qureshi et al., 
2009  
21 Coronopus 
didymus Linn. 
(Bracicacea) 
Whole plant Water CCl4  
- Serum AST, ALT 
- Liver GSH, LPO, TP 
Mantena et 
al., 2005  
22 Curcuma longa  
Linn. (Zingiberaceae)
Glycyrrhiza glabra 
L. (Leguminosae) 
Moringa oleifera 
Lam. (Moringaceae) 
Rhizome Ethanol, 
Water 
Diclofenac  
- Serum ALT, ALB 
- Liver GSH, LPO, 
CAT, SOD 
- Histopathology 
Hamza, 2007 
23 Cuscuta chinensis 
Lam. 
(Convolvulaceae) 
Seeds Ethanol, 
Water 
Acetaminophen  
-  Serum AST, ALT, 
ALP 
- Liver LPO, CAT, 
GPx, SOD  
- Histopathology 
Yen et al., 
2007  
24 Cytisus scoparius 
L. (Leguminosae) 
Aerial part Ethanol: 
Water 
(7:3) 
CCl4 
- Serum AST, ALT, 
LDH 
- Liver GSH, LPO, 
CAT, SOD, GPx, 
GST, GR 
Raja et al., 
2007  
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25 Decalepis 
hamiltonii Wight. 
(Asclepiadaceae) 
Root Water  CCl4  
- Serum ALT, AST, 
ALP, LDH 
- Liver LPO, CAT, 
SOD, GPx, GST, 
GSH, GR 
- Histopathology 
Srivastava and 
Shivanandappa, 
2010  
26 Diospyros 
malabarica Kostel. 
(Ebenaceae) 
Bark Methanol CCl4  
- Serum AST, ALT, 
ALP, TP, TB 
- Liver GSH, LPO, 
CAT 
Mondal et al., 
2005  
27 Enicostemma 
axillare Raynal. 
(Gentianaceae) 
Swertiamarin 
from 
Whole plant 
Ethyl 
acetate 
D-galactosamine 
- Serum AST, ALT, 
ALP, TG, TC, TB, 
TP, ALB, CR, GSH, 
LPO, CAT, SOD 
- Liver and kidney 
GSH, LPO, CAT, 
SOD 
Jaishree and 
Badami, 2010  
28 Epaltes divaricata 
L. (Compositae) 
Whole plant Water CCl4  
- Serum AST, ALT, 
ALP 
- Liver GSH 
- Histopathology 
Hewawasam 
et al., 2004  
29 Euphorbia 
fusiformis D.Don. 
(Euphorbiaceae) 
Tubers Ethanol Rifampicin  
- Serum ALT, AST, 
ALP, GGT, TP, TB 
- Histopathology 
Anusuya et 
al., 2010 
30 Glycyrrhiza glabra 
L. (Leguminosae) 
 
Glycyrrhizin 
from  Root 
 
Methanol CCl4 
- Serum AST, ALT 
- Liver LPO, GSH 
- Histopathology 
Lee et al., 
2007  
31 Grewia tiliaefolia 
Vahl. (Tiliaceae) 
γ-lactones 
from  
Stem bark 
- CCl4  
- Serum AST, ALP, 
ALP, TP, TB 
- Liver GSH, LPO 
- Histopathology 
Ahamed et al., 
2010  
32 Halenia elliptica 
(Gentianaceae) 
Whole plant 70% 
Methanol 
CCl4  
- Serum AST, ALT, 
ALP, TB 
- Histopathology 
Huang et al., 
2010a  
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33 Hedyotis 
corymbosa Lam. 
(Rubiaceae) 
Whole plant Methanol Acetaminophen  
- Serum AST, ALT, 
ALP, TB 
- Hexobarbitone 
induced sleeping time 
- Histopathology 
Sadasivan et 
al., 2006  
34 Hibiscus sabdariffa 
L. (Malvaceae) 
Rosmarinus 
officinalis L. 
(Lamiaceae) 
Salvia officinalis 
L. (Lamiaceae) 
Flowers 
 
Leaves 
 
 
Leaves 
Water Azathioprine  
- Serum AST, ALT 
- Liver GSH, LPO, 
CAT, SOD 
Amin and 
Hamza, 2005  
35 Hybrophila 
auriculata Heine. 
(Acanthaceae) 
Root Water CCl4  
- Serum AST, ALT, 
ALP, LDH, TB, TP 
- Histopathology 
Shanmugasund
aram and 
Venkataraman, 
2006  
36 Justicia simplex D. 
Don. (Acanthaceae) 
 
Whole plant 
(Isolated 
lignans) 
Petroleum 
ether 
CCl4 
- Serum AST, ALT, 
ALP, LPO, TG, TP 
- Liver GSH, LPO 
Jasemine et 
al., 2007  
37 Kyllinga nemoralis 
L. (Cyperaceae) 
Rhizome Petroleum 
ether, 
Ethanol 
CCl4  
- Serum ALT, AST, 
ALP, ACP 
- Liver GSH, LPO, 
CAT, SOD 
Somasundaram 
et al., 2010  
38 Laggera alata (D. 
Don) Sch.-Bip. 
Whole plant - CCl4  
- Serum AST, ALP, 
TP, ALB 
- Histopathology 
Wu et al., 
2009  
39 Ligustrum 
robustum Roxb. 
(Oleaceae) 
Leaves Water CCl4  
- Serum AST, ALT 
- Histopathology 
Lau et al., 
2002 
40 Lygodium 
flexuosum (L.) Sw. 
(Lygodiaceae) 
Whole plant Hexane CCl4  
- Serum AST, ALT, LDH
- Liver GSH, LPO 
- Histopathology 
Wills and 
Asha, 2006  
41 Mamordica 
subangulata Blume. 
(Cucurbitaceae) 
Naragamia alata 
W& A. (Meliaceae) 
Leaves Water Acetaminophen 
- Serum AST, ALT, 
ALP 
Asha, 2001  
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42 Moringa oleifera 
Lam. 
(Moringeaceae) 
Seed 70% 
Ethanol 
CCl4  
- Serum AST, ALT, 
TP, ALB, GL 
- Liver LPO, SOD, TP 
Hamza, 2010  
43 Nelumbo nucifera 
Gaertn. 
(Nelumbonaceae) 
Leaves 60% 
Ethanol 
CCl4  
- Serum ALT, AST, 
ALP, GGT, TB 
- Liver GSH, CAT, 
SOD, LPO 
Huang et al., 
2010b  
44 Operculina 
turpethum L. 
(Convolvulaceae) 
Root Ethanol Acetaminophen  
- Serum AST, ALT, 
ALP, TB 
- Histopathology 
Suresh kumar 
et al., 2006  
45 Pergularia daemia 
Forsk. 
(Asclepiadaceae) 
Aerial part Ethanol CCl4  
- Serum AST, ALT, 
ALP, TB, TP, TC, 
ALB 
- Histopathology 
Suresh kumar 
and Mishra, 
2006  
46 Petroselinum 
crispum (Mill.) 
(Umbelliferae) 
Leaves Ethanol CCl4  
- Plasma AST, ALT, 
ALP, TB 
- Phenobarbital 
induced sleeping 
time 
- Histopathology 
Al-Howiriny 
et al., 2003 
47 Phyllanthus 
amarus Schum. et 
Thonn.  
(Euphorbiacae) 
Aerial Ethanol Aflatoxin B1  
- Liver LPO, GSH, GPx, 
GST, SOD, CAT 
- Histopathology 
Naaz et al., 
2007  
48 Phyllanthus niruri 
L. (Euphorbiaceae) 
Aerial part Hexane Acetaminophen  
- Serum ALT, AST, 
ALP, TB 
Iqbal et al., 
2007  
49 Phyllanthus niruri 
L. (Euphorbiaceae) 
Protein 
isolated 
from Leaves 
- CCl4  
- Serum ALT, ALP 
- Liver LPO, GSH, 
CAT, SOD 
- Histopathology 
Bhattacharjee 
and Sil, 2007  
50 Phyllanthus niruri 
L.(Euphorbiaceae) 
Leaves, 
Stem 
PO4 buffer Nimesulide  
- Serum ALT, AST, 
ALP 
- Liver GSH, LPO, 
CAT, SOD, TP 
Chatterjee and 
Sil, 2007  
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51 Phyllanthus 
urinaria L. 
(Euphorbiaceae) 
 
Whole plant 80% 
Ethanol 
Acetaminophen 
- In vitro cytochrome 
P450 CYP2E1 enzyme 
assay 
- Histopathology 
Hau et al., 
2009  
52 Physalis peruviana 
L. (Solanaceae) 
Whole plant Water Acetaminophen  
- Serum ALT, AST, 
ALP 
- Liver CAT, GPx, SOD 
Chang et al., 
2008  
53 Physalis peruviana 
Linn. (Solanaceae) 
Leaves Hexane, 
Ethanol, 
Water 
CCl4 
- Serum AST, ALT, 
LDH 
- Liver GSH, LPO 
- Histopathology 
Arun and 
Asha, 2007  
54 Picrorrhiza 
rhizoma Benth. 
(Scrophulariaceae) 
Whole plant Water Poloxamer (PX)- 407  
- Serum AST, ALT, 
LDL, HDL, TG, TC 
Lee et al., 
2006  
55 Piper chaba Trel. 
& Yunck. 
(Piperaceae) 
Amide 
constituents 
from Fruit 
- D-galactosamine  
- Serum ALT, AST 
Matsuda et 
al., 2009  
56 Pittosporum 
neelgherrense 
Wight & Arn. 
(Pittosporaceae) 
Stem bark Methanol CCl4 
D- galactosamine  
Acetaminophen  
- Serum AST, ALT 
- Histopathology 
Shyamal et 
al., 2006  
57 Plantago major L. 
(Plantaginaceae) 
Diplotaxis acris 
Boiss. (Compositae) 
Schouwia thebaica 
Webb. (Brassicaceae)
Seeds Methanol CCl4 
- Serum AST, ALT, 
GGT, GL, TB, TG, 
TC, TP, ALB 
Atta et al., 
2006 
58 Platycodon 
grandiflorum 
 A. DC. 
(Campanulaceae) 
Saponins 
derived 
from Root  
Water CCl4  
- Serum ALT, AST 
- Liver LPO 
- Histopathology  
Lee et al., 
2008  
59 Polyalthia longifolia
var. pendula. 
(Annonaceae) 
Leaves Methanol Diclofenac 
- Serum TP, ALB, GL, 
GLY, ALT, AST, TB 
Tanna et al., 
2009  
60 Polygala arvensis 
Willd. 
(Polygalaceae) 
Leaves Chloroform D-galactosamine 
- Serum AST, ALT, 
ALP, TP, ALB, TB, 
TG, TC, LDH 
Dhanabal et 
al., 2006  
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61 Pracparatum mungo Fermented 
product 
- CCl4  
- Serum AST, ALT 
- Liver LPO, GSH, SOD
- Histopathology 
Kuo et al., 
2010  
62 Pterocarpus 
marsupium Roxb. 
(Papilionaceae) 
Stem bark Methanol, 
Water  
CCl4  
- Serum AST, ALT, 
ALP, TB, TP 
- Histopathology 
Krishna et 
al., 2005  
63 Punica granatum 
Linn. (Punicaceae) 
Flowers Water CCl4  
- Serum ALT, AST, 
ALP, LDH 
- GSH, MDA, GPx, SOD 
from different organ 
Celik et al., 
2009  
64 Quercus aliena 
Blum. (Fagaceae) 
- Water, 
Ethanol, 
Methanol, 
Chloroform 
CCl4 
- Serum AST, ALT 
- Liver LPO 
- Histopathology 
Jin et al., 
2005  
65 Rhoicissus tridentata 
Wild. (Vitaceae) 
Root Water CCl4  
- Serum AST, ALT 
- Liver LPO, G-6-Pase 
Opoku et al., 
2007  
66 Saccharomyces 
cerevisiae Meyen. 
(Saccharomycetaceae) 
Fermented 
substance 
- CCl4  
- Serum AST, ALT, 
ALB 
- Liver LPO, CAT, 
GPx, GSH, SOD 
Lai et al., 
2009 
 
67 Sida acuta Burm. f. 
(Malvaceae) 
 
Root Methanol Acetaminophen 
- Hexobarbitone-
induced sleeping time 
studies 
- Serum GOT, GPT, 
ALP, TB 
- Histopathology 
Sreedevi et 
al., 2009   
 
 
68 Sophora flavescens 
Aiton. 
(Leguminosae),  
Glycyrrhiza glabra L. 
(Leguminosae) 
Matrine, 
 
Glycyrrhiz
in  from 
root 
- Acetaminophen 
- Liver GSH 
Xu-ying et 
al., 2009  
69 Strychnos  potatorum 
Linn. (Loganiaceae) 
Seed Water CCl4  
- Serum AST, ALT, 
ALP, TB 
- Liver GSH, LPO, 
SOD, GPx 
- Histopathology 
Sanmugapriya 
and 
Venkataraman, 
2006  
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Table 3: Cont… 
 
Sr. 
No. 
Plant (Family) Part used Solvent 
used 
Hepatotoxicant used 
and parameters done 
References 
70 Syzygium cumini 
L. (Myrtaceae)  
Leaves Water CCl4  
- Serum ALT, AST 
 
Moresco et 
al., 2007  
71 Taraxacum 
officinale 
(Asteraceae) 
Root 12% 
Ethanol  
CCl4  
- Serum AST, ALT, 
ALP 
- Liver TP, SOD, HP 
- Histopathology 
Domitrovic et 
al., 2010  
72 Terminalia arjuna 
Bedd. 
(Combretaceae) 
Bark Water CCl4  
- Serum AST, ALT, 
ALP 
- Liver and kidney 
GSH, LPO, CAT, 
SOD, GST 
Manna et al., 
2006  
73 Terminalia 
catappa L. 
(Combretaceae) 
Leaves Ethanol CCl4  
- Serum AST, ALT 
- Histopathology  
 
Gao et al., 
2004  
74 Thunbergia 
laurifolia Linn. 
(Acanthaceae) 
Leaves Water Ethanol  
- Determination of 
cell viability in 
primary cultures of  
rat hepatocytes 
- Serum AST, ALT, 
TG 
- Histopathology 
Pramyothin et 
al., 2005  
75 Trichosanthes 
cucumerina L. 
(Cucurbitaceae) 
Whole plant Methanol CCl4  
- Serum ALT, AST, 
ALP, TB, TP, ALB 
- Liver GSH, MDA 
- Histopathology 
Sathesh 
Kumar et al., 
2009  
76 Vernonia 
amygdalina Delile. 
(Astereaceae) 
Leaves 90% 
Methanol 
CCl4  
- Serum AST, ALP, 
GST 
- Liver LPO, CAT, 
SOD, GSH 
- Histopathology 
Adesanoye 
and Farombi, 
2010  
77 Vitis vinifera L. 
(Vitaceae) 
Leaves 80% 
Ethanol 
CCl4 
- Plasma AST, ALT, 
LPO 
- Liver GSH, LPO 
- Histopathology 
 
Orhan et al., 
2007  
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Table 3: Cont… 
 
Sr. 
No. 
Plant (Family) Part used Solvent 
used 
Hepatotoxicant used 
and parameters done 
References 
78 Zanthoxylum 
armatum DC. 
(Rutaceae) 
Bark 70% 
Ethanol 
CCl4  
- Serum ALT, AST, 
ALP, TP, TB 
- Liver GSH, LPO, 
CAT, SOD 
- Histopathology 
Ranawat et 
al., 2010  
79 Zingiber officinale 
Roscoe. 
(Zingiberaceae) 
Rhizome 50% 
Ethanol 
Acetaminophen  
- Serum ALT, AST, 
ALP 
- Liver GSH, LPO, 
CAT, SOD, GPx, 
GST 
- Histopathology 
Ajith et al., 
2007  
80 Ziziphus 
mauritiana Lam. 
(Ramnaceae) 
Leaves 80% 
Ethanol 
CCl4 
- Serum AST, ALT, 
ALP, TB 
- Liver GSH, LPO, 
Vit-E 
Dahiru et al., 
2005  
 
Abbreviations  
ACP: acid phosphatase, ALB: albumin, ALP: alkaline phosphatase, ALT: alanine transaminase, 
AST: aspartate transaminase, BUN: blood urea nitrogen, CAT: catalase, CR: creatinine, DB: direct 
bilirubin, G-6-Pase: glucose 6 phosphatase, GGT: gamma glutamyl transpeptidase, GL: globulin, 
GL: glucose, GLY: glycogen, GPx: glutathione peroxidase, GR: glutathione reductase, GSH: 
glutathione, reduced, GSSG: glutathione (oxidized form), GST: glutathione-S-transferase, HDL: 
high density lipoproteins, HP: hydroxyproline, IL-1: interleukin-1, K+: potassium, LDH: lactate 
dehydrogenase, LDL: low density lipoproteins, LPO: lipid peroxidation, Na+: sodium, PL: 
phospholipids, SOD: superoxide dismutase, TB: total bilirubin, TC: total cholesterol, TG: 
triglycerides, TL: total lipid, TNF-α: Tumor necrosis factor-α, TP: total protein, T-SH: total (protein 
and nonprotein) sulfhydryl groups, Vit-C: vitamin-C, Vit-E: vitamin-E. 
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Table 4: The reported activities of Woodfordia fruticosa Kurz. with part and solvent used 
 
Sr. 
No. 
Activity Part used Solvent used References 
1 Antibacterial Flowers Petroleum ether, 
Chloroform, Methanol
Ethanol, Water 
Kumaraswamy et 
al., 2008 
2 Antibacterial Flowers Methanol Parekh and 
Chanda, 2007b 
3 Antibacterial Leaves Ethanol Bajracharya et al., 
2008 
4 Antibacterial Kutajarista- A 
ayurvedic 
preparation 
- Shenoy and 
Yoganarasimhan, 
2009 
5 Antidiarrhoeal Kutajarista- A 
ayurvedic 
preparation 
- Shenoy and 
Yoganarasimhan, 
2008 
6 Antifertility Flowers 50% Alcohol, 
Water 
Khushalani et al., 
2006 
7 Antimicrobial Leaves Essential oil and 
Hexane, Methanol, 
Acetone 
Kaur and Kaur, 
2010 
8 Antimicrobial Flowers Hexane, Chloroform, 
Acetone, Methanol, 
Water 
Dabur et al., 2007 
9 Antioxidant Flowers Petroleum ether, 
Chloroform, 
Methanol, Water 
Kumaraswamy 
and Satish, 2008 
10 Antitumor Isolated 
compound 
from flowers 
- Yoshida et al., 
1990 
11 Antitumor Isolated 
compound 
- Kuramochi-Motegi 
et al., 1992 
12 Hepatoprotective Flowers 50 % Alcohol Brindha and 
Geetha, 2009 
13 Hepatoprotective Flowers Water Chandan et al., 
2008 
14 Immunomodulatory Fermented 
product from 
flowers 
- Kroes et al., 1993 
15 Immunostimulatory Flowers Ethanol Shah and Juvekar, 
2010 
16 Pharmacognosy Flowers 
 
- Shome et al., 1981 
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3.1. COLLECTION AND IDENTIFICATION OF PLANT MATERIAL 
 
The fresh flowers of Woodfordia fruticosa were collected from Junagadh (Girnar 
region), Gujarat in the month of March 2008. The plant was compared with voucher 
specimen (voucher specimen No. PSN303) deposited at Department of Biosciences, 
Saurashtra University, Rajkot, Gujarat, India.  
 
3.2. PHARMACOGNOSTIC STUDIES 
 
3.2.1. Macroscopic characteristics 
 
The plant was macroscopically examined for shape, size, surface characteristics, 
texture, color, consistency, odour, taste, etc. (Khandelwal, 2008). 
 
3.2.2. Microscopic characteristics  
 
Free hand sections of pedicel, calyx, sepal and ovary of fresh flower of Woodfordia 
fruticosa were taken. Sections were cleared with chloral hydrate and then stained with 
phloroglucinol and hydrochloric acid and mounted with glycerin. Same procedure 
was followed for microscopic characteristics of powdered material of Woodfordia 
fruticosa flower (Khandelwal, 2008). 
 
3.3. PREPARATION OF THE EXTRACT 
 
The flowers were washed under tap water, air dried, homogenized to fine powder and 
stored in airtight bottles. Ten grams of dried powder was first defatted with petroleum 
ether and then extracted with methanol by using Soxhlet apparatus (Lin et al., 1999). 
The solvent was evaporated to dryness and the dried crude extract was stored in air 
tight bottle at 4°C. The percentage yield of methanol extract was 36%. The methanol 
extract of Woodfordia fruticosa (WFM) was used for the entire study. 
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3.4. PHYSICOCHEMICAL ANALYSIS  
 
The following physicochemical parameters were carried out (WHO, 2002; The 
Ayurvedic Pharmacopoeia of India 2008; Vaghasiya et al., 2008) in dried powder and 
or methanol extract of Woodfordia fruticosa flowers. 
 
 Loss on drying 
 Total ash  
 Acid insoluble ash 
 Water soluble ash 
 Petroleum ether soluble extractive 
 Hexane soluble extractive 
 Ethyl acetate soluble extractive 
 Acetone soluble extractive 
 Methanol soluble extractive 
 Water soluble extractive 
 pH  
 Melting point  
 Solubility test 
 Heavy metals analysis  
 
3.4.1. Loss on drying 
 
Two grams of crude powder of Woodfordia fruticosa flowers was taken in an 
evaporating dish and then dried in an oven at 105ºC till constant weight was obtained. 
The weight after drying was noted and loss on drying was calculated. The percentage 
was calculated on the basis of sample taken initially. 
 
3.4.2. Total ash 
 
Two grams of dried powder of Woodfordia fruticosa flowers was taken in a silica 
crucible and ignited it by gradually increasing the heat to 500°C until it was white, 
indicating the absence of carbon. Ash was cooled in a desiccator and weighed without 
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delay. The percentage of total ash was calculated on the basis of sample taken 
initially. 
 
3.4.3. Acid insoluble ash 
 
To the crucible containing total ash, 25 ml of hydrochloric acid (HCl, ~70g/l) was 
added; it was covered with a watch-glass and boiled gently for 5 minutes. The watch-
glass was rinsed with 5 ml of hot water and this liquid was added to the crucible. The 
insoluble matter was collected on an ashless filter paper and it was washed with hot 
water until the filtrate was neutral. The filter paper containing the insoluble matter 
was transferred to the original crucible; it was dried on a hot plate and ignited to 
constant weight. The residue was allowed to cool and then weighed without delay. 
The percentage of acid insoluble ash was calculated on the basis of sample taken 
initially. 
 
3.4.4. Water soluble ash 
 
To the crucible containing the total ash, 25 ml of water was added and boiled for 5 
minutes. The insoluble matter was collected on an ashless filter paper. It was washed 
with hot water and ignited in a crucible for 15 minutes. The residue was allowed to 
cool and then weighed without delay. Weight of insoluble matter was subtracted from 
the weight of total ash. The percentage of water soluble ash was calculated on the 
basis of sample taken initially.  
 
3.4.5. Determination of petroleum ether soluble extractive 
 
Five grams of dried powder of Woodfordia fruticosa flowers was taken in 100 ml of 
petroleum ether in a conical flask, plugged with cotton wool and then kept on a rotary 
shaker at 120 rpm for 24 h. Thereafter, it was filtered and the filtrate was evaporated 
to dryness at 105°C till constant weight was obtained. The percentage of extractable 
matter was calculated with reference to the sample taken initially. 
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3.4.6. Determination of hexane soluble extractive 
 
Five grams of dried powder of Woodfordia fruticosa flowers was taken in 100 ml of 
hexane in a conical flask, plugged with cotton wool and then kept on a rotary shaker 
at 120 rpm for 24 h. Thereafter, it was filtered and the filtrate was evaporated to 
dryness at 105°C till constant weight was obtained. The percentage of extractable 
matter was calculated with reference to the sample taken initially. 
 
3.4.7. Determination of ethyl acetate soluble extractive 
 
Five grams of dried powder of Woodfordia fruticosa flowers was taken in 100 ml of 
ethyl acetate in a conical flask, plugged with cotton wool and then kept on a rotary 
shaker at 120 rpm for 24 h. Thereafter, it was filtered and the filtrate was evaporated 
to dryness at 105°C till constant weight was obtained. The percentage of extractable 
matter was calculated with reference to the sample taken initially. 
 
3.4.8. Determination of acetone soluble extractive 
 
Five grams of dried powder of Woodfordia fruticosa flowers was taken in 100 ml of 
acetone in a conical flask, plugged with cotton wool and then kept on a rotary shaker 
at 120 rpm for 24 h. Thereafter, it was filtered and the filtrate was evaporated to 
dryness at 105°C till constant weight was obtained. The percentage of extractable 
matter was calculated with reference to the sample taken initially. 
 
3.4.9. Determination of methanol soluble extractive 
 
Five grams of dried powder of Woodfordia fruticosa flowers was taken in 100 ml of 
methanol in a conical flask, plugged with cotton wool and then kept on a rotary shaker 
at 120 rpm for 24 h. Thereafter, it was filtered and the filtrate was evaporated to 
dryness at 105°C till constant weight was obtained. The percentage of extractable 
matter was calculated with reference to the sample taken initially. 
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3.4.10. Determination of water soluble extractive 
 
Five grams of dried powder of Woodfordia fruticosa flowers was taken in 100 ml of 
water in a conical flask, plugged with cotton wool and then kept on a rotary shaker at 
120 rpm for 24 h. Thereafter, it was filtered and the filtrate was evaporated to dryness 
at 105°C till constant weight was obtained. The percentage of extractable matter was 
calculated with reference to the sample taken initially. 
 
3.4.11. Determination of pH 
 
The methanol extract of Woodfordia fruticosa flowers was dissolved in distilled water 
and was kept in a water bath for 20 min. It was then filtered and the pH of the filtrate 
was noted with the help of pH meter. 
 
3.4.12. Determination of melting point 
 
The melting point of methanol extract of Woodfordia fruticosa flowers was done at 
Department of Chemistry, Saurashtra University, Rajkot, by open capillary method 
(Sukhwal et al., 1995). 
 
3.4.13. Determination of solubility 
 
The quantitative solubility test of methanol extract of Woodfordia fruticosa flowers 
was determined in different solvents. 10 mg of extract was weighed for solubility test 
for different solvents. The extract was added in each solvent until saturated solution 
developed. Solubility was calculated in mg/ml. 
 
3.4.14. Determination of heavy metals 
 
The analysis of heavy metals like mercury, lead, chromium, arsenic and cadmium for 
crude powder and methanol extract of Woodfordia fruticosa flowers were done at 
Choksi Laboratries Limited, Baroda, Gujarat.  
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3.5. PHYTOCHEMICAL ANALYSIS 
 
3.5.1. Qualitative phytochemical analysis 
 
Preliminary chemical tests were carried out for crude powder and methanolic extract 
to identify different phyto-constituents (Harborne, 1973; Parekh and Chanda 2007c). 
 
3.5.1.1. Alkaloids 
 
The crude powder and methanol extract of Woodfordia fruticosa flowers was 
dissolved in 2 N HCl. The mixture was filtered and the filtrate was divided into 3 
equal portions. One portion was treated with few drops of Mayer's reagent; one 
portion was treated with equal amount of Dragondroff’s reagent and the other portion 
was treated with equal amount of Wagner's reagent. The creamish precipitate, orange 
precipitate and brown precipitate indicated the presence of respective alkaloids. A (+) 
score was recorded if the reagent produced only a slight opaqueness; a (++) score was 
recorded if a definite turbidity but no flocculation was observed and a (+++) score 
was recorded if heavy precipitate or flocculation was observed (Salehi-Surmaghi et 
al., 1992). 
 
3.5.1.2. Flavonoids 
 
3.5.1.2.1. Shinoda test 
 
The presence of flavonoids was estimated by Shinoda test. The crude powder and 
methanol extract of Woodfordia fruticosa flowers were treated with few drops of 
concentrated HCl and magnesium ribbon. The appearance of pink or tomato red 
colour within few minutes indicated the presence of flavonoids (Somolenski et al., 
1972). 
 
3.5.1.2.2. Alkaline reagent test  
 
The crude powder and methanol extract of Woodfordia fruticosa flowers was treated 
with few drops of diluted sodium hydroxide (NaOH) separately. Formation of intense 
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yellow color which turned colorless on addition of few drops of diluted HCl indicated 
presence of flavonoids. 
 
3.5.1.3. Cardiac glycosides 
 
Keller-kiliani test was performed for the presence of cardiac glycosides. The crude 
powder and methanol extract of Woodfordia fruticosa flowers was treated with 1 ml 
mixture of 5% FeCl3 and glacial acetic acid (1:99 v/v). To this solution, few drops of 
concentrated H2SO4 were added. Appearance of greenish blue color within few 
minutes indicated the presence of cardiac glycosides (Ajaiyeobu, 2002). 
 
3.5.1.4. Plobotannins 
 
The crude powder and methanol extract of Woodfordia fruticosa flowers was boiled 
with 1% aqueous HCl. Deposition of red precipitate was taken as evidence for the 
presence of phlobatanins (Harborne, 1973). 
 
3.5.1.5. Saponins 
 
The presence of saponins was determined by Frothing test. The crude powder and 
methanol extract of Woodfordia fruticosa flowers was vigorously shaken with 
distilled water and was allowed to stand for 10 min and classified for saponin content 
as follows: no froth indicates absence of saponins and stable froth for more than 1.5 
cm indicated the presence of saponins (Kapoor et al., 1969). 
 
3.5.1.6. Steroids 
 
Liebermann-Burchard reaction was performed for the presence of steroids. A 
chloroformic solution of the crude powder and methanol extract of Woodfordia 
fruticosa flowers was treated with acetic anhydride and few drops of concentrated 
H2SO4 were added down the sides of test tube. A blue green ring indicated the 
presence of steroids.  
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3.5.1.7. Tannins 
 
The crude powder and methanol extract of Woodfordia fruticosa flowers was treated 
with alcoholic ferric chloride (FeCl3) reagent. Blue color indicated the presence of 
tannins (Segelman et al., 1969).  
 
3.5.1.8. Triterpenes 
 
Chloroform extract of the crude powder and methanol extract of Woodfordia fruticosa 
flowers was treated with concentrated sulphuric acid (H2SO4). Appearance of reddish 
brown ring indicated the presence of triterpenes (Harborne, 1973). 
 
3.5.2. Quantitative phytochemical analysis 
 
3.5.2.1. Determination of total phenol content 
 
The amount of total phenol content was determined by Folin-Ciocalteu reagent 
method (McDonald et al., 2001). 0.5 ml of extract and 0.1 ml of Folin-Ciocalteu 
reagent (0.5 N) was mixed and incubated at room temperature for 15 min. Then 2.5 
ml saturated sodium carbonate was added. The mixture was allowed to stand for 30 
min at room temperature and the absorbance of the reaction mixture was measured at 
760 nm. The total phenolic content is expressed in terms of gallic acid equivalent 
(mg/g of extracted compound). 
 
3.5.2.2. Determination of flavonoid content 
 
The amount of total flavonoid content was determined by Aluminium chloride 
method (Chang et al., 2002). The reaction mixture consisted of 1.0 ml extract, 1 ml 
methanol, 0.5 ml aluminium chloride (1.2%) and 0.5 ml potassium acetate (120 mM). 
The mixture was allowed to stand for 30 min at room temperature and the absorbance 
of the reaction mixture was measured at 415 nm. The flavonoid content is expressed 
in terms of quercetin equivalent (mg/g of extracted compound). 
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3.6. ANIMALS  
 
Wistar albino rats of both sexes (180-220 g) were used for the study. The animals 
were obtained from the animal house of Sarabhai Research Center (SRC), Baroda and 
Xcelris Labs Ltd., Ahmedabad. All the rats were kept in standard plastic rat cages 
with stainless steel coverlids and wheat straw was used as bedding material. The 
animals were kept at the animal house of Department of Biosciences, Saurashtra 
University, Rajkot. The animals were facilitated with standard environmental 
condition of photoperiod (12:12 h dark: light cycle) and temperature (25 ± 2°C). They 
were provided with commercial rat and mice feed (Pranav Agro Industries Ltd., 
Baroda. Amruth Brand rat & mice pellet feed) and water given ad libitum. The use of 
these animals and the study protocols were approved by CPCSEA recognized local 
ethical committee. 
 
3.7. SELECTION OF THE DOSES FOR ANIMAL STUDY 
 
The dose considered for the experiment on rats was obtained from conversion of 
human dose of Woodfordia fruticosa (3-5 g/kg). The conversion factor of human dose 
(per 200 g body weight) is 0.018 for rats (Ghosh 1984). Hence the calculated dose for 
the rats (considering human dose 5 g/kg) is 450 mg/kg. Thus, anti-inflammatory and 
hepatoprotective activity were done at two different doses 400 and 600 mg/kg body 
weight. Acute toxicity was done at three different doses 450, 1800, and 3600 mg/kg 
body weight. 
 
3.8. ANTI-INFLAMMATORY STUDIES 
 
3.8.1. Animal grouping for anti-inflammatory studies 
 
The animals were divided into four groups (six animals in each group) for anti-
inflammatory studies. 
 
Group I:    Vehicle treated control (distilled water) 
Group II:   Methanol extract of Woodfordia fruticosa - 400 mg/kg body weight  
                  (WFM-400) 
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Group III: Methanol extract of Woodfordia fruticosa- 600 mg/kg body weight  
                  (WFM-600)  
Group IV: Diclofenac sodium- 10 mg/kg body weight (diclofenac- 10) 
 
3.8.2. Carrageenan induced rat paw edema  
 
Carrageenan induced rat paw edema was done by the method of Winter et al. (1962). 
Inflammation was induced by injection of 0.1 ml of freshly prepared carrageenan 
(1%) aqueous suspension in normal saline underneath the plantar tissue of the right 
hind paw of rats. The different groups of rats were administered with WFM (400 and 
600 mg/kg, p.o.) and diclofenac (10 mg/kg, p.o.). The control group received vehicle 
(distilled water, 10 ml/kg, p.o.). 1 h after drug treatment, paw edema was induced by 
the injection of carrageenan (an edematogenic agent). The paw volume was measured 
by a Plethysmometer. The measures were determined at 0 h (Vo: before edematogenic 
agent injection) and 1,2,3,4 and 5h intervals later (Vt). The difference between Vt and 
Vo was taken as the edema value. The percentage of inhibition was calculated 
according to the following formula:  
                 % inhibition = (Vt − Vo)control − (Vt − Vo)treated(Vt − Vo)control  X 100 
 
3.8.3. Histamine induced rat paw edema 
 
Inflammation was induced by injection of 0.1 ml of freshly prepared histamine (1%) 
aqueous suspension in normal saline underneath the plantar tissue of the right hind 
paw of rats (Suleyman et al., 1999). The drug treatment and paw volume was 
measured in a similar manner to that of carrageenan induced paw edema model. 
 
3.8.4. Dextran induced rat paw edema 
 
Inflammation was induced by injection of 0.1 ml of freshly prepared dextran (1%) 
aqueous suspension in normal saline underneath the plantar tissue of the right hind 
paw of rats (Winter and Porter, 1957). The drug treatment and paw volume was 
measured in a similar manner to that of carrageenan induced paw edema model. 
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3.8.5. Serotonin induced rat paw edema 
 
Inflammation was induced by injection of 0.1 ml of freshly prepared Serotonin (1%) 
aqueous suspension in normal saline underneath the plantar tissue of the right hind 
paw of rats (Mukherjee et al., 1997; Suleyman et al., 1999). The drug treatment and 
paw volume was measured in a similar manner to that of carrageenan induced paw 
edema model. 
 
3.8.6. Formaldehyde induced rat paw edema 
 
Inflammation was induced by injection of 0.1 ml of freshly prepared Formaldehyde 
(3%) underneath the plantar tissue of the right hind paw of rats (Brownlee, 1950). The 
test drug was administered consecutively for seven days to all the groups. On seventh 
day, after 1 h of drug administration, paw edema of the rat was induced by subplantar 
injection of formaldehyde solution. The paw volume was determined at 0 h and at 3, 
24 and 48 h after formaldehyde injection as described in carrageenan model. 
 
3.8.7. Cotton pellet induced granuloma in rats 
 
The effect of methanol extract of Woodfordia fruticosa flowers on the chronic phases 
of inflammation was assessed in the cotton pellet induced granuloma rat model, as 
described by Swingle and Shideman (1972).  Autoclaved cotton pellets weighing 100 
mg each were implanted subcutaneously. One on each side of the abdomen of the 
animal, through a small ventral incision of rats anesthetized with ether.  The different 
groups of rats were administered with WFM (400 and 600 mg/kg, p.o.) and diclofenac 
(10 mg/kg. p.o.) once daily for 7 consecutive days from the day of cotton pellet 
insertion.  The control group received vehicle (distilled water, 10 ml/kg, p.o.).  On the 
eighth day the animals were sacrificed and the cotton pellets were removed, dried at 
60°C for 24 h and their mass was determined.  The results are expressed as mg 
granulation tissue formed per 100 g body weight. 
 
3.8.7.1. Biochemical analysis  
 
On the eighth day, the animals were sacrificed under mild ether anesthesia and blood 
was collected in clean centrifuge tubes. The serum was obtained by centrifugation and 
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used for the estimation of various biochemical parameters. The absorbance of all the 
biochemical parameters was measured in a UV-VIS Spectrophotometer -1601 
(Shimadzu, Tokyo, Japan). 
 
3.8.7.1.1. Estimation of total protein content 
 
The serum total protein was estimated by modified Biuret method (Yatzidis, 1977) 
using the total protein test kit (Span Diagnostics Ltd.). 
  
Reagents 
 
Reagent I: Biuret Reagent (Copper sulphate  - 7 mM/L; sodium hydroxide - 200 
mM/L; sodium potassium tartrate - 20 mM/L) 
Reagent II: Protein standard (BSA - 6.5 g/dL) 
 
Procedure 
 
3.0 ml of Reagent I was added to all the test tubes. Thereafter, 0.03 ml serum was 
added for the test and 0.03 ml Reagent II was added for the standard, while in blank 
0.03 ml of purified water was added. They were then mixed well and incubated at 
37ºC for 5 minutes. The absorbance was read at 578 nm.  
 
3.8.7.1.2. Estimation of albumin content 
 
The serum albumin was estimated by the method given by Corcoran and Durnan 
(1977) using albumin test kit (Span Diagnostics Ltd.). 
 
Reagents 
 
Reagent I: Albumin reagent (Succinic acid - 37 mM/L; bromocresol green - 0.15 
mM/L; sodium hydroxide - 1 mM/L; buffer pH - 3.68). 
Reagent II: Albumin standard (BSA - 4 g/dL). 
 
Procedure 
 
3.0 ml of albumin reagent (Reagent I) was added to all the test tubes. Thereafter, 0.03 
ml serum was added for the test and 0.03 ml Reagent II was added for the standard, 
Chapter 3                                                                                      Material and Methods 
 
63 
 
while in blank 0.03 ml of purified water was added. They were then mixed well and 
incubated at room temperature for 1 min. The absorbance was read at 630 nm.   
 
3.8.7.1.3. Estimation of acid phosphatase (ACP) activity 
 
The serum acid phosphatase activity was estimated by the method of King and 
Jagatheesan (1959) using ACP test kit (Span Diagnostics Ltd.). 
 
Reagents 
 
Reagent I: Buffered substrate, pH 4.9 
Reagent II: Sodium hydroxide, 0.5 N 
Reagent III: Sodium bicarbonate, 0.5 N 
Reagent IV: 4-aminoantipyrine, 0.6% 
Reagent V: Potassium ferricyanide, 2.4% 
Reagent VI: Stock phenol standard, 10 mg% 
Solution I: Reconstitute one vial of reagent I, buffered substrate with 2 ml of purified 
water. 
Solution II: Dissolve reagent 4 in 25 ml of purified water 
Solution III: Dissolve reagent 5 in 25 ml of purified water 
Working standard: Dilute stock phenol standard 0.5 to 5 with purified water 
 
Procedure 
 
All the test tubes were marked properly as blank (B), standard (S), control (C) and test 
(T). 0.5 ml of solution I was added in control (C) and test (T). 0.5 ml of purified water 
was added in control (C) and test (T). 0.6 ml of purified water was added in standard 
(S) and 1.1 ml of purified water was added in blank (B). All the tubes were mixed 
well and incubated at 37ºC for 3 min. 0.1 ml of serum was added in test (T), 0.5 ml of 
working standard was added in standard (S). All the tubes were mixed well and 
incubated at 37ºC for 60 min. 0.5 ml of reagent II was added in all the tubes. 0.1 ml of 
serum was added in control (C). 0.5 ml of reagent III, 0.5 ml of solution II and 0.5 ml 
of solution III was added in all the tubes. All the tubes were mixed well and 
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absorbance was read at 510 nm. Serum acid phosphatase activity is expressed as KA 
units.  
 
3.8.7.1.4. Estimation of alkaline phosphatase (ALP) activity  
 
Alkaline phosphatase activity was estimated by the method of Kind and King (1954) 
using ALP test kit (Span Diagnostics Ltd.). 
 
Reagents  
 
Reagent I: Buffered substrate, pH 10.0 
Reagent II: Chromogen reagent 
Reagent III: Phenol standard, 10 mg% 
Working solution: Reconstitute one vial of reagent I, buffered substrate with 2.2 ml of 
purified water.  
 
Procedure 
 
All the test tubes were marked properly as blank (B), standard (S), control (C), and 
test (T). 0.5 ml of working buffered substrate was added in clean tubes. 1.5 ml of 
purified water was added in all the tubes. They were mixed well and incubated at 
37°C for 3 min. 0.05 ml of serum was added in test (T), 0.05 ml of reagent III (Phenol 
standard) was added in standard (S) and 0.05 ml of purified water was added in blank 
(B) tubes. All the tubes were mixed well and incubated at 37°C for 15 min. 1 ml of 
reagent II was added in all the tubes. 0.05 ml of serum was added in control (C). All 
the tubes were mixed well and absorbance was read at 510 nm. Serum alkaline 
phosphatase activity is expressed as KA units.  
 
3.9. ANALGESIC STUDY 
 
3.9.1. Formaldehyde induced paw licking response in rats 
 
The effect of methanol extract of Woodfordia fruticosa flowers on formaldehyde 
induced paw licking response was evaluated by the procedure of Magali et al. (2000). 
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The test drug was administered once daily for seven consecutive days to all the 
groups. On seventh day, after 1 h of drug administration the subplantar injection of 
0.1 ml of 3% formaldehyde solution in normal saline was injected. After the injection 
of formaldehyde, the animals were kept under observation for half an hour. The 
amount of time spent licking the injected paw was noted, and was considered to be 
indicative of pain. The time taken for the onset of paw licking was initially measured. 
The first of the nociceptive responses normally peaked 5 min after formaldehyde 
injection and the second phase 15-30 min after formaldehyde injection, representing 
the neurogenic and inflammatory pain (Hunskaar and Hole, 1987). Therefore the 
frequency of paw licking was measured in five intervals at 0-5 min., 6-10 min., 11-15 
min., 16-20 min. and 21-30 min. 
 
3.10. HEPATOPROTECTIVE STUDIES   
 
3.10.1. Diclofenac induced hepatotoxicity 
 
The rats were divided into five groups with six rats in each. Group I (Control) served 
as normal and received the vehicle alone (Sterile distilled water, 10 ml/kg, p.o.) for 5 
days. Group II (Toxin control) animals received diclofenac (50 mg/kg i.p.) (Tanna et 
al., 2009) on the 3rd and 4th day. Group III (WFM-400) and IV (WFM-600) were 
treated with WFM at a dose level of 400 mg/kg and 600 mg/kg body weight p.o. per 
day respectively for 5 days and on the 3rd and 4th day diclofenac (50 mg/kg i.p.) was 
given 1 h after the treatment of the extract. Group V (Standard) was treated with 
standard drug silymarin (100 mg/kg p.o.) for 5 days and on the 3rd and 4th day 
diclofenac (50 mg/kg i.p.) was given 1 h after the treatment of the drug. The animals 
were sacrificed 48 h after the last injection of diclofenac under mild ether anesthesia. 
The blood was collected and allowed to stand for 30 min at 37°C and then centrifuged 
to separate the serum to estimate various biochemical parameters. 
 
3.10.2. Carbon tetrachloride induced hepatotoxicity 
 
The rats were divided into five groups with six rats in each. Group I (Control) served 
as normal and received the vehicle alone (Sterile distilled water, 10 ml/kg, p.o.) for 5 
days. Group II (Toxin control) animals received CCl4 (2 ml/kg, 1:1 in olive oil, i.p.) 
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(Jain et al., 2006) on the 3rd and 4th day. Group III (WFM-400) and IV (WFM-600) 
were treated with WFM at a dose level of 400 mg/kg and 600 mg/kg body weight p.o. 
per day respectively for 5 days and on the 3rd and 4th day CCl4 (2 ml/kg, 1:1 in olive 
oil, i.p.) was given 1 h after the treatment of the extract. Group V (Standard) was 
treated with standard drug silymarin (100 mg/kg p.o.) for 5 days and on the 3rd and 4th 
day CCl4 (2 ml/kg, 1:1 in olive oil, i.p.) was given 1 h after the treatment of the drug. 
The animals were sacrificed 48 h after the last injection of CCl4 under mild ether 
anesthesia. The blood was collected and allowed to stand for 30 min at 37°C and then 
centrifuged to separate the serum to estimate various biochemical parameters. 
 
3.10.3. Acetaminophen induced hepatotoxicity 
 
The rats were divided into five groups with six rats in each. Group I (Control) served 
as normal and received the vehicle alone (Sterile distilled water, 10 ml/kg, p.o.) for 5 
days. Group II (Toxin control) animals received acetaminophen (3 g/kg, p.o.) (Ajith et 
al., 2007) on the 4th day. Group III (WFM-400) and IV (WFM-600) were treated with 
WFM at a dose level of 400 mg/kg and 600 mg/kg body weight p.o. per day 
respectively for 5 days and on the 4th day acetaminophen (3 g/kg, p.o.) was given 1 h 
after the treatment of the extract. Group V (Standard) was treated with standard drug 
silymarin (100 mg/kg p.o.) for 5 days and on the 4th day acetaminophen (3 g/kg, p.o.) 
was given 1 h after the treatment of the drug. The animals were sacrificed 48 h after 
the dose of acetaminophen under mild ether anesthesia. The blood was collected and 
allowed to stand for 30 min at 37°C and then centrifuged to separate the serum to 
estimate various biochemical parameters. 
 
In above three hepatoprotective models, various in vivo antioxidant parameters were 
estimated from liver. 
 
3.10.4. Preparation of liver homogenate  
 
The liver was quickly removed and perfused immediately with ice-cold saline (0.9% 
NaCl). A portion of the liver was homogenized in chilled Tris-HCl buffer (0.025 M, 
pH 7.4) using a homogenizer. The homogenate obtained was centrifuged at 5,000 rpm 
for 10 min, supernatant was collected and used for analysis. 
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3.10.5. Biochemical analysis from serum 
 
The absorbance of all the biochemical parameters was measured in a UV–VIS 
Spectrophotometer - 1601 (Shimadzu, Tokyo, Japan). 
 
3.10.5.1. Estimation of total protein content 
 
As described in section 3.8.7.1.1. 
 
3.10.5.2. Estimation of albumin content 
 
As described in section 3.8.7.1.2. 
 
3.10.5.3. Estimation of blood urea nitrogen (BUN) content 
 
The serum blood urea nitrogen was estimated by Enzymatic Urease (Berthelot) 
method (Fawcett and Scott, 1960) using Urea Berthelot test kit (Span Diagnostics 
Ltd.).  
 
Reagents  
 
Reagent I: Urease reagent (Phosphate buffer - 20 mM; urease - >20000 U/L; sodium 
nitroprusside - 3.2 mM/L; sodium salicylate - 60 mM/L)  
Reagent II: Urea chromogen reagent (Sodium hypochlorite - 0.2 %; sodium hydroxide 
– 400 mM/L) 
Reagent III: Urea standard, 50 mg/dL 
Reagent IV: Purified water 
Solution I: To Reagent I add 50 ml Reagent IV and mix gently.  
Solution II: Dilute the contents of Reagent II, with 160 ml reagent IV.  
 
Procedure 
 
1.5 ml Solution I was added to clean test tubes. 0.01 ml serum was added for the test 
and 0.01 ml Reagent III was added for the standard. It was then mixed well and 
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incubated at 37ºC for 3 min; then 1.5 ml of Solution II was added. It was then mixed 
well and incubated at 37ºC for 5 min. The absorbance was read at 578 nm against 
reagent blank. 
  
3.10.5.4. Estimation of alkaline phosphatase (ALP) activity 
  
As described in section 3.8.7.1.4. 
 
3.10.5.5. Estimation of aspartate aminotransferase (AST) activity 
 
The serum aspartate aminotransferase was estimated by the method of Reitman and 
Frankel (1957) using AST test kit (Span Diagnostics Ltd.).  
 
Reagents 
 
Reagent I: Buffered aspartate - α-KG substrate, pH 7.4 
Reagent II: DNPH (2,4- Dinitrophenyl hydrazine) colour reagent 
Reagent III: Sodium hydroxide, 4 N 
Reagent IV: Working pyruvate standard, 2 mM  
Solution I: Dilute 1 ml of Reagent III up to 10 ml with purified water. 
 
Procedure 
 
0.25 ml of Reagent I was added in clean test tubes and incubated at 37ºC for 5 
minutes. 0.05 ml of serum was added in the test, 0.05 ml Reagent IV was added in 
standard and 0.05 ml distilled water was added in the blank. They were mixed well 
and incubated at 37ºC for 60 minutes. Thereafter, 0.25 ml of Reagent II was added to 
all the tubes, mixed well and allowed to stand at room temperature for 20 min. Then 
2.5 ml of Solution I was added to all the tubes, mixed well and allowed to stand at 
room temperature for 10 min. The absorbance of blank, standard and test were read at 
505 nm.  
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3.10.5.6. Estimation of alanine aminotransferase (ALT) activity 
 
The serum alanine aminotransferase was estimated by the method of Reitman and 
Frankel (1957) using ALT test kit (Span Diagnostics Ltd.).  
 
Reagents 
 
Reagent I: Buffered alanine - α-KG substrate, pH 7.4 
Reagent II: DNPH (2,4- Dinitrophenyl hydrazine) colour reagent 
Reagent III: Sodium hydroxide, 4 N 
Reagent IV: Working Pyruvate Standard, 2 mM 
Solution I: Dilute 1 ml of Reagent III up to 10 ml with purified water. 
 
Procedure 
 
0.25 ml of Reagent I was added in clean test tubes and incubated at 37ºC for 5 
minutes. 0.05 ml of serum was added in the test, 0.05 ml Reagent IV was added in the 
standard and 0.05 ml distilled water was added in the blank. They were mixed well 
and incubated at 37ºC for 30 minutes. Thereafter, 0.25 ml of Reagent II was added to 
all the tubes, mixed well and allowed to stand at room temperature for 20 min. Then 
2.5 ml of Solution I was added to all the tubes, mixed well and allowed it to stand at 
room temperature for 10 min. The absorbance of blank, standard and test were read at 
505 nm.  
 
3.10.6. Antioxidant parameters from liver homogenate 
 
3.10.6.1. Estimation of total protein content 
 
The total protein content was measured by the method of Lowry et al. (1951). The 
assay mixture contained 0.1 ml of liver homogenate, 0.9 ml of NaOH (0.1 N) and 5.0 
ml of alkaline copper sulphate reagent. The reaction mixture was incubated for 15 min 
at room temperature and then 0.5 ml of Folin Ciocalteau reagent (1 N) was added. 
The reaction mixture was further incubated for 30 min at room temperature. The 
absorbance was measured at 660 nm. Bovine serum albumin was used as standard.  
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3.10.6.2. Estimation of glutathione reduced level 
 
The glutathione reduced was estimated by the method of Ellman (1959). 1.0 ml of 
liver homogenate in Tris-HCl buffer (25 mM, pH 7.4) was added to 1.0 ml of TCA 
(10 %) and mixed thoroughly. The mixture was then centrifuged at 5000 rpm for 5 
min at room temperature. The assay mixture consisted of 1.0 ml of this supernatant,  
0.5 ml of Ellman’s reagent (0.02% of 5,5’ dithio(bis)nitrobenzoic acid (DTNB) in 1% 
tri sodium citrate) and 3 ml of phosphate buffer (200 mM, pH 8.0). The yellow colour 
developed was immediately measured at 412 nm. The values were calculated using 
molar extinction coefficient of chromophore (1.36 X 104 M-1cm-1). 
 
3.10.6.3. Estimation of catalase activity 
 
The catalase was colorimetrically assayed as described by Sinha (1972). The reaction 
mixture (1.5 ml) contained 1.0 ml of phosphate buffer (10 mM, pH 7.0), 0.1 ml of 
liver homogenate and the reaction was started by addition of 0.4 ml of H2O2 (2000 
mM). The reaction mixture was incubated for 3 min at room temperature.  The 
reaction was stopped by addition of 2.0 ml of dichromate-acetic acid reagent (5% 
potassium dichromate and glacial acetic acid were mixed in 1:3 ratio), was incubated 
at 100°C for 2 min. The absorbance was measured at 620 nm. Catalase activity is 
expressed as µM H2O2 consumed/min/mg protein (U/mg protein). For control, 0.1 ml 
of Tris-HCl buffer (25 mM, pH 7.4) was used in place of the liver homogenate.  
 
3.10.6.4. Estimation of glutathione peroxidase activity  
 
The glutathione peroxidase activity was measured by the method described by 
Rotruck et al. (1973) and Mills (1959). The reaction mixture contained 1.0 ml of Tris-
HCl buffer (400 mM, pH 7.0), 0.5 ml of sodium azide (10 mM), 0.5 ml liver 
homogenate, 0.5 ml glutathione (4 mM) and the reaction was started by addition of 
1.0 ml of H2O2 (1.25 mM). The reaction mixture was incubated for 3 min at 37ºC. 
The reaction was stopped by addition of 1.5 ml TCA (10%) and centrifuged for 5 min 
at 5000 rpm. GSH in the protein free filtrates was determined by mixing 1.0 ml of 
supernatant with 2.0 ml of phosphate buffer (200 mM, pH 8.0) and 1.0 ml of DTNB 
solution (0.02% DTNB in 1% tri sodium citrate). The absorbance was read at 412 nm. 
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Glutathione peroxidase activity is expressed as µM of GSH utilized/min/mg protein 
(U/mg protein). For control, 0.5 ml of Tris-HCl buffer (25 mM, pH 7.4) was used in 
place of the liver homogenate. 
 
3.10.7. Histopathological study 
 
The liver was transferred to 4% formalin solution for fixation and later on processed 
for histopathological studies following the standard procedure described by 
Raghuramulu et al. (1983). The microtome sections were cut processed and stained 
with hematoxylin and eosin. The section thus obtained was scanned in Carl-Zeiss 
microscope (Germany) with photographic facility and photomicrographs were taken. 
Changes if any in the cytoarchitecture were noticed. 
 
3.10.7.1. Fixation 
 
Fixation is the process of preserving, hardening and preventing postmortem changes 
of the tissues. The tissues were excised out immediately after sacrificing, cleaned of 
extraneous matter, cut in to pieces of such thickness that the fixative readily 
penetrated throughout the tissue to be fixed. Tissue was transferred to the 4% 
formaldehyde solution and allowed to remain in it till they were taken up for 
processing. 
 
3.10.7.2. Tissue processing 
 
Tissue processing involves dehydration, clearing and infiltration of the tissue with 
paraffin. The usual dehydrating agent is ethyl alcohol; acetone and isopropyl alcohol 
can also be used. Following dehydration, the tissue was transferred to a paraffin 
solvent, which is miscible with the dehydrating agent as well. These are known as 
clearing agents such as chloroform and xylene. Tissue were thoroughly washed by 
placing them under running tap water and then conveyed through a series of the 
following solvents as per schedule for dehydration, clearing and paraffin infiltration. 
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Alcohol 70%   -  20 minutes 
Alcohol 80%   -  20 minutes 
Alcohol 90%   -  20 minutes 
Alcohol 95% (2 changes) -  20 minutes each 
Isopropyl alcohol  -  20 minutes 
Acetone (2 changes)  -  20 minutes each 
Chloroform (3 changes) -  20 minutes each 
Melted paraffin wax (60°C) (3 changes) -  30 minutes each 
 
Then the tissues were embedded in paraffin wax to prepare tissue blocks, which were 
oriented so that sections could be cut in desired plane of the tissue. Tissues were then 
fixed to metal object holder after trimming them to suitable size. 
 
3.10.7.3. Section cutting 
 
A smear of 5% Mayer’s egg albumin was prepared and smeared onto the slide and 
dried. The tissue sections of 6 µm thickness were cut with the help of Spencer type 
rotating microtome. The tissue sections were put on slide and then section were 
floated in water on slide at 55-60°C, water drained off and slide dried on hot plate at 
about 50°C for 30 minutes. This section was ready for staining. 
 
3.10.7.4. Staining procedure 
 
Reagents 
 
1) Mayer’s hematoxylin stain 
2) Eosin stain, 2% w/v in alcohol  
 
After fixing the sections on slides, they were stained by serially placing them in the 
following reagents: 
 
Xylol (2 changes)   -  3 minutes 
Acetone    -  3 minutes 
Alcohol 95%    -  3 minutes 
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Haematoxyline stain   -  20 minutes 
Running water   -  20 minutes 
Eosin stain    -  5 minutes 
Alcohol 95% (3 changes)  -  3 minutes each 
Acetone (2 changes)   -  3 minutes each 
Xylol (2 changes)   -  3 minutes each 
 
After passing through all the above reagents and stains, the slides were mounted with 
D.P.X. (Diphenyl Phthalate Xylene) and cover slip was placed. Care was taken to 
avoid air bubbles while mounting the slide.  
 
3.11. ACUTE TOXICITY STUDY 
 
Acute oral toxicity (Ryu et al., 2004), study was performed as per OECD-404 
guidelines (1987). 10 rats/group (5 males and 5 females) were used for the study. 
Group 1 was control group and other three groups were that of WFM at different 
doses (450, 1800, and 3600 mg/kg body weight). Single dose of the extract was 
administrated orally to each animal. Signs of toxicity, body weight, feed and water 
consumption of each animal was observed every day for 14 days. 
 
3.11.1. Cage side observations 
 
In acute toxicity study, the animals were observed prior to dosing. Thereafter, 
observations were made at every hour, for five hours and then at 24 h and then every 
day for 14 days. All observations were systematically recorded, with individual 
records being maintained for each animal. Cage side observations included evaluation 
of skin and fur; eyes; respiratory effect; autonomic effects, such as salivation, 
diarrhea, urination; and central nervous system effects, including tremors and 
convulsions, straub tail, ptosis, relaxation, changes in the level of activity, gait and 
posture, reactivity to handling, altered strength and stereotypy (Demma et al., 2007; 
Nair et al., 2009).  
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3.11.2. Feed and water consumption and body weight measurement   
 
The animals were monitored daily for mortality, feed and water consumption and 
changes in body weight for 14 days in acute toxicity study. Feed intake was calculated 
as g/animal/day. Water intake was calculated as ml/animal/day. Individual animal 
body weight was recorded daily till the end of the experiment. 
 
3.11.3. Hematological analysis  
 
At the end of the study, all animals were fasted for 12 h and then under mild ether 
anesthesia, animals were sacrificed and blood samples were collected.  Blood was 
collected immediately into tubes containing EDTA for analysis of hematological 
parameters viz. hemoglobin, total red blood cells (RBC), packed cell volume, mean 
corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), total white blood cells (WBC), neutrophils, 
lymphocytes, eosinophils, monocytes, basophiles, total platelet count (Theml et al., 
2004) using hematology analyzer Sysmex XS800i (Sysmex corporation, USA).  
 
3.11.4. Relative organ weight (ROW) analysis  
 
Heart, liver, brain, kidneys, lungs, thymus glands, spleen, adrenal glands, testes and 
uterus were mopped with filter paper, weighed and the relative weights were 
calculated and expressed as g/100 g b.w. 
 ROW = Absolute organ weight (g)Body weight of rats on sacriϐice day (g)  X 100 
 
3.12. STATISTICAL ANALYSIS 
 
The data obtained from animal experiments are expressed as mean ± SEM (standard 
error of mean). For statistical analysis data were subjected to analysis of variance 
(ANOVA) followed by Student’s t-test. Values are considered statistically significant 
at F < 0.05 for ANOVA and P < 0.05 for t-test. 
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4.1. PHARMACOGNOSTIC STUDIES 
 
4.1.1. Macroscopic characteristics 
 
The full-grown Woodfordia fruticosa shrub is about 3.0 m high, having long and 
spreading branches with fluted stems. The flowers are bright red, innumerable, 
arranged in dense axillary paniculate-cymose clusters (Figure 1), with short glandular 
pubescent pedicels. The inflorescence is deep red, 2-15 flowered, fascicled cymes. 
The calyx is long (11-33 mm), striated, covered with glandular dots, with a small 
campanulate base and a long slightly curved bright red tube. The petals are pink, 
papery, slightly longer than the calyx-teeth, narrowly linear, extended at the apex to a 
long fine point. The fruits are small capsules, ellipsoid and membranous, usually 
splitting the calyx near the base, and are irregularly dehiscent. The seeds are brown, 
numerous, very minute, smooth, shining, angular and obovate. 
 
4.1.2. Microscopic characteristics 
 
Pedicel 
 
A transverse section of the pedicel flower shows a single-layered epidermis, with a 
fairly thick cuticle. Numerous unicellular trichomes arise from this layer. The 
epidermis is followed by a 7-8 layered cortex, differentiated into collenchyma and 
parenchyma with plenty of air spaces. The primary xylem is represented by uni- or bi-
seriate groups of 3 or 4 tracheids arranged in a ring with phloem on either side of the 
xylem. The rosette and cluster crystals of calcium oxalate are found in the cortex 
(Figure 2). 
 
Calyx 
 
A transverse section of the calyx tube is circular in outline. The cells of the upper 
epidermis in surface showed scattered trichomes. The calyx tube consists of several 
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layers of ground tissue containing rosettes and cluster of calcium oxalate crystals and 
bounded on either side by upper and lower epidermis respectively. Anomocytic, 
actinocytic and anisocytic stomata are present. Vascular bundles are small, collateral 
and surrounded by bundle sheath. In sepals, the cells of the lower epidermis in surface 
view are broad, slightly irregular, thin walled in the upper region but thick walled in 
the basal region of the calyx. The tissue is differentiated into an adaxial palisade and 
an abaxial spongy parenchyma in the upper ¾ of the calyx tube (Figure 2).  
 
Anther lobes 
 
The anther lobes are tetrasporangiate and the walls separating the locules get 
disorganized. A transaction of a lobe shows an epidermis formed of large colourless 
cells followed by a fibrous layer, which appears crinkled (Figure 3).  
 
Pollen grains 
 
Pollen grains are 3-zonocolporate, oblate spheroidal shape and it’s surface is psilate 
(Figure 3).  
 
TS of ovary 
 
The ovary is bicarpellary and laterally flattened and as such appears elongated in 
transaction (Figure 3).  
 
4.1.3. Powder characteristic  
 
The crude powder of Woodfordia fruticosa flower was light brown in color, slightly 
bitter and astringent in taste.  The specific characteristics determined from the powder 
study were (Figure 4): 
 
 Epidermis in surface view showed straight wall cells.  
 Few cells of fibrous layer observed in powder.  
 Cluster crystals of calcium oxalate were present in powder.  
 Pollen grains either in groups or singly found.  
A twig of Woodfordia fruticosa
Inflorescence From left to right three stages of development  of bud, flower and fruit
Figure 1: Macroscopic characteristics of Woodfordia fruticosa.
Actinocytic Stomata Anisocytic Stomata
Anomocytic Stomata
Pedicel Pedicel with Trichome
Figure 2: Microscopic characteristics of Woodfordia fruticosa flower.
Rosette and Cluster Crystal
TS of  Anther  Lobe
Pollen
Sepal
Palynogram of  Pollen
Figure 3: Microscopic characteristics of Woodfordia fruticosa flower.
Calyx
TS of Ovary
Figure 4: Powder characteristics of Woodfordia fruticosa flower.
Epithelial Cell Fiber
Unicellular Trichome Annular Xylem Vessel
Pollen Grain Cluster Calcium Oxalate Crystal
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 Simple covering unicellular trichomes are present.  
 Annular xylem vessels were found. 
 
4.2. PHYSICOCHEMICAL ANALYSIS 
 
4.2.1. Proximate parameters analysis  
 
The result of proximate analysis of crude powder of Woodfordia fruticosa flower is 
shown in Table 5. The average values are expressed as percentage of air-dried 
material. The loss on drying was 8%. Total ash was 5.45%, acid insoluble ash was 
0.57% and water soluble ash was 2.47%. The extractive value of crude powder was 
maximum in water (41.59%), followed by methanol (32.77%) and minimum was in 
hexane (0.71%). pH and melting point of methanol extract was 3.5 and 114°C 
respectively.  
 
Table 5: Proximate parameters of crude powder of Woodfordia fruticosa flowers 
 
Parameters Value (w/w) 
Loss on drying 8.00% 
Total ash 5.45% 
Acid insoluble ash 0.57% 
Water soluble ash 2.47% 
Petroleum ether soluble extractive 0.74% 
Hexane soluble extractive 0.71% 
Ethyl acetate soluble extractive 1.80% 
Acetone soluble extractive 8.08% 
Methanol soluble extractive 32.77% 
Water soluble extractive 41.59% 
pH of methanol extract 3.5 
Melting point methanol extract 114°C 
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4.2.2. Solubility test 
 
The methanol extract of Woodfordia fruticosa flowers was evaluated for solubility in 
10 solvents with varied polarities. The extract was highly soluble in 
dimethylformamide, methanol and dimethylsulphoxide but insoluble in hexane, 
petroleum ether and toluene solvents (Table 6). 
 
Table 6: Solubility of methanol extract of Woodfordia fruticosa flowers in 
different solvents 
 
Solvent Solubility (mg/ml) 
Acetone 6.0 
Chloroform 3.0 
Dimethylformamide (DMF) 119.0 
Dimethylsulphoxide (DMSO) 109.8 
Distilled water 34.2 
Ethyl acetate 3.0 
Hexane - 
Methanol 113.1 
Petroleum ether - 
Toluene - 
        (-): Not soluble 
 
4.2.3. Heavy metals analysis 
 
The crude powder of Woodfordia fruticosa flowers and its methanol extract were 
analysed for the presence of heavy metals. The results (Table 7) showed that crude 
powder and methanol extract contained 0.053 ppm and 0.05 ppm mercury; 0.12 ppm 
and 0.061 ppm arsenic respectively. Lead, chromium and cadmium were not detected 
in crude powder and methanol extract.  
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Table 7: Heavy metals in crude powder and methanol extract of Woodfordia fruticosa 
flowers 
 
Plant extract 
Heavy metals (ppm) 
Mercury 
(Hg) 
Lead 
(Pb) 
Chromium 
(Cr) 
Arsenic 
(As) 
Cadmium 
(Cd) 
Crude powder 0.053 NDT NDT 0.12 NDT 
Methanol 
extract 
0.05 NDT NDT 0.061 NDT 
NDT: Not detected  
 
4.3. PHYTOCHEMICAL ANALYSIS 
 
4.3.1. Qualitative phytochemical analysis 
 
The results of qualitative phytochemical analysis of the crude powder and the 
methanol extract of Woodfordia fruticosa flowers is shown in Table 8.  
 
Table 8: Preliminary qualitative phytochemical analysis of Woodfordia fruticosa 
flowers 
 
Phytochemical Test Crude  
powder 
Methanol extract 
Alkaloids Dragondroffs test ++ + 
 Mayers test + + 
 Wagners test ++ +++ 
Flavonoids Shinoda test ++ + 
 Alkaline reagent test + + 
Cardiac 
glycosides 
 
Keller-kilianni test - - 
Phlobotannins HCl test ++ + 
Saponins Frothing test + ++ 
Steroids Liebermann-Burchard 
reaction 
 
- - 
Tannins FeCl3 test +++ +++ 
Triterpenes H2SO4 test ++ + 
   (-): No presence, (+): Less presence, (++): Moderate presence, (+++): High presence 
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In crude powder and methanol extract maximum amount of tannins and alkaloids 
were present. Flavonoids, phlobotannins, saponins and triterpenes were present in 
moderate amount. Cardiac glycosides and steroids were absent in crude powder as 
well as in methanol extract.  
 
4.3.2. Quantitative phytochemical analysis 
 
The results of quantitative phytochemical analysis of the methanol extract of 
Woodfordia fruticosa flowers is shown in Table 9. The total phenol and flavonoid 
content was 64.24 mg/g and 13.07 mg/g respectively.  
 
Table 9: Quantitative phytochemical analysis of methanol extract of Woodfordia 
fruticosa flowers 
 
Total Phenol (mg/g) Flavonoid (mg/g) 
64.24 ± 0.93 13.07 ± 0.25 
 
 
4.4. ANTI-INFLAMMATORY STUDIES 
 
4.4.1. Carrageenan induced rat paw edema 
 
The results of anti-inflammatory activity of methanol extract of Woodfordia fruticosa 
flowers on carrageenan induced paw edema is shown in Table 10. The lower dose i.e. 
WFM-400 showed inhibition at both early and late phase; though maximum inhibition 
was at late phase (69%, P < 0.01).  The higher dose i.e. WFM-600 also showed 
maximum anti-inflammatory activity at late phase (42%) but this activity was less 
than that of WFM-400 at both early and late phase.  The standard Diclofenac-10 
showed maximum activity at early phase (59%, P < 0.01).  In this model, the lower 
dose showed more inhibition of edema formation than standard diclofenac.   
 
4.4.2. Histamine induced rat paw edema 
 
The results of anti-inflammatory activity of methanol extract of Woodfordia fruticosa 
flowers on histamine induced paw edema is shown in Table 11.  
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In this model, the Woodfordia fruticosa flower extract at both dose levels and 
standard diclofenac showed anti-inflammatory activity at late phase.  A clear dose 
dependent inhibition of paw edema was observed.  The percentage inhibition of 
WFM-400 was 36% (P < 0.05) while that of WFM-600 was 46% (P < 0.01).  The 
later was nearer to standard Diclofenac-10 (55%, P < 0.01). 
 
4.4.3. Dextran induced rat paw edema 
 
The results of anti-inflammatory activity of methanol extract of Woodfordia fruticosa 
flowers on dextran induced paw edema is shown in Table 12. In this model, a clear 
dose dependent inhibition of paw edema was observed at both early and late phases.  
The higher dose showed distinctly more inhibition than lower dose at both phases (P < 
0.05).  The anti-inflammatory activity of higher dose was more at later phase (50%) 
than early phase.  The standard diclofenac showed poor anti-inflammatory activity in 
this model. 
 
4.4.4. Serotonin induced rat paw edema 
 
The results of anti-inflammatory activity of methanol extract of Woodfordia fruticosa 
flowers on serotonin induced paw edema is shown in Table 13. The maximum paw 
thickness was observed at 3rd h after sub-planter injection in all groups. The animals 
treated with lower and higher doses of WFM (400 and 600 mg/kg) produced 
statistically significant inhibition at 1st h (P < 0.05; P < 0.01, respectively), 2nd and 3rd 
h (P < 0.05) and at 5th h (P < 0.01). Standard drug diclofenac-10 showed significant 
decrease in paw volume at 1st, 2nd h (P < 0.05) and at 3rd, 4th and 5th h (P < 0.01). The 
maximum decrease of paw volume in both the doses of WFM and diclofenac treated 
groups was found at 5th h (F < 0.001). The percent inhibition of WFM-400 group at 
5th h was same as that of standard group. The extract effectively suppressed the 
inflammation produced by serotonin.  
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4.4.5. Formaldehyde induced rat paw edema 
 
The results of anti-inflammatory activity of methanol extract of Woodfordia fruticosa 
flower in formaldehyde induced paw edema is shown in Table 14. Injection of 
formaldehyde subcutaneously into hind paw of rats produces localized inflammation. 
The administration of WFM-400, WFM-600 and diclofenac-10 daily for 7 days 
successfully significantly (F < 0.001) inhibited edema induced by formaldehyde. 
WFM-400 and WFM-600 group showed maximum decrease in paw volume at 3 h (P 
< 0.05 and P < 0.01 respectively). Diclofenac-10 group showed decrease in paw 
volume at 3 h (45.65%, P < 0.001) and the decreased in paw volume at 48 h was 
almost same (46.06%, P < 0.01). 
 
Table 14: Anti-inflammatory activity of methanol extract of Woodfordia fruticosa 
flowers in formaldehyde induced rat paw edema 
 
Treatment 
group 
% Increase in paw volume 
After 3 h After 24 h After 48 h 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Control 53.94 ± 3.02  
57.94 
± 1.97  
43.11 
± 2.23 
 
 
 
WFM-400 34.23 ± 5.23* 36.53↓ 
36.96 
± 2.89** 36.22↓ 
32.26 
± 5.13 
 
25.16↓ 
 
WFM-600 33.44 ± 3.87** 38.01↓ 
37.52 
± 6.64* 35.24↓ 
30.31 
± 4.13* 
 
29.69↓ 
 
Diclofenac-10 29.32 ± 1.53*** 45.65↓ 
33.11 
± 3.39** 42.86↓ 
23.26 
± 1.95** 
 
46.06↓ 
 
ANOVA - test F < 0.001  F < 0.01  F < 0.01  
Values are expressed as mean ± SEM, (n = 6). *P < 0.05; **P < 0.01; ***P < 0.001.  
↓ decreased 
 
4.4.6. Cotton pellet induced granuloma in rats 
 
The results of anti-inflammatory activity of methanol extract of Woodfordia fruticosa 
flower in cotton pellet induced granuloma is shown in Table 15. WFM-400 and 
WFM-600 groups showed 1.28% and 11.45% decrease in granuloma formation 
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respectively as compared to control group, while standard diclofenac-10 group 
showed significant decrease in granuloma formation (37.15%, P < 0.001). 
 
Table 15: Anti-inflammatory activity of methanol extract of Woodfordia 
fruticosa flowers in cotton pellet induced granuloma in rats 
 
Treatment 
group 
Pellet weight 
(g / 100 g b.w.) 
 
% Change 
 
Control 0.107 ± 0.005 - 
WFM-400 0.106 ± 0.005 1.28↓ 
WFM-600 0.095 ± 0.005 11.45↓ 
Diclofenac-10 0.067 ± 0.004*** 37.15↓ 
ANOVA - test F < 0.001  
        Values are expressed as mean ± SEM, (n = 6). ***P < 0.001. 
 
The results of changes in serum total protein and albumin levels in cotton pellet 
induced granuloma are given in Table 16. The total protein level increased at higher 
concentration (P < 0.01), and decreased at lower concentration of WFM, while 
diclofenac-10 group showed increase in total protein level as compared to control 
group. In standard and WFM-400 group, the albumin level was decreased as 
compared to control group.  
 
Table 16: Effect of methanol extract of Woodfordia fruticosa flowers on serum    
biochemical parameters in cotton pellet induced granuloma in rats 
 
Treatment 
group 
Total protein 
(g/dl) 
Albumin 
(g/dl) 
ACP 
(KA units) 
ALP 
(KA units) 
Control 6.23 ± 0.06 3.56 ± 0.04 13.03 ± 1.0 52.07 ± 7.12 
WFM-400 6.15 ± 0.07 3.36 ± 0.03 13.26 ± 1.2 36.97 ± 6.26 
WFM-600 6.54 ± 0.06** 3.57 ± 0.08 13.13 ± 0.61 43.69 ± 5.04 
Diclofenac-10 6.35 ± 0.13 3.32 ± 0.36 18.41 ± 5.4 60.25 ± 13.08 
         Values are expressed as mean ± SEM, (n = 6). *P < 0.05; **P < 0.01. 
 
The results of changes in serum ACP and ALP levels in cotton pellet induced 
granuloma are given in Table 16. The ACP level in both the doses of WFM was 
almost similar to that of control group. In standard group, the level of ACP was more 
as compared to control group. The ALP levels decreased in both the studied  
Drug administration (P.O.) Subplantar injection 
Measurement of paw volume
Implantation of cotton pellet Stitching of incision 
Figure 5: Photographs of anti-inflammatory study
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concentrations, and the decrease in lower concentration was more than that of the 
higher concentration.  In contrast, the ALP level in the standard group increased.  
 
4.5. ANALGESIC STUDY 
 
4.5.1. Formaldehyde induced paw licking test in rats  
 
The result of formaldehyde induced paw licking test in rats of methanol extract of 
Woodfordia fruticosa flower is given in Table 17. The onset time of paw licking was 
measured after formaldehyde injection. WFM-400 and WFM-600 showed 82.72% (P 
< 0.05) and 45.06% increase in onset time respectively, while diclofenac-10 group 
showed 26.54% increase in onset time as compared to the control group. After 
formaldehyde injection, the frequency of paw licking was measured between 0-5 min, 
6-10 min, 11-15 min, 16-20 min and 21-30 min. As compared with the control group, 
in the first phase (0-5 min), the extract reduced the paw licking up to 34.48% and 
18.39% at WFM-400 and WFM-600 dose level respectively, while diclofenac-10 
reduced the paw licking up to 21.84%. In second phase (16-20 min) both the extract 
and diclofenac reduced the dose dependent paw licking up to 27.42%, 47.96% and 
49.33 and (during 21-30 min) 24.04%, 29.23% and 35.07% respectively.  
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4.6. HEPATOPROTECTIVE STUDIES 
 
4.6.1. Diclofenac induced hepatotoxicity 
 
The results of serum biochemical parameters in pre-treatment of WFM with respect to 
induction of hepatotoxicity using diclofenac are shown in Figure 6. The level of total 
protein and albumin depleted in the group treated with diclofenac (toxin control) and 
were significantly decreased (P < 0.001) when compared with the normal control 
group. The BUN and ALP levels increased significantly (P < 0.01, P < 0.001 
respectively) in the group treated with diclofenac. The administration of diclofenac 
markedly increased serum AST and ALT levels which were significant as compared 
to normal control group (P < 0.05, P < 0.01 respectively).  
 
The groups that received the pre-treatment of WFM at dose levels of 400 and 600 
mg/kg body weight significantly controlled the change in the biochemical parameters. 
The extract at dose levels of 400 and 600 mg/kg exhibited significant increase (P < 
0.05) in the serum total protein level as compared to toxin control group. The albumin 
level in lower as well as in higher dose group increased significantly (P < 0.01, P < 
0.001 respectively) as compared to toxin control group and the effect was comparable 
with the standard group (P < 0.01) treated with silymarin. The BUN level decreased in 
both the dose groups significantly (P < 0.05) as compared to toxin control group. The 
ALP level also significantly decreased in WFM-400 (P < 0.05) as well as in WFM-
600 group (P < 0.001). In WFM-600 group, the level of ALT and AST significantly 
decreased (P < 0.05), the result was comparable to that of standard group.  
 
The results of relative liver weight, liver total protein, GSH and antioxidant enzymes 
in diclofenac induced hepatotoxicity are given in Figure 7. The relative liver weight in 
toxin control group increased significantly (P < 0.001) as compared to normal control 
group. The total protein and GSH levels from the liver homogenate decreased 
significantly (P < 0.001, P < 0.01 respectively) in toxin control group. The catalase 
(CAT) and GPx activity in the toxin control group was also significantly (P < 0.001, P 
< 0.05 respectively) depleted as compared to the normal control group. The   mean 
relative liver weight decreased significantly in WFM-400 (P < 0.001) and WFM-600  
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Figure 6: Effect of methanol extract of Woodfordia fruticosa flowers on different serum 
biochemical parameters in diclofenac (50 mg/kg) induced hepatic damage in rats. Group I: 
Normal control, Group II: Toxin control diclofenac, Group III: WFM-400 mg/kg + 
diclofenac, Group IV: WFM-600 mg/kg + diclofenac, Group V: Silymarin-100 mg/kg + 
diclofenac. Results are expressed as mean ± SEM, (n = 6). #P < 0.05, ##p < 0.01, ###p < 0.001 
as compared with normal control group; *p < 0.05, **p < 0.01, ***p < 0.01 as compared with 
toxin control group. 
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Figure 7: Effect of methanol extract of Woodfordia fruticosa flowers on relative liver 
weight, liver total protein and different liver antioxidants in diclofenac (50 mg/kg) induced 
hepatic damage in rats. Group I: Normal control, Group II: Toxin control diclofenac, Group 
III: WFM-400 mg/kg + diclofenac, Group IV: WFM-600 mg/kg + diclofenac, Group V: 
Silymarin-100 mg/kg + diclofenac. Results are expressed as mean ± SEM, (n = 6). #p < 0.05, 
##p < 0.01, ###p < 0.001 as compared with normal control group; *p < 0.05, **p < 0.01, ***p < 
0.01 as compared with toxin control group. 
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Figure 8: Photographs of liver sections of diclofenac (50 mg/kg) toxicity in rats 
(hematoxylin and eosin stained, 10x). (A) Normal control group, (B) Toxin control 
(diclofenac) group, (C) WFM-400 mg/kg + diclofenac, (D) WFM-600 mg/kg + diclofenac, 
(E) Silymarin-100 mg/kg + diclofenac. 
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(P < 0.01) treated group as compared to the toxin control group. The result of the 
higher dose group was comparable to the standard drug treated group (P < 0.001). The 
total protein and GSH levels from liver homogenate in WFM treated groups elevated, 
but total protein level was not significant. However, pretreatment with WFM 
significantly recovered the diclofenac induced GSH depletion in lower and higher 
dose group (P < 0.01, P < 0.05 respectively). The catalase and GPx activity increased 
at both the dose levels; at higher dose WFM exhibited good activity (P < 0.01, P < 
0.05 respectively). GPx activity of WFM-600 group was similar to that of standard 
drug treated group. 
 
In normal control animal liver, histological sections showed hepatocytes that were 
well-preserved, uniform cytoplasm and sinusoidal spaces (Figure 8A). Compared with 
the normal control group, liver tissue in the rats treated with diclofenac revealed 
extensive liver injuries, characterized by severe hepatocellular degeneration, necrosis, 
inflammatory cell infiltration, sinusoidal dilatation and cytoplasmic vacuolation 
(Figure 8B). However, the histopathological hepatic lesions induced by administration 
of diclofenac was remarkably improved by the treatment with both the doses of WFM 
(Figure 8C & 8D), and showed marked protective effect by decreasing hepatocellular 
degeneration and necrosis. The protective effect was also observed in silymarin 
treated animals (Figure 8E). This was in good agreement with the results of serum 
aminotransferase activity and hepatic oxidative stress level. 
 
4.6.2. Carbon tetrachloride induced hepatotoxicity 
 
The results observed from serum biochemical parameters in pre-treatment of WFM 
with respect to induction of hepatotoxicity using CCl4 are given in Figure 9. A 
marked reduction in total protein and albumin levels was observed in the group 
treated with CCl4 and they were significantly decreased (P < 0.05) when compared 
with the normal control group. The BUN and ALP levels increased in the group 
treated with CCl4 but not to a significant level. Rats treated with CCl4 (toxin control) 
developed significant liver damage and it was well indicated by elevated levels of 
hepato specific enzymes like AST (P < 0.01) and ALT (P < 0.001) in serum.  
 
The groups received the pre-treatment of WFM at dose levels of 400 and 600 mg/kg 
body weight significantly controlled the change in the biochemical parameters. The 
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extract at dose levels of 400 and 600 mg/kg exhibited significant increase (P < 0.01, p 
< 0.05 respectively) in the serum total protein level as compared to toxin control 
group and the effect was comparable with the standard group (P < 0.01) treated with 
silymarin (Sily-100). The albumin level also increased in drug treated groups but not 
to a significant level. The level of BUN was reduced in both the dose of WFM and 
standard drug treated groups, but it was not significant. The ALP (P < 0.05), AST (P 
< 0.01) and ALT (P < 0.01) levels significantly decreased in WFM-400 group as 
compared to toxin control group. WFM-600 group also showed significant decreased 
(P < 0.05) AST and ALP levels.  
 
The result of relative liver weight, liver total protein, GSH and antioxidant enzymes in 
CCl4 induced hepatotoxicity are given in Figure 10. The relative liver weight in toxin 
control group increased significantly (P < 0.001) as compared to normal control 
group. The total protein level in liver decreased significantly (P < 0.001) in toxin 
control group. The level of GSH in toxin control group decreased, but it was non-
significant. The catalase (CAT) and GPx activities in the toxin control group  depleted 
significantly (P < 0.05, P < 0.001 respectively) as compared to the normal control 
group. The mean relative liver weight in WFM at both the doses was slightly elevated 
as compared to the toxin control group. The total protein level in liver, in WFM 
treated as well as in the standard drug treated group, increased significantly (P < 
0.001) as compared to toxin control group. GSH level increased significantly (P < 
0.01) at higher dose as compared to toxin control group. Catalase activity increased at 
both the dose levels though not significantly, while in silymarin group, catalase 
activity decreased. Administration of WFM did not display effect of increase in the 
GPx activity. 
 
The histopathological feature, as shown in Figure 11(A) indicated the normal liver 
lobular architecture and cell structure of the liver in the normal control animals. There 
were no pathological changes observed in normal control animals. In CCl4 treated 
animals, there was a vacuolar degeneration of hepatocytes around central vein with 
moderate to severe hepatocyte necrosis due to CCl4 toxicity (Figure 11B). The 
histological observations also supported results obtained from the serum enzyme 
levels. 
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Figure 9: Effect of methanol extract of Woodfordia fruticosa flowers on different serum 
biochemical parameters in CCl4 (2 ml/kg) induced hepatic damage in rats. Group I: Normal 
control, Group II: Toxin control CCl4, Group III: WFM-400 mg/kg + CCl4, Group IV: WFM-
600 mg/kg + CCl4, Group V: Silymarin-100 mg/kg + CCl4. Results are expressed as mean ± 
SEM, (n = 6). #p < 0.05, ##p < 0.01, ###p < 0.001 as compared with normal control group; *p < 
0.05, **p < 0.01, ***p < 0.01 as compared with toxin control group. 
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Figure 10:  Effect of methanol extract of Woodfordia fruticosa flowers on relative liver 
weight, liver total protein and different liver antioxidants in CCl4 (2 ml/kg) induced hepatic 
damage in rats. Group I: Normal control, Group II: Toxin control CCl4, Group III: WFM-400 
mg/kg + CCl4, Group IV: WFM-600 mg/kg + CCl4, Group V: Silymarin-100 mg/kg + CCl4. 
Results are expressed as mean ± SEM, (n = 6). #p < 0.05, ##p < 0.01, ###p < 0.001 as 
compared with normal control group; *p < 0.05, **p < 0.01, ***p < 0.01 as compared with 
toxin control group. 
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Figure 11: Photographs of liver sections of CCl4 (2 ml/kg) toxicity in rats (hematoxylin and 
eosin stained, 10x). (A) Normal control, (B) Toxin control (CCl4), (C) WFM-400 + CCl4, (D) 
WFM-600 + CCl4, (E) Silymarin-100 + CCl4. 
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These histopathological changes were remarkably reversed in WFM treated animals, 
dose dependently with lesser vacuolar degeneration and hepatic necrosis (Figure 11C 
& 11D). Similar changes were also observed in the silymarin treated animals (Figure 
11E). 
 
4.6.3. Acetaminophen induced hepatotoxicity 
 
Oral administration of Acetaminophen (APAP) caused significant liver damage as 
evidenced by altered biochemical parameters (Figure 12). APAP significantly (P < 
0.001) decreased serum levels of total protein and albumin as compared to normal 
control group. APAP significantly (P < 0.01) enhanced BUN, ALP, AST and ALT 
levels in the blood circulation; about 3-fold increase was observed in AST and ALT 
levels in serum.  
 
Treatment with WFM did not exhibit potential effect on recovery of total protein and 
albumin levels; while in standard drug treated group, the level of total protein and 
albumin levels increased significantly (P < 0.01). The BUN and ALP levels also 
decreased significantly in lower as well as higher dose of WFM (P < 0.01, P < 0.05 
respectively) as compared to toxin control group. 400 and 600 mg/kg of WFM treated 
group showed significant (P < 0.001, P < 0.01 respectively) decrease in AST level as 
compared to toxin control group. The result of AST was similar to that of the standard 
drug treated group (P < 0.001). ALT level decreased in WFM treated groups towards 
normalization though not significantly.  
 
The result of relative liver weight, liver total protein, GSH and antioxidant enzymes in 
APAP induced hepatotoxicity are given in Figure 13. The administration of APAP 
significantly increased the liver weight (P < 0.001) as compared to normal control 
group. 
 
Significant decreased level was observed in hepatic total protein (P < 0.001). The 
administration of APAP significantly decreased the hepatic non-enzymatic 
antioxidant GSH contents (P < 0.05). The treatment of WFM decreased liver weight 
significantly (P < 0.05) at both the dose levels as compared to toxin control group.  
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Figure 12: Effect of methanol extract of Woodfordia fruticosa flowers on different serum 
biochemical parameters in APAP (3 g/kg) induced hepatic damage in rats. Group I: Normal 
control, Group II: Toxin control APAP, Group III: WFM-400 mg/kg + APAP, Group IV: 
WFM-600 mg/kg + APAP, Group V: Silymarin-100 mg/kg + APAP. Results are expressed 
as mean ± SEM, (n = 6). #p < 0.05, ##p < 0.01, ###p < 0.001 as compared with normal control 
group; *p < 0.05, **p < 0.01, ***p < 0.01 as compared with toxin control group. 
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Figure 13: Effect of methanol extract of Woodfordia fruticosa flowers on relative liver 
weight, liver total protein and different liver antioxidants in APAP (3 g/kg) induced hepatic 
damage in rats. Group I: Normal control, Group II: Toxin control APAP, Group III: WFM-
400 mg/kg + APAP, Group IV: WFM-600 mg/kg + APAP, Group V: Silymarin-100 mg/kg + 
APAP. Results are expressed as mean ± SEM, (n = 6). #p < 0.05, ##p < 0.01, ###p < 0.001 as 
compared with normal control group; *p < 0.05, **p < 0.01, ***p < 0.01 as compared with 
toxin control group. 
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Figure 14:  Photographs of liver sections of APAP (3 g/kg) toxicity in rats (hematoxylin and 
eosin stained, 10x). (A) Normal control, (B) Toxin control (APAP), (C) WFM-400 + APAP, 
(D) WFM-600 + APAP, (E) Silymarin-100 + APAP. 
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In higher dose, the level of hepatic total protein increased significantly (P < 0.01). The 
hepatoprotective efficacy of the WFM-600 was comparable with that of standard drug 
silymarin. WFM treatment enhanced the production of GSH towards normal control, 
but not to a significant level. Administration of APAP did not diminish the anti-
oxidative status of hepatic catalase and GPx activity.  
 
Liver histopathologic examination showed no histological abnormalities in normal 
control liver (Figure 14A); the hepatic lobular architecture was normal, connective 
tissue proliferation was not seen. In acetaminophen treated animals, the liver 
pathological changes were characterized by severe hepatocellular degeneration and 
necrosis along with periportal mononuclear cell infiltration due to acetaminophen 
toxicity (Figure 14B). WFM protected the liver tissue against acetaminophen toxicity 
(Figure 14C & 14D), with mild hepatocellular degeneration, necrosis, less 
inflammatory cell infiltration and well preserved hepatocytes were observed in most 
areas when compared with that of APAP group. The recovery from degeneration of 
hepatic cells of WFM treated animals was comparable to that of standard drug treated 
animals (Figure 14E). 
 
4.7. ACUTE TOXICITY STUDY 
 
In acute toxicity study, no adverse reactions or mortality were observed after 
administration of WFM (450, 1800, and 3600 mg/kg bw) and no behavioral changes 
were observed during the entire period of experimentation. Some alteration was 
noticed in daily feed and water intake in both male and female rats (Figure 15 & 16) 
treated with single dose of extract as well as in control animals. As compared to the 
control group, drug treated groups had several consecutive days of reduced/increased 
feed and water consumption at different times in the study. These periods of 
reduced/increased feed and water intake were not significant to the overall feed and 
water consumption rates. Individual body weights were recorded daily during the 
experimental period. Mean body weight gains were calculated for each group. In 
control and WFM treated groups, body weight of animals slightly increased during 
experimental period (Figure 17), but the increase was not significant. 
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Figure 15: Changes in feed consumption (g/day/animal) of male and female rats 
during  acute toxicity study. 
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 Figure 16: Changes in water consumption (ml/day/animal) of male and female 
rats during acute toxicity study. 
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Figure 17: Changes in body weight (g) of male and female rats during acute toxicity 
study. 
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The relative organ weights of male and female rats are shown in Table 18 and 19 
respectively. Gross examination of internal organs of all the rats revealed no 
detectable abnormalities. The organs like heart, liver, brain, thymus, spleen and 
adrenal of rats did not illustrate any significant change in their relative organ weights 
at any doses as compared to control. There were alterations in the weight of a few 
organs but this was not observed with all doses. The relative weight of kidney in male 
rats significantly increased (P < 0.05) at 450 mg/kg dose, while in female rats it 
significantly decreased (P < 0.05) at 1800 and 3600 mg/kg dose level.  
 
Table 18: Relative organ weight (g/100 g body weight) of male rats treated with 
methanol extract of Woodfordia fruticosa flowers in acute toxicity study 
 
Organs Control 
WFM (mg/kg, b.w.) treated group 
450 1800 3600 
Heart 0.324 ± 0.009 0.350 ± 0.012 0.334 ± 0.011 0.338 ± 0.013 
Liver 2.556 ± 0.059 2.647 ± 0.090 2.711 ± 0.043 2.558 ± 0.070 
Brain 0.652 ± 0.021 0.676 ± 0.057 0.734 ± 0.061 0.734 ± 0.050 
Kidney 0.348 ± 0.009 0.388 ± 0.012* 0.364 ± 0.012 0.356 ± 0.011 
Lung 0.575 ± 0.023 0.701 ± 0.027* 0.579 ± 0.031 0.781 ± 0.049* 
Thymus 0.217 ± 0.012 0.205 ± 0.010 0.199 ± 0.007 0.195 ± 0.015 
Spleen 0.243 ± 0.005 0.244 ± 0.012 0.243 ± 0.016 0.241 ± 0.013 
Adrenal 0.0075 ± 0.000 0.0088 ± 0.001 0.0080 ± 0.000 0.0087 ± 0.001 
Testis 0.507 ± 0.006 0.531 ± 0.005* 0.539 ± 0.019 0.555 ± 0.009* 
           Values are expressed as mean ± SEM (n = 5), *P < 0.05. 
 
The relative weight of lung in male rats significantly increased (P < 0.05) at 450 and 
3600 mg/kg dose level and in female rats it significantly increased (p < 0.05) at 3600 
mg/kg dose level. In female rats relative lung weight at lower doses slightly increased 
but not to a significant level. The relative weight of testis significantly increased (P < 
0.05) at 450 and 3600 mg/kg dose level, while at the same doses the relative uterus 
weight significantly (P < 0.05) decreased.  
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Table 19: Relative organ weight (g/100 g body weight) of female rats treated with 
methanol extract of Woodfordia fruticosa flowers in acute toxicity study 
 
Organs Control 
WFM (mg/kg, b.w.) treated group 
450 1800 3600 
Heart 0.330 ± 0.01 0.332 ± 0.008 0.325 ± 0.005 0.316 ± 0.027 
Liver 2.728 ± 0.059 2.589 ± 0.045 2.636 ± 0.052 2.475 ± 0.266 
Brain 0.857 ± 0.051 0.851 ± 0.091 0.916 ± 0.059 0.787 ± 0.054 
Kidney 0.376 ± 0.013 0.354 ± 0.015 0.338 ± 0.14* 0.318 ± 0.025* 
Lung 0.720 ± 0.028 0.779 ± 0.023 0.846 ± 0.059 0.902 ± 0.062* 
Thymus 0.226 ± 0.010 0.228 ± 0.023 0.223 ± 0.006 0.208 ± 0.019 
Spleen 0.272 ± 0.010 0.298 ± 0.009 0.294 ± 0.008 0.247 ± 0.026 
Adrenal 0.0117 ± 0.001 0.0122 ± 0.001 0.0131 ± 0.001 0.0134 ± 0.001 
Uterus 0.390 ± 0.023 0.304 ± 0.021* 0.327 ± 0.031 0.239 ± 0.015* 
            Values are expressed as mean ± SEM (n = 5), *P < 0.05. 
 
The hematological parameters of male and female rats are shown in Table 20 and 21 
respectively. In male rats the RBC count, Hb and PCV increased significantly (P < 
0.05) at 3600 mg/kg dose level. In female rats at dose level of 1800 and 3600 mg/kg, 
the Hb level significantly (P < 0.05) increased. The WBC count in both sexes 
decreased at lower dose, in male rats it was significant (P < 0.05) while in female rats 
it was not significant. This increase and decrease level of some parameters was not 
dose dependent. There were no significant changes observed in MCV, MCH, MCHC, 
platelet count and differential leukocyte counts of the treated animals as compared to 
control animals. 
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Table 20: Hematological parameters of male rats treated with methanol extract of 
Woodfordia fruticosa flowers in acute toxicity study 
 
Parameters Control 
WFM (mg/kg, b.w.) treated group 
450 1800 3600 
RBC (106/µl) 8.48 ± 0.12 8.544 ± 0.14 8.616 ± 0.17 9.078 ± 0.17* 
Hb (g/dl) 15.52 ± 0.24 15.34 ± 0.26 15.5 ± 0.31 16.4 ± 0.16* 
PCV (%) 43.98 ± 0.58 43.66 ± 0.77 44.44 ± 0.84 46.34 ± 0.63* 
MCV (F1) 51.86 ± 0.19 51 ± 0.24 51.6 ± 0.19 51.06 ± 0.52 
MCH (pg) 18.3 ± 0.09 17.96 ± 0.13 17.96 ± 0.13 18.08 ± 0.24 
MCHC (g/dl) 35.26 ± 0.24 35.18 ± 0.19 34.84 ± 0.20 35.15 ± 0.23 
Platelet Count 
(103/µl) 
940.2 ± 175.6 1299.4 ± 30.8 1172.8 ± 92.0 1254.0 ± 49.7 
WBC (103/µl) 11.70 ± 0.70 9.68 ± 0.20* 9.02 ± 1.02 12.98 ± 1.19 
Neutrophils (%) 22.4 ± 2.01 18.2 ± 2.13 22.2 ± 2.22 24.4 ± 3.98 
Lymphocytes (%) 77.4 ± 2.06 81.4 ± 2.16 77.6 ± 2.16 75.4 ± 3.89 
Eosinophls (%) 0.2 ± 0.00 0.4 ± 0.24 0.2 ± 0.00 0.2 ± 0.00 
Monocytes (%) 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 
Basophils (%) 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 
Values are expressed as mean ± SEM (n = 5), *P < 0.05.   
 
RBC - red  blood cell; Hb - hemoglobin; PCV - packed cell volume; MCV - mean 
corpuscular volume; MCH - mean corpuscular hemoglobin; MCHC - mean corpuscular 
haemoglobin concentration; WBC - white blood cell        
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Table 21: Hematological parameters of female rats treated with methanol extract of 
Woodfordia fruticosa flowers in acute toxicity study 
 
Parameters Control 
WFM (mg/kg b.w.) treated group 
450 1800 3600 
RBC (106/µl) 7.864 ± 0.28 7.688 ± 0.13 8.246 ± 0.25 8.286 ± 0.10 
Hb (g/dl) 14.7 ± 0.28 14.66 ± 0.22 15.98 ± 0.39* 16.16 ± 0.22* 
PCV (%) 39.9 ± 1.22 38.92 ± 0.62 42.48 ± 1.05 42.84 ± 0.60 
MCV (F1) 50.78 ± 0.47 50.64 ± 0.54 51.54 ± 0.31 51.7 ± 0.29 
MCH (pg) 18.74 ± 0.49 19.08 ± 0.27 19.4 ± 0.21 19.52 ± 0.18 
MCHC (g/dl) 36.9 ± 0.70 37.7 ± 0.28 37.64 ± 0.24 37.58 ± 0.70 
Platelet Count 
(103/µl) 
1041.2 ± 159.0 1018.0 ± 217.8 1119.6 ± 207.0 981.4 ± 187.2 
WBC (103/µl) 9.52 ± 0.92 8.10 ± 0.72 9.20 ± 0.97 8.34 ± 1.36 
Neutrophils (%) 17.8 ± 1.98 13.6 ± 1.36 20 ± 3.08 23.4 ± 2.11 
Lymphocytes (%) 81.8 ± 2.03 86.8 ± 1.66 79.4 ± 3.03 76 ± 2.30 
Eosinophls (%) 0.4 ± 0.00 0.4 ± 0.00 0.6 ± 0.00 0.6 ± 0.00 
Monocytes (%) 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 
Basophils (%) 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 
Values are expressed as mean ± SEM (n = 5), *P < 0.05. 
   
RBC - red  blood cell; Hb - hemoglobin; PCV - packed cell volume; MCV - mean 
corpuscular volume; MCH - mean corpuscular hemoglobin; MCHC - mean corpuscular 
haemoglobin concentration; WBC - white blood cell        
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5.1. PHARMACOGNOSTIC STUDIES 
 
The pharmacognostical study is a major and reliable criterion of identification of plant 
drugs. The pharmacognostic parameters are necessary for confirmation of the identity 
and determination of quality and purity of a crude drugs (Bhattacharya and Zaman, 
2009). To ensure reproducible quality of herbal products, proper control of starting 
material is utmost essential (Venkatesh et al., 2004). Thus, in recent years there has 
been an emphasis on standardization of medicinal plants, and evaluation of plant 
drugs by pharmacognostical studies is still more reliable, accurate and inexpensive 
means. Pharmacognostic studies on different plants has been done by various workers 
(Khatoon et al., 2006; Abere et al., 2007; Dave et al., 2010; Essiett et al., 2010; 
Sandhya et al., 2010). According to World Health Organization (WHO) the 
macroscopic and microscopic description of a medicinal plant is the first step towards 
establishing its identity and purity and should be carried out before any tests are 
undertaken (WHO, 2002). The flowers of Woodfordia fruticosa have three types of 
matured stomata viz. anomocytic, actinocytic and anisocytic. Stomata is the main 
factor responsible for the physiological activities of the plant, abnormal stomata is 
responsible for behavior and hormonal imbalance in plants (Kridemann et al., 2000). 
In calyx both rosette and cluster type of calcium oxalate crystals were found; these 
could be used to distinguish the species. 
 
5.2. PHYSICOCHEMICAL ANALYSIS 
 
The physical constant evaluation of the powder is an important parameter in detecting 
adulteration or improper handling of drugs. The percentage of active chemical 
constituents in crude drugs is mentioned on air-dried basis. Therefore, the loss on 
drying of plant materials should be determined and the water content should also be 
controlled. The moisture content of dry powder of Woodfordia fruticosa flowers was 
8 % which is not very high, hence it would discourage bacteria fungi or yeast growth 
(Bhattacharya and Zaman, 2009). The total ash is particularly important in the 
evaluation of purity of drugs, i.e. the presence or absence of foreign inorganic matter 
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such as metallic salts and/or silica (Musa et al., 2006; Chanda et al., 2010). Low 
amount of total ash, acid insoluble ash and water soluble ash indicate that the 
inorganic matter and non-physiological matter such as silica is less in Woodfordia 
fruticosa flowers. The extractive values are useful to evaluate the chemical 
constituents present in the crude drug and also help in estimation of specific 
constituents soluble in a particular solvent. The variation in extractable matter in 
various solvents is suggestive of the fact that the formation of the bioactive principle 
of the medicinal plants is influenced by number of intrinsic and extrinsic factors. High 
alcohol soluble and water soluble extractive values reveal the presence of polar 
substance like phenols, tannins and glycosides, as reported by Sharma et al. (2009) 
and Baravalia et al. (2010). 
 
Heavy metals like lead, chromium and cadmium were absent, while mercury and 
arsenic were present in very low amount, which was within the permissible limits of 
heavy metals (The Ayurvedic Pharmacopoeia of India, 2008). Therefore it can be 
stated that the extract was free from heavy metal contamination. 
 
5.3. PHYTOCHEMICAL ANALYSIS 
 
The phytoconstituents are known to play an important role in bioactivity of medicinal 
plants. In qualitative phytochemical analysis, tannins and alkaloids were present in 
high amount as compared to other phytoconstituents analyzed. In quantitative 
phytochemical analysis, phenolic content was much more than flavonoid content. The 
presence of alkaloids, phenolic compounds, tannins, flavonoids have been associated 
with various degrees of anti-inflammatory, analgesic (Wang JR et al., 2008) and 
antioxidant activities (Molina et al., 2003; Gholivand et al., 2010). Therefore, the anti-
inflammatory, analgesic and hepatoprotective effects observed in this study may be 
due to the activity(s) of one or a combination of some of the classes of compounds 
present in Woodfordia fruticosa flowers. 
 
5.4. ANTI-INFLAMMATORY STUDIES 
 
It is believed that current anti-inflammatory drugs such as opioids and non-steroidal 
anti-inflammatory drugs are not useful in all cases because of their side effects and 
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low potency (Jaishree et al., 2009). As a result, search for other alternatives became 
necessary and imperative. Novel anti-inflammatory agents could be discovered from 
medicinal plants containing a wide variety of phytoconstituents. Traditional medicine 
for the treatment of various diseases is becoming more popular. Many medicinal 
plants provide relief of symptoms comparable to that of conventional medicinal 
agents. Therefore, the present study was aimed at evaluating the scientific basis for 
the traditional use of Woodfordia fruticosa flowers using in vivo anti-inflammatory 
models. 
 
5.4.1. Carrageenan induced rat paw edema 
 
Carrageenan has been widely used as a harmful agent able to induce experimental 
inflammation for the screening of compounds possessing anti-inflammatory activity. 
This phlogistic agent, when injected locally into the rat paw, produced a severe 
inflammatory reaction, which was discernible within 30 min (John and Nodine, 1999; 
Marzouk et al., 2010). Carrageenan induced rat paw edema is a suitable in vivo model 
to predict the value of anti-inflammatory agents, which act by inhibiting the mediators 
of acute inflammation (Morebise et al., 2002). Carrageenan-induced hind paw edema 
in rat is a biphasic event. The early phase (90 - 180 min) of the inflammation is due to 
the release of histamine, serotonin and similar substances; and the later phase (270–
360 min) is associated with the activation of kinin-like substances, i.e., 
prostaglandins, proteases and lysosome (Erdemoglu et al., 2009; Thomazzi et al., 
2010). The methanol extract of Woodfordia fruticosa flowers inhibited the 
carrageenan induced rat paw edema formation, at both early and later phase. This 
result tends to suggest that the inhibitory effect of the extract on edema formation is 
probably due to the inhibition of the synthesis and/or release of the inflammatory 
mediators, especially the cyclooxygenase products. The carrageenan induced paw 
edema test is effectively controlled with the arachidonate cyclooxygenase (COX) 
inhibitors due to its COX-dependent mechanism, thus, it is suggested that the WFM 
may possess arachidonate COX inhibitory property. 
 
5.4.2. Histamine induced rat paw edema 
 
Histamine is another pro-inflammatory mediator involved in exudation and cell 
chemotaxis (Jutel et al., 2005). The histamine is a basic amine related with 
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inflammatory and allergic process causing, among several effects, both vasodilatation 
and increase of vascular permeability (Rang et al., 2001). Edema was reduced by 
WFM in a dose dependent manner till the end of 5th hour. The antihistaminic activity 
may be related to the inhibition of inflammation mediator formation. The extract may 
also inhibit histamine release from mast cells and/or block histamine receptors. 
 
5.4.3. Dextran induced rat paw edema 
 
Dextran is a polysaccharide of high molecular weight that induces anaphylactic 
reaction after injection in rats extremities, which is characterized by extravasation and 
edema formation, as a consequence of liberation of histamine and serotonin from mast 
cells (Van Wauwe and Goossens, 1989; Prakash et al., 2009). Thus, carrageenan and 
dextran induced models are suitable test procedure to screen anti-inflammatory 
agents. In this study, WFM exhibited dose-dependent inhibitory effect in dextran 
induced paw edema and was capable to reduced the inflammation up to 5 h. The 
ability of the extract to reduce the edema volume suggests that the phytochemicals 
present in the extract may block or counteract the release of any of those mediators, 
alone or in combination. 
 
5.4.4. Serotonin induced rat paw edema 
 
The extract effectively suppressed the inflammation produced by serotonin. The 
extract of Woodfordia fruticosa was able to significantly reduce paw edema, and these 
effects were similar to those exhibited by the group of rats treated with diclofenac. So 
it may be suggested that its anti-inflammatory activity is possibly backed by its anti-
serotonin activity. 
 
5.4.5. Formaldehyde induced rat paw edema 
 
It is well known that inhibition of formaldehyde induced paw edema in rats is one of 
the most suitable test procedures to screen anti-arthritic and anti-inflammatory agents 
as it closely resembles human arthritis (Greenwald, 1991). Thus formaldehyde 
induced paw edema is a model used for the evaluation of an agent with 
antiproliferative activity (Banerjee et al. 2000). Injection of formaldehyde 
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subcutaneously into hind paw of rats produces localized inflammation. In the present 
study, the methanol extract of Woodfordia fruticosa flowers significantly inhibited 
paw edema induced by formaldehyde. WFM showed significant decrease in paw 
volume till 48 h with both doses, which suggests its long duration of action. 
 
5.4.6. Cotton pellet induced granuloma in rats 
 
Cotton pellet-induced granuloma formation is a typical feature of an established 
chronic inflammatory reaction and can serve as a subchronic and chronic 
inflammatory test model for investigation of anti-arthritic substances (Panthong et al., 
2004). This model has been employed to assess the transudative and proliferative 
components of chronic inflammation. The fluid adsorbed by the pellet greatly 
influences the wet weight of the granuloma whereas the dry weight correlates well 
with the amount of granulomatous tissue formed. The extract showed decrease in 
granuloma formation. This reflected its efficacy to reduce an increase in the number 
of fibroblasts and synthesis of collagen with mucopolysaccharide, which are natural 
proliferative events of granulation tissue formation. 
 
At higher concentration of extract the protein level increased. Increase in protein level 
at higher concentration of methanol extract of P. longifolia was also reported by 
Tanna et al., (2009). The rise in protein and albumin levels at high doses suggests 
stabilization of the endoplasmic reticulum, leading to protein synthesis (Mondal et al., 
2005). 
 
5.5. ANALGESIC STUDY 
 
5.5.1. Formaldehyde induced paw licking test in rats  
 
The formaldehyde test has been described as a convenient method for producing and 
quantifying pain in rats (Dubuisson and Dennis, 1977). The test employs an adequate 
painful stimulus to which the animals show a spontaneous response and it is sensitive 
to commonly used analgesics. The pain stimulus, a continuous rather than a transient 
one, may have resemblance to some kinds of clinical pain and observations are made 
on animals which are restrained only lightly or not at all (Hunskaar et al., 1985; 
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Ghannadi et al., 2005). The advantage of the formaldehyde model of nociception was 
that it could discriminate between central and peripheral pain components. The test 
consists of two different phases which could be separated in time: the first one that 
occurs on the first 5 min after the formaldehyde injection was generated in the 
periphery through the activation of nociceptive neurons by the direct action of 
formaldehyde and the second phase that occurs between the 15th and 30th minute after 
formaldehyde injection, occurred through the activation of the ventral horn neurons at 
the spinal cord level (Tjolsen et al., 1992; Li et al., 2010). In the present study, WFM 
orally administered 1 h before formaldehyde injection, was capable of inhibiting the 
paw licking process when compared with the control group. It was observed that rats 
treated with WFM showed nociceptive reaction, which was dose-related and inhibited 
in second phase of formaldehyde test. Drugs that act primarily on the central nervous 
system inhibit both phases equally, while peripherally acting drugs inhibit the second 
phase only (Shibata et al., 1989). The second phase is an inflammatory response with 
inflammatory pain that can be inhibited by anti-inflammatory drugs (Hunskaar and 
Hole, 1987; Rosland et al., 1990). The experimental results show that WFM produced 
better inhibitory effect during the second phase of the formaldehyde test. This 
experimental evidence suggests that the analgesic effect produced by WFM was 
involved in its peripheral action. 
 
The anti-inflammatory activity and anti-nociceptive activity of WFM, justifies the 
traditional uses of Woodfordia fruticosa for the treatment of pain and inflammatory 
related ailments. Previous studies have revealed that the NSAIDs were capable of 
inhibiting this test (Vinegar et al., 1969; Rosa et al., 1971); Therefore mechanism of 
anti-inflammation of WFM may be similar to the mechanism exerted by the NSAIDs. 
Since prostaglandins are known to take part in the inflammatory and nociceptive 
processes (Marieb, 2000; Katzung, 2005; Zakaria et al., 2010), the anti-inflammatory 
and anti-nociceptive activities of the WFM could be due to the modulation of the 
COX or prostaglandins actions. 
 
5.6. HEPATOPROTECTIVE STUDIES 
 
Hepatic fibrosis is usually initiated by hepatocyte damage. Biologic factors such as 
hepatitis virus, bile duct obstruction, cholesterol overload, etc. or chemical factors 
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such as CCl4 administration, alcohol intake are known to contribute to liver fibrosis. 
The incidence of chronic fibrosis is high, but there are no satisfactory agents with 
ascertained effectiveness and with fewer side effects on liver. So, finding effective 
ways to inhibit liver fibrosis and prevent the development of cirrhosis are of great 
significance (Wang et al., 2009). The ability of a hepatoprotective drug to reduce the 
injurious effects or to preserve the normal hepatic physiological mechanisms which 
have been disturbed by a hepatotoxic agent is the index of its protective effect (Yadav 
and Dixit, 2003). 
 
5.6.1. Diclofenac induced hepatotoxicity 
 
Hepatotoxicity is currently a class warning for NSAIDs and infrequent hepatic injury 
has been observed for nearly all NSAIDs currently on the market. There are 3 drugs 
that have more commonly been associated with liver disease: diclofenac, sulindac, 
and aspirin (Purcell et al., 1991; Bjorkman, 1998).  
 
Diclofenac, undergoes similar hepatic metabolism both in rat and in humans. Major 
metabolic pathways are the hydroxylation in position 4 and 5 and to a much lesser 
extent the formation of 3′-hydroxy- (humans) and 4′,5-dihydroxydiclofenac (rat and 
humans). Diclofenac and its metabolites undergo extensive conjugation with 
glucuronic acid and sulfate (Riess et al., 1978; Stierlin et al., 1979). The major 
constitutive P450 form involved in diclofenac hydroxylation in man is cytochrome 
P4502C9, the human orthologous form of rat 2C11. Diclofenac forms selective protein 
adducts in livers of treated mice (Pumford et al., 1993; Kretz-Rommel and Boelsterli, 
1994). This is caused by a transacylation reaction of its glucuronide conjugate. This 
mechanism has been proposed to explain both the allergic and intrinsic hepatotoxicity 
of the drug. 
 
Since unwanted side effects of diclofenac in man and other mammals was reported to 
occur particularly in the liver (Ramesh et al., 2002; Triebskorn et al., 2004) it was 
thought of interest to evaluate WFM for its hepatoprotetive property in diclofenac 
induced hepatic damage in rats. In the present study, the administration of diclofenac 
to rats decreased the total protein and albumin level and increased the BUN level 
significantly. The pretreatment of WFM at two different dose levels restored the level 
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of protein, albumin and BUN towards normalization. Hepatocellular injury from 
metabolic inhibition, oxygen radical toxicity, immunologically mediated damage, or 
some other mechanism results in predominant elevations of aminotransferase and 
alkaline phosphatase (Manoukian and Carson, 1996). The ALT, AST and ALP levels 
were significantly elevated when rats were administered with diclofenac indicating 
hepatocellular damage. The increased levels of these enzymes were significantly 
decreased by pretreatment with WFM in dose dependent manner. This is the 
indication of stabilization of plasma membrane as well as repair of hepatic tissue 
damages caused by diclofenac. The hepatoprotetive property of Polyalthia longifolia 
(Tanna et al., 2009), Curcuma longa, Glycyrrhiza glabra and Moringa oleifera 
(Hamza, 2007) in diclofenac induced hepatic damage in rats was reported. 
 
The significant increased liver weight of diclofenac exposed animals seems to be due 
to toxic potential of diclofenac. The significant increase in weight of liver was, 
however, found to be associated with concomitant increase of serum AST and ALT 
enzyme levels. It is important to note that the elevated activity of serum AST and 
ALT recorded in this study may be due to loss of enzymes of liver tissue. 
Pretreatment of WFM decreased the liver weight significantly indicating recovery of 
liver tissue from damage. Significant decrease in total protein of the liver contents is a 
reflection of hepatic toxicity (Gatsing et al., 2005; Adebayo et al., 2010). The 
significant reductions of protein in diclofenac intoxicated group indicate depletion in 
the protein reserve and thus suggest hepatic toxicity. WFM administration increased 
the total protein content leading to normalization. GSH is an extremely efficient 
intracellular buffer for oxidative stress and GSH acts as a non-enzymatic antioxidant 
that reduces H2O2, hydroperoxides (ROOH) and xenobiotic toxicity (Kadiiska et al., 
2000). The level of GSH depleted when animals were injected with diclofenac. The 
depleted level of GSH raised with the pretreatment of WFM. The catalase and GPx 
are enzymatic antioxidants widely distributed in all animal tissues that decomposes 
hydrogen peroxide and protects the tissue from highly reactive hydroxyl radicals. 
Therefore, the reduction in the activity of these two enzymes may result in a number 
of deleterious effects due to the accumulation of superoxide radicals and hydrogen 
peroxide. In the present study, WFM significantly restored the hepatic catalase and 
GPx activity, which indicated that WFM could scavenge reactive free radicals that 
eventually lessen the oxidative damage to the tissues and subsequently improved the 
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activities of these antioxidant enzymes. The preventive effect of WFM was also 
confirmed by the results of histopathological study, as evidenced by a dose related 
decrease in the incidence and severity of histopathological hepatic lesions. 
 
Woodfordia fruticosa extract pretreatment prevented the reduction in the antioxidant 
enzyme activities and consequent oxidative damage to the liver. In fact, the multiple 
dose pretreatment of W. fruticosa extract alone significantly boosted the antioxidant 
enzyme activities. Molina et al. (2003), Srivastava and Shivanandappa (2010) also 
reported  good hepatoprotective activity in their studies; and they suggested that the 
hepatoprotective activity of plant extract could be a result of boosting the antioxidant 
capacity of the liver. 
 
5.6.2. Carbon tetrachloride induced hepatotoxicity 
  
CCl4 is a well-known hepatotoxic agent and the preventive action of liver damage by 
CCl4 has been widely used as an indicator of liver protective activity of drugs in 
general (Clawson, 1989). Hepatotoxicity induced by CCl4 is the most commonly used 
model system for the screening of hepatoprotective activity of plant extracts/drugs 
(Srivastava and Shivanandappa, 2010). The changes associated with CCl4-induced 
liver damage are similar to that of acute viral hepatitis (Rubinstein, 1962). Toxicity 
begins with the changes in endoplasmic reticulum, which results in the loss of 
metabolic enzymes located in the intracellular structure (Recknagel, 1983). 
 
CCl4 is a xenobiotic that produces hepatotoxicity in various experimental animals. 
CCl4 is metabolized by cytochrome P450 to form a reactive trichloromethyl radical 
(CCl3) and a trichloromethyl peroxyl radical (CCl3O2). Both radicals are capable of 
binding to DNA, lipids, proteins or carbohydrates, leading to lipid peroxidation, cell 
necrosis, excessive deposition of collagen in liver, and liver fibrosis (Sheweita et al., 
2001; Weber et al., 2003). The effect of CCl4 is generally observed after 24 h of its 
administration. Hence the withdrawal of the blood for biochemical parameters should 
be carried out only after 24 h of CCl4 intoxication (Sureshkumar and Mishra, 2006). 
 
The total protein and albumin levels decreased due to the hepatotoxin intoxication. 
The reduction is attributed to the damage produced and localized in the endoplasmic 
Chapter 5                                                                                                        Discussion 
 
120 
 
reticulum which results in the loss of P450 leading to its functional failure with a 
decrease in protein synthesis and accumulation of triglycerides. In the present study, 
CCl4 intoxication reduced the serum total protein and albumin levels. The pre-
treatment of WFM restored the total protein and albumin levels. The rise in protein 
and albumin level suggests the stabilization of endoplasmic reticulum leading to 
protein synthesis (Sureshkumar and Mishra, 2006). 
 
The liver marker enzymes (AST, ALT and ALP) are cytoplasmic in nature; upon liver 
injury these enzymes enter into the circulatory system due to altered permeability of 
membrane (Zimmerman and Seeff, 1970). In this study, significant increase in AST 
and ALT levels in the serum was observed after administration of CCl4. ALP level 
also increased after CCl4 administration. The increased levels of these enzymes 
significantly decreased by pretreatment with WFM extract. Reduction in the levels of 
AST, ALT and ALP towards the normal value is an indication of stabilization of 
plasma membrane as well as repair of hepatic tissue damages caused by CCl4 
(Ranawat et al., 2010). 
 
Many studies have demonstrated that the hepatoprotective effect of plant extracts may 
be related to its antioxidant capacity to scavenge reactive oxygen species (Naik and 
Panda, 2007; Tsai et al., 2009). CCl4 intoxication reduced the total protein level in 
liver homogenate, which restored significantly with the pretreatment of WFM. Liver 
cells possess antioxidant defense system consisting of antioxidants such as GSH and 
antioxidant enzymes such as catalase and GPx to protect own cells against oxidative 
stress, which causes destruction of cell components and cell death. GSH is widely 
distributed among living cells and is involved in many biological functions, acting as 
an essential intracellular reducing agent for maintenance of intracellular redox status. 
It is also the most important biomolecule protecting against chemically induced 
cytotoxicity, by participating in the elimination of reactive intermediates by 
conjugation and hydroperoxide reduction, or by direct quenching of free radicals 
(Jewell et al., 1986; Wang et al., 2000). CCl4 intoxication slightly reduced the level of 
GSH, which was significantly restored in WFM treated (higher dose) rats. 
Trichloromethyl peroxy radical, the metabolic product of CCl4 binds covalently to the 
macromolecules and causes peroxidative degradation of cellular membrane leading to 
the necrosis of hepatocytes (Brattin et al., 1985; Ranawat et al., 2010). The hepatic 
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antioxidant enzymatic activity of catalase and GPx  significantly decreased in CCl4-
intoxicated rats as compared with control rats. The decreased enzymatic activity 
would result in an increased steady-state level of oxidants, contributing to cell injury. 
The catalase level was elevated by administration of WFM to CCl4 intoxicated rats 
suggesting that it has the ability to restore the enzyme activity towards normalization 
in CCl4 damaged liver. However, administration of WFM to CCl4 intoxicated rats had 
no effect in hepatic GPx activity and relative liver weight as compared to the CCl4 
treated toxin control group. This result suggests that WFM markedly inhibited CCl4 
induced liver damage by elevated hepatic antioxidant enzymatic system such as 
catalase and GSH. 
 
The rise in marker enzymes level in CCl4 treated animals has been attributed to 
damaged structural integrity of the liver. Administration of the WFM preserved the 
structural integrity of the hepatocellular membrane as evidenced from attenuation of 
the marker enzymes level when compared to CCl4 treated animals. It was further 
confirmed by the histopathological assessment of the liver tissue. 
 
5.6.3. Acetaminophen induced hepatotoxicity 
 
Acetaminophen (APAP), a frequently used analgesic and antipyretic drug, is known 
to be hepatotoxic in higher doses, which is primarily metabolized by sulfation and 
glucuronidation to unreactive metabolites, and then activated by the cytochrome P450 
system to produce liver injury. It is established that acetaminophen is bioactivated to a 
toxic electrophile, N-acetyl p- benzoquinone imine (NAPQI), which binds covalently 
to tissue macromolecules, and probably also oxidizes lipids, or the critical sulphydryl 
groups (protein thiols) and alters the homeostasis of calcium (Lin et al., 1997). The 
massive production of reactive species may lead to depletion of protective 
physiological moieties (glutathione and α-tocopherol, etc.), ensuing wide-spread 
propagation of the alkylation as well as peroxidation, causing damage to the 
macromolecules in vital biomembranes (Aldridge, 1981; Gilani et al., 2005). The 
experimental evidence suggests that during metabolism of this type of drug, different 
reactive metabolites are produced that covalently modify proteins (Bernareggi, 1998), 
impose oxidative stress (Berson et al., 1991; Ritter and Malejka-Giganti, 1998) and 
causes mitochondrial injury (Mingatto et al., 2000). 
Chapter 5                                                                                                        Discussion 
 
122 
 
In the present study, a reduction in total serum protein including albumin levels 
observed in the APAP treated rats may be associated with the decrease in the number 
of hepatocytes which in turn may result into decreased hepatic capacity to synthesize 
protein. But the treatment with WFM did not have protective effects in regards to total 
protein and albumin levels. Blood urea nitrogen (BUN) is also a marker of liver and 
renal functions, which is used to diagnose acute and chronic diseases related to liver 
and kidney. APAP administration to the rats increased the BUN level. The increase in 
BUN after APAP administration was prevented by WFM. 
 
The hepatic cells consist of higher concentrations of AST, ALT and ALP in 
cytoplasm and AST in particular exists in mitochondria (Wells, 1988). Due to the 
damage caused to hepatic cells, the leakage of plasma cause an increased level of 
hepatospecific enzymes in serum (Zimmerman and Seef, 1970). The elevated serum 
enzyme levels are indicative of cellular leakage and functional integrity of cell 
membrane in liver (Drotman and Lawhorn, 1978; Sathesh Kumar et al., 2009). The 
hepatoprotective index of a drug can be evaluated by its capability to reduce the 
injurious effects or to preserve the normal hepatic physiological mechanisms, which 
have been induced by a hepatotoxin. The measurement of serum AST, ALT and ALP 
levels serve as a means for the indirect assessment of condition of liver. The level of 
these enzymes significantly increased in serum, when animals were administered with 
APAP. The pre-treatment of the animals with WFM with respect to intoxication with 
APAP controlled the AST, ALT and ALP levels when compared with the toxic group. 
 
The relative liver weight significantly increased in APAP intoxicated animals 
indicating toxic effect of APAP. Pretreatment of WFM decreased the liver weight 
significantly indicating recovery of liver tissue from damage. GSH, a major known 
protein thiol in living organisms plays a central role in coordinating the body’s 
antioxidant defense process (Boyd et al., 1981). Excessive peroxidation causes 
increased GSH consumption. GSH is a scavenger of toxic metabolites, including 
NAPQI, which is a metabolite of APAP (Hwang et al., 2008; Yuan et al., 2010). GSH, 
plays a major protective role as a scavenger of free radicals that combine with non-
protein thiols at the GSH reactive center to abolish free radical toxicity (Vane et al., 
1994; Swierkosz et al., 1995). Anti-oxidation by GSH protects the body from many 
diseases and conditions such as damage by H2O2, ethanol and numerous other toxins 
Chapter 5                                                                                                        Discussion 
 
123 
 
(Choi et al., 2009). Because GSH plays an important role in the antioxidant defense 
system (Hsu et al., 2008), it becomes the key determinant in the APAP-induced 
hepatotoxicity. In the present study, the contents of liver protein and GSH in the 
APAP group decreased significantly after APAP administration, when compared with 
the control group. Pretreatment with WFM restored the total protein and GSH levels 
towards normalization. Administration of APAP as well as WFM did not have any 
effects in catalase and GPx activity. 
 
Histopathological observations after APAP administration showed severe damage in 
hepatocytes, which basically supported the alterations observed in biochemical 
analysis. Hepatocellular  necrosis, infiltration of periportal mononuclear cell of liver 
cells were characteristic alterations occurred due to acetaminophen intoxication. 
Treatment of WFM decreased focal necrosis, vacuolation and reduced the 
lymphocytic infiltration in liver and presented regenerative effects. This can be 
considered as an expression of the functional improvement of hepatocytes, which 
might be due to accelerated regeneration of parenchymal cells or little damage of 
cells. 
 
5.7. ACUTE TOXICITY STUDY 
 
Toxicology is a science to study adverse-effects of chemicals or physical agents on 
biological system and preclinical toxicology is a science to evaluate safety of a drug 
(mostly) in animals to decide if the drug is safe for human use or not. Plants, 
vegetables and herbs used as food and in the folk treatment have been accepted 
currently as one of the main source of drug discovery and development, but only a 
few of them have been scientifically investigated, especially regarding their toxic 
aspects (Pereira et al., 2010). 
 
Acute toxicity studies in animals are usually necessary for any pharmaceutical 
intended for human use. The information obtained from these studies is useful in 
choosing doses for repeat-dose studies, providing preliminary identification of target 
organs of toxicity and occasionally, revealing delayed toxicity. Acute toxicity studies 
may also aid in the selection of starting doses for Phase 1 human studies, and provide 
Chapter 5                                                                                                        Discussion 
 
124 
 
information relevant to acute overdosing in humans. It could also be used to estimate 
the therapeutic index (LD50/ED50) of drugs (Rang et al., 2001; Maikai et al., 2008). 
 
In the present study, acute toxicity test was done to establish if any adverse effects of 
the administration of the methanol extract of Woodfordia fruticosa on some 
observable and hematological parameters. The results indicate no abnormal symptoms 
and no death of the rats. Changes in body weight have been used as an indicator of 
adverse effects of drugs and chemicals (Hilaly et al., 2004; Mukinda and Eagles, 
2010). In the present study, no significant changes were observed in the general 
behavior, body weight, feed and water intake of rats in the treated groups as compared 
to the control group, suggesting that at single oral doses administered, methanol 
extract of Woodfordia fruticosa flowers had no effect on the normal growth of rats. 
 
Organ weight changes have long been accepted as a sensitive indicator of chemically 
induced changes to organs and in toxicological experiments, comparison of organ 
weights between control and treated groups have conventionally been used to predict 
toxic effect of a test material (Pfeiffer, 1968; Nisha et al., 2009). In acute toxicity 
study in male rats at lower dose kidney weight increased while in female rats at higher 
dose kidney weight decreased significantly. The weight of lung in acute toxicity study 
increased in both male and female rats; but this was not associated with 
morphological changes and no evidence of toxicity was found. Increased testis weight 
and decreased uterus weight in treatment groups cannot be considered as a 
manifestation of toxicity due to the variability attributable to its small size and 
physiological factors unrelated to treatment like estrus cycle and relative infrequency 
of these organs as target organs of toxicity. The absence of significant changes in 
other organs in the present study points to the fact that ingestion of Woodfordia 
fruticosa methanol extract did not induce any anomalous growth or inflammation to 
these organs which would otherwise have resulted in higher relative organ weights in 
the treatment groups. 
 
The hematopoietic system is one of the most sensitive targets for toxic compounds 
and an important index of physiological and pathological status in man and animal 
(Mukinda and Syce, 2007). The various hematological parameters investigated in this 
study are useful indices of evaluating the toxicity of plant extract in animals (Toyin et 
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al., 2008). Assessment of hematological parameters are not only used to determine the 
extent of deleterious effect of extracts on the blood of animals, but it can also be used 
to explain blood relating functions of a plant extract or its products (Toyin et al., 
2007). Analysis of blood parameters is relevant in risk evaluation as changes in the 
haematological system have higher predictive value for human toxicity when the data 
are translated from animal studies (Olson et al., 2000; Adebayo et al., 2010). 
 
The hematological studies revealed increase in RBC count and PCV (P < 0.05) at 
higher dose in male rats and Hb (P < 0.05) in both male in female rats during acute 
toxicity study. It also revealed a fall (P < 0.05) in WBC level in lower dose during 
acute toxicity study in male rats. The general decrease in the values of these 
hematological parameters can be due to direct destruction of mature circulating cells 
or loss of cells from the circulation by hemorrhage, or leakage through capillary walls 
and reduced cell production (Nunia et al., 2007). However, this was not considered to 
be adverse or related to exposure to the WFM because similar differences were not 
observed in both sexes.  
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In pharmacognostic study, Woodfordia fruticosa flowers showed the presence of 
unicellular trichomes, rosettes and cluster of calcium oxalate crystals; and 
anomocytic, actinocytic and anisocytic stomata. In physicochemical analysis, crude 
powder and methanol extract of Woodfordia fruticosa flowers were free from heavy 
metals. The highest extractive value was obtained from water and methanol. The 
solubility of the extract was maximum in polar solvents like DMF, methanol and 
DMSO; the extract was acidic in nature. In qualitative phytochemical analysis tannins 
and alkaloids were present in higher amount, while cardiac glycosides and steroids 
were totally absent. In quantitative analysis of phytoconstituents, total phenol content 
was higher than flavonoid content. Hence, the determination of pharmacognostical 
and phyto-physicochemical profile of Woodfordia fruticosa Kurz. flowers may be 
useful to supplement information in respect to its identification, authentication and 
standardization of herbal drugs. In other words, the pharmacognostic features 
examined in the present study may serve as tool for identification of the plant for 
validation of the raw material and for standardization of its formulations at herbal 
industrial level in the coming days.  
 
In anti-inflammatory studies the methanol extract of Woodfordia fruticosa flowers 
inhibited the carrageenan induced paw edema at both early and late phase. The action 
of early phase may be due to the inhibition of histamine and serotonin. The action of 
later phase may be due to the inhibition of prostaglandins, proteases and lysosome. 
Dose dependent inhibition of inflammation was observed in histamine and dextran 
induced paw edema. This may be due to antihistaminic activity of WFM. The extract 
also significantly reduced the paw volume in serotonin induced edema, and the 
activity of WFM-400 was almost similar to that of standard diclofenac treated group. 
The subcutaneous injection of formaldehyde into paw of rats produces localized 
inflammation. WFM and standard diclofenac administered continuously for 7 days 
successfully inhibited edema induced by formaldehyde. From the results of acute 
inflammatory models, it can be concluded that the WFM showed antiedematogenic 
effects on carrageenan, histamine, dextran, serotonin and formaldehyde induced 
edema, which may be related to inhibition of inflammatory mediators formation. In 
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chronic cotton pellet induced granuloma model, WFM reduced the granuloma 
formation in dose dependent manner.  In analgesic study, WFM effectively reduced 
the frequency of paw licking in formaldehyde induced paw licking test at both early 
(0-5 min) and late (15-30 min) phases. But better analgesic effect of WFM was 
observed at later phase.  
 
In hepatoprotective studies, the induced diclofenac toxicity elevated levels of serum 
marker enzymes ALT, AST, ALP and the level of BUN along with the decrease in 
total protein and albumin levels. It also increased the relative liver weight and 
decreased the level of liver total protein and GSH. The activity of catalase and GPx  
significantly decreased in diclofenac intoxicated animals. The pre-treatment of 
methanol extract of Woodfordia fruticosa at dose levels of 400 and 600 mg/kg had 
restored the ALT, AST, ALP and BUN levels towards normalization and the effects 
were comparable with standard drug (Silymarin 100 mg/kg). The total protein, 
albumin, GSH levels and catalase, GPx activity increased significantly in the animals 
received pre-treatment of the WFM. The histopathological study showed the 
reduction of hepatic damage in WFM treated animals.  
 
In CCl4 and acetaminophen induced hepatotoxicity models, the serum biochemical 
parameters and liver antioxidants were altered when animals were intoxicated with 
CCl4 and acetaminophen. The treatment with WFM restored the level of serum 
biochemical parameters as well as liver antioxidants in both the animal models. The 
administration of acetaminophen and WFM did not have any effect in serum total 
protein level, catalase and GPx activity. The treatment with WFM prevented the 
structural damage of hepatocellular membrane.  
 
In acute toxicity study, the methanol extract of Woodfordia fruticosa flowers had no 
mortality and observable acute toxic effect on the experimental animals and therefore 
can be considered as non-toxic. However, acute toxicity data sometimes is of limited 
clinical application since accumulative toxic effect may not be seen in short period 
with a single dose application. Hence, sub acute and chronic evaluation of the extract 
should be carried out in evaluating the safety profile of Woodfordia fruticosa. 
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These studies have shown that the methanol extract of flowers of Woodfordia 
fruticosa contain some active ingredients with the potential of being good anti-
inflammatory, analgesic and hepatoprotective agents. NSAIDs like diclofenac, used as 
standard drug in anti-inflammatory study, is having good anti-inflammatory and 
analgesic property, but is also having side effects on liver. Therefore, Woodfordia 
fruticosa may become the alternative to the NSAIDs. For that, further study for 
detailed investigation of the mechanism of action of WFM is needed. 
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Inflammation is a major threat to human health and plays an important role in the 
development of various infectious and non-infectious diseases such as Alzheimer’s, 
heart disease, asthma, rheumatoid arthritis, etc. Depending on the intensity of this 
process, mediators generated in the inflammatory site can reach the circulation and 
cause fever. Clinical treatment of inﬂammatory diseases is dependent on drugs, which 
belong either to the non-steroidal or to the steroidal chemical groups. The use of non-
steroidal anti-inflammatory drugs (NSAIDs) in the treatment of diseases associated 
with inflammatory reactions has potent activity, but long term uses of these drugs 
have various and severe adverse effects on liver, gastrointestinal tract, etc. Hence, 
new anti-inflammatory and analgesic drugs lacking such effects are being searched 
for as alternatives to NSAIDs. 
 
Owing to safety concerns associated with the use of synthetic anti-inflammatory and 
analgesic agents, generally the people prefer to take natural anti- inflammatory and 
analgesic treatments from edible materials such as fruits, spices, herbs and vegetables. 
Therefore, the development and utilization of more effective anti-inflammatory and 
analgesic agents with fewer side effects from natural origin are desired. 
 
Liver diseases are a serious health problem. In the absence of reliable liver protective 
drugs in allopathic medical practices, herbs play an important role in the management 
of various liver disorders. Numerous medicinal plants and their formulations are used 
for liver disorders in ethnomedical practices and in traditional system of medicine in 
India. Medicinal plants are believed to be an important source of new chemical 
substances with potential therapeutic effect. The research into plants with alleged 
folkloric use as pain relievers, anti-inflammatory and hepatoprotective agents, should 
therefore be viewed as a fruitful and logical research strategy in search for new drugs. 
 
In the present study, the prime objective was to select a medicinal plant which can be 
used as anti-inflammatory and hepatoprotective agent with fewer/without side effects. 
On the basis of literature survey, medicinal uses and availability of the plant, 
Woodfordia fruticosa Kurz. flowers were selected for evaluation of anti-inflammatory 
and hepatoprotective property. 
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Woodfordia fruticosa Kurz. belongs to the family Lythraceae, is a much branched 
beautiful shrub. It is the plant of tropical and subtropical regions with a long history of 
medicinal use. English names of the plant are Fire Flame Bush and Shiranjitea. The 
plant is abundantly present throughout India. Locally (In Gujarat) it is known as 
Dhavdi. All parts of this plant possess valuable medicinal properties viz. anti-
inflammatory, anti-tumor, hepatoprotective and free radicals scavenging activity, but 
flowers are in maximum demand. The flowers are being used in the preparation of 
Ayurvedic fermented drugs called ‘Aristha’s and ‘Asava’s, and very popular in the 
Indian subcontinent as also in other South Asian countries. 
 
For the identification of plant, macroscopic and microscopic study of Woodfordia 
fruticosa flowers was done by evaluating different characteristics from free hand 
sections of fresh flower and dried powder. The T.S of the pedicel showed single 
layered epidermis, with a fairly thick cuticle. The unicellular trichomes were present 
in this layer. The rosette and cluster crystals of calcium oxalate were found in pedicel 
and calyx. Anomocytic, actinocytic and anisocytic stromata were also found in calyx. 
The anther lobes were tetrasporangiate; the T.S of anther lobe showed large colourless 
cells followed by a fibrous layer. The dried powder of Woodfordia fruticosa flowers 
was light in colour, slightly bitter and astringent in taste. Microscopic observation of 
dried powder showed the presence of straight wall cells of epidermis, cluster crystals 
of calcium oxalate and unicellular trichomes. The pollen grains were present either 
singly or in a group.  
 
Woodfordia fruticosa flowers were collected in March, 2008 from Girnar region, 
Junagadh, dried, powdered and stored in air tight bottles.  The dried powder was 
defatted with petroleum ether and then extracted in methanol in soxhlet apparatus.  In 
all further studies methanol extract was used (WFM).  
 
The result of physicochemical analysis showed 8% loss on drying. It contained 5.45% 
total ash, 0.57% acid insoluble ash and 2.47% water soluble ash. The maximum 
percentage of extractive value was obtained in water (41.59%) followed by methanol 
(32.77%). The extract was acidic in nature and maximum solubility was in DMF, 
methanol and DMSO. Mercury and arsenic were present in very minor amount in 
crude powder and extract but they were within the permissible limits reported by The 
Ayurvedic Pharmacopoeia of India; lead, chromium and cadmium were not detected. 
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The preliminary qualitative phytochemical analysis of crude powder and WFM 
revealed the presence of alkaloids, flavonoids, phlobotannins, saponins, tannins and 
triterpenes. Tannins and alkaloids were present in more amount as compared to other 
phytoconstituents. Quantitatively estimated total phenol content was higher than that 
of flavonoid content in the methanol extract.  
 
Anti-inflammatory studies of WFM was done using carrageenan, histamine, dextran, 
serotonin and formaldehyde induced rat paw edema acute models; cotton pellet 
induced granuloma chronic model and formaldehyde induced paw licking test as 
analgesic model. Among these models, carrageenan induced rat paw edema is most 
widely used for evaluation of anti-inflammatory properties of medicinal plants. WFM 
inhibited the carrageenan induced paw edema at both early and late phase. In 
histamine and dextran induced paw edema, dose dependent inhibition of paw volume 
was observed at both early and late phase. WFM also inhibited the increase in paw 
volume in serotonin and formaldehyde induced edema. In chronic inflammatory 
model, WFM dose dependently reduced the granuloma tissue formation. WFM 
effectively reduced the frequency of paw licking at both early and late phase in 
formaldehyde induced paw licking test. Thus, WFM showed promising activity in all 
the studied anti-inflammatory models, but it was more effective in acute models than 
in chronic model.  
 
Hepatoprotective study of WFM was done by diclofenac, carbon tetrachloride and 
acetaminophen (APAP) induced hepatotoxicity in rats. In all the three models, 
different serum biochemical parameters (viz. total protein, albumin, blood urea 
nitrogen, alkaline phosphatase, aspartate aminotransferase and alanine 
aminotransferase),  liver total protein, liver antioxidant  glutathione reduced, and 
antioxidant enzymes viz. catalase and glutathione peroxidase and liver 
histopathological study were carried out. 
 
Diclofenac, is one of the most widely used NSAID for the treatment of inflammatory 
diseases and analgesia. However, long term use of diclofenac causes hepatotoxicity. 
In the present study, administration of diclofenac to the animals caused significant 
changes in the serum biochemical parameters and liver antioxidants as compared to 
the normal control group. Treatment with WFM restored the level of serum 
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biochemical parameters and liver antioxidants towards normalization; and the effect 
of WFM on these parameters was comparable to that of standard silymarin.  
 
CCl4 induced hepatotoxicity is frequently used model for evaluating the 
hepatoprotective properties of medicinal plants. APAP has been widely used as a 
medicine for pain and fever relief. Since APAP can be purchased easily from any 
pharmaceutical outlet and even from supermarkets, without prescriptions from 
clinicians, it is commonly considered as a ‘‘safe drug’’ when taken within the 
suggested therapeutic dose. However, APAP can be hepatotoxic when an overdose is 
administered. The administration of CCl4 and APAP to the animals caused the 
alteration in serum biochemical parameters and liver antioxidants as compared to the 
normal control group. Treatment with WFM restored the serum biochemical 
parameters and liver antioxidants towards normalization. The hepatoprotective effect 
of WFM was also confirmed by histopathological study. The severe hepatocytes 
necrosis, periportal mononuclear cell infilteration, cytoplasmic vacuolation were seen 
in diclofenac, CCl4 and APAP intoxicated animals. Administration of WFM preserved 
the structural integrity of the hepatocellular membrane. The results of 
histopathological study supported the result obtained from serum biochemical and 
liver antioxidants parameters. 
 
Any drug whether promising or more promising without toxicity evaluation, loses its 
importance because non toxic nature of the drug is more important than efficacy.  
Therefore, acute toxicity study was done to check toxicity profile of the WFM. No 
adverse reaction or mortality was observed in rats up to highest dose (3600 mg/kg, 
b.w.) studied. No significant change was observed in feed and water consumption and 
body weight of animals treated with WFM as compared to normal control group. No 
significant changes were recorded in organ weight of the animals. Hematological 
parameters were also not affected. 
 
Overall it can be concluded that methanol extract of Woodfordia fruticosa flowers had 
good potential as anti-inflammatory, analgesic and hepatoprotective agent and so this 
plant can be used to discover bioactive natural products that may serve as leads for the 
development of new pharmaceuticals. 
 
